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1. INTRODUCTION 
Chronic kidney disease (CKD) is a disease characterized by a progressive loss 
of kidney function which develops within years or decades. Kidney diseases are 
common, harmful, and often treatable. The most common causes of kidney 
disease are diabetes, hypertension and renal vascular diseases. CKD is a world-
wide problem in the modern world, mostly caused by ageing and an unhealthy 
lifestyle. The first consequence of undetected CKD is the risk of developing 
progressive loss of the kidney function that can lead to end-stage kidney disease 
(ESKD) which needs renal replacement therapy (RRT) – either a regular 
dialysis treatment or a kidney transplant to survive. The second consequence of 
CKD is that it increases the risk of premature death from associated cardio-
vascular disease (myocardial infarction or strokes). The individuals who appear 
to be healthy but are later found to have CKD have an increased risk of dying 
prematurely from cardiovascular disease regardless of whether or not they ever 
develop ESKD (Cardiovascular Disease. World Kidney Day 2015). Therefore, 
the optimal treatment of kidney disease and the management of risk factors 
(hypertension, smoking, unhealthy diet, overweight) are essential to arrest the 
progression of kidney disease as well as cardiovascular disease. However, when 
ESKD develops, kidney transplantation is the most efficient method of treat-
ment in the final stadium of CKD beside dialysis treatment. In conjunction with 
the development of medical science and a wider choice of treatment, the role of 
kidney transplantation for the patients of renal replacement therapy (RRT) is 
increasing from year to year. 
 During the period from 1968 to 2015, over 1,000 kidneys were transplanted 
in Estonia. Each year, on average, 30–40 transplantations of cadaveric or live 
donor kidneys were carried out. The retrospective RRT patientsʼ epidemio-
logical data analysis in Estonian hospitals indicated that in the year 2000 there 
were only 161 patients with a transplanted kidney, which constituted 58 percent 
of the patients needing RRT treatment, but by the year 2014 the number of 
patients with a transplanted kidney had increased thrice: 496 kidney transplant 
recipients formed 59 percent of all the RRT population (Epidemiological Data 
Chronic Kidney Disease in Estonia, Annual Report 2014). In Estonia, kidney 
transplantations are performed at the Tartu University Hospital. After the 
transplantation of a kidney, the patient gets hospital treatment for a couple of 
weeks at the Surgical and Internal Medicine Departments. Thereafter, outpatient 
observation will at first take place two times a month, later at intervals of 1– 
2 months. A nephrologist carefully monitors the state of the transplanted kidney 
but many patients need additional counselling.  
 CKD progression prevention, including kidney transplant nephropathy 
progression prevention, comprises drug and non-drug treatment where lifestyle 
modification has special significance. Therefore, it is of essential importance 
that in every patient with a transplanted kidney, beside drug treatment, suffi-
cient attention is paid to nutritional issues. Having a healthy diet, avoiding 
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weight gain and excessive amounts of alcohol, also regular exercising can 
reduce the potentiality of developing chronic transplant nephropathy. For this 
reason, nutrition counselling is usually performed for kidney recipients by a 
dietitian who considers each patientʼs age, gender, the stage of chronic kidney 
damage, body build, eating habits, the twenty-four-hour need for food energy 
and nutrients. 
 Over the years, a need arose for more contemporary, profound and inter-
nationally recognized diets which consider the needs of hospitals and at the 
same time are related to the patientsʼ eating habits. In the year 1990, the reorga-
nization of medical nutrition was started at the Tartu University Hospital. The 
establishment of the system of diets was the first step in the modernization of 
diets, taking different diseases into consideration. While developing the system 
of diets, the experience of the dietitians of the Central Hospital of the University 
of Kuopio and the Meilahti Hospital of the University of Helsinki were taken 
into account. 
 Since 3 February 1997, three software programs have been developed: the 
first computer software program MediC, developed in Tartu, the second com-
puter software program 7+7, and the last electronic-Health computer system (e-
HL) in 2008. They have been implemented in the work of organizing nutrition 
plans for patients. The author of the thesis has been the main consultant in the 
development and implementation of the system of diets for these programs. 
Since 14 November 2002, the unified system of diets applied in the hospitals of 
Tartu was taken into use in all medical institutions of the Republic of Estonia 
(Regulation no 131, Estonian Ministry of Social Affairs, 2002). The created 
system allows patient counselling which considers a patient´s disease, the type 
of body build and the peculiarities of metabolism, the performed clinical 
analyses. The codified system of ordinary foods and diets has been incorporated 
in the data base which takes into consideration the specific features of treatment 
as well as the nutritional needs of the hospital and outpatient departments. 
Beside inpatient counselling, a dietitianʼs task is also to inform and carry out 
further education courses for medical personnel. 
 Considering the ideas given above, the author of the thesis set herself the 
aim to assess, in a complex manner, the biochemical analyses of blood, the 
anthropometrical and nutritional peculiarities of the patients with the trans-
planted kidney within three years after transplantation when the main changes 
of body composition and difficulties to maintain body weight take place. 
According to literature, the main problem after kidney transplantation is the 
gain of body weight; therefore, we planned to test if intensive nutritional 
counselling has an effect on patientsʼ nutritional habits in preventing the gain of 
body weight. 
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2. REVIEW OF LITERATURE 
2.1. Peculiarities of the progression  
of chronic kidney disease 
2.1.1. Chronic kidney disease: epidemiology and classification 
Chronic kidney disease (CKD) is an important determinant of the poor health 
outcome for the major non-communicable diseases that are the leading cause of 
death worldwide. CKD is a worldwide public health problem in connection with 
the ageing of the population, changing of eating habits, growth in body weight, 
the increase in the frequency of diabetes and other reasons.  
 Between 8–10 percent of adult population have a form of kidney damage, 
and every year millions die prematurely of the complications related to CKD 
(Chronic Kidney Disease. World Kidney Day 2015). It has also been noticed 
that there is a tendency of growth in the number of the patients who have CKD 
and need kidney replacement treatment (Locatelli et al. 2001, Locatelli 2002). 
In Europe, the ERA-EDTA Registry study showed that in the data of the renal 
replacement therapy (RRT), the incidence rate between the periods 1997–2001 
and 2002–2006 increased linearly by 2.7% per year. Thereafter, a newer study 
indicated that the rise in the incidence rate of RRT in several age groups has 
now stabilized in many countries, including Estonia (Kramer et al. 2009). The 
prevalence of RRT still has an increasing tendency in all countries because the 
therapy of RRT patients has improved and the mortality rate has decreased 
during the last decade.  
 The main causes of CKD are: chronic glomerulonephritis, hypertension, dia-
betic nephropathy, chronic pyelonephritis, polycystic kidney disease and other 
kidney diseases. Kidney transplantation is the most efficient method of treat-
ment in the final stadium of CKD beside dialysis treatment. In conjunction with 
the development of medical science and a wider choice of treatment, the role of 
kidney transplantation for renal replacement therapy (RRT) patients is 
increasing from year to year. However, because of progressive damage during 
the lifespan of the graft, a patient with a transplanted kidney is also considered 
to be a CKD patient. 
 Chronic kidney damage is defined as the presence of structural abnormalities 
of the kidney that can lead to decreased kidney function (K/DOQI 2002, 
KDIGO 2012). According to CKD clinical practice guidelines and management, 
the definition of CKD is abnormalities or a decreased level of kidney function 
or kidney structure, present for three months or more, with the implications for 
health. CKD is classified based on the cause, the GFR category, and the 
albuminuria category (KDIGO 2012). The classification by CKD categories 
helps to work out strategies to improve outcomes. Marcén and co-authors 
throughout 5–10 years of investigation of four hundred and forty-seven 
cadaveric kidney transplant patients diagnosed CKD, and observed the 
increased risk of the graft loss based on the estimated glomerular filtration rate 
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(e-GFR) in more than 60% of patients. They also found other accompanying 
changes in connection with GFR decrease in the kidney transplant patients, such 
as anaemia, hypertension, rejection and dyslipidaemia (Marcén et al. 2005). 
 
 
2.1.2. Progression of chronic kidney disease  
The progression of CKD, including chronic transplant nephropathy, is charac-
terized by the loss of renal cells and their replacement with extracellular matrix 
and fibroblasts. The progressive loss of renal function is a common pheno-
menon in renal failure irrespective of the underlying cause of kidney disease 
(Hayslett 1979, Remuzzi et al. 1997, Ots et al. 2000). Once a critical amount of 
nephron mass has been lost, the progression of CKD is irreversible and results 
in end-stage renal disease (ESRD) and the need of renal replacement therapy 
(Brenner et al. 1982). Among the risk factors for the development of CKD, 
similar risk factors can be found which influence the development of cardio-
vascular disease (CVD): high blood pressure, diabetes, overweight, hyper-
cholesterolemia, smoking, age over 50 years and others. Later, in the progres-
sion of CKD anaemia, mineral metabolism disorders and bone disease, abnor-
malities as well as premature atherosclerosis develop which then in turn 
predispose the development of ESKD. The progression of CKD often lasts for 
years or decades, and the end stadium kidney disease develops where RRT is 
needed.  
 Organ transplantation has always been considered to be the optimal thera-
peutic intervention in patients with end-stage organ failure but one of the crucial 
drawbacks in successful renal transplantation is chronic allograft rejection 
(Khan et al. 2016). Whereas immunological mechanisms dominate the injury 
that leads to chronic allograft dysfunction and nephropathy, there is circu-
mstantial evidence that non-immunological factors, such as advanced age, 
hyperfiltration, overweight, delayed graft function, heavy proteinuria, smoking, 
anaemia, arterial hypertension, hyperlipidaemia also play an important role in 
the progression (Young et al. 2010).  
 
 
2.1.3. Prevention of the progression of chronic kidney disease  
For the countries in the WHO European region, an action plan has been drawn 
up to reduce risk factors and control premature deaths from non-communicable 
diseases (NCD) ”Global action plan for the prevention and control of non-
communicable diseases 2013–2020ˮ. In the action plan, global risk factors were 
noted, such as tobacco use, salt intake, physical inactivity, high blood pressure 
and the use of alcohol. The report also gives information about NCDs and the 
guidance how to prevent and control them (WHO 2015). All these general 
recommendations fit in the management of CKD progression and nutrition 
modification as well. 
14 
 Today, the prevention of the progression of CKD is one of the most 
important tasks among the management of chronic diseases. The growth in the 
number of CKD patients is an important problem to the health care system 
because of the cost (Liyanage et al. 2015) and the decline of the patientsʼ life 
quality (Aggarwal et al. 2016): this is why a lot of capacious experimental and 
clinical research has been carried out for slowing the progression of kidney 
diseases. Early recognition with screening programs of CKD and co-morbid 
conditions, like hypertension, diabetes, or toxic environments, can potentially 
slow progression to renal failure, improve the quality of life and reduce health-
care cost. Prevention, early detection, and proper treatment of CKD help reduce 
the risk of CKD complications and progression to ESKD. There are effective 
interventions to prevent or delay the progression of CKD, which result in less 
ESKD and cardiovascular comorbidity. These interventions focus on risk factor 
modification and should be initiated as early as possible to be most effective. 
Persistent albuminuria or proteinuria should always be evaluated and it is an 
independent marker for the progression of disease and mortality. Angiotensin 
blockade is a cornerstone of therapy for CKD. The blockade of the renin-
angiotensin-aldosterone system preserves the kidney function not only by 
lowering blood pressure, but also by reducing proteinuria and exerting 
additional anti-proteinuric, anti-fibrotic, and anti-inflammatory effects (Kato et 
al. 1999). Kidneys belong to the cardiovascular system and this is why the same 
essential factors are taken into consideration: hypertension, overweight, hyper-
lipidaemia, hyperglycaemia, but also smoking and an unhealthy diet. Additio-
nally, other modifiable risk factors, such as anaemia, metabolic acidosis, 
dyslipidaemia, and altered bone-mineral homeostasis may also contribute to the 
progression of CKD. It is recommended to prevent or, if possible, treat all risk 
factors to avoid kidney disease progression (Chertow et al. 1997, Jardine 2000, 
Schwenger et al. 2001). The increasing use of treatments to attenuate pro-
gressive CKD, most notably glycaemic control in diabetic CKD and blood 
pressure treatment with ACE inhibitors and ARBs in almost all forms of CKD, 
have coincided with a plateau in the incidence of ESKD in the United States 
over the past few years (Turner at al. 2002). Similar tendencies have also been 
seen in other countries including Estonia (Epidemiology data of CKD in 
Estonia, 2014).  
 
 
2.1.4. Role of nutrition in the progression  
of chronic kidney disease  
Patients with CKD have many challenges including the management of multiple 
medications, major changes in diet, and surgery for dialysis access months 
before any symptoms of kidney failure occur. Chronic kidney disease (CKD) 
requires extensive changes regarding food and lifestyle. Poor adherence to diet, 
medications and treatments has been estimated to vary between 20% and 70%, 
which in turn can contribute to increased mortality and morbidity. Delivering 
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effective nutritional advice to patients with CKD coordinates multiple diet 
components including calories, protein, sodium, potassium, calcium, phospho-
rus, and fluid (Beto et al. 2000). Multidisciplinary CKD programs use patient 
education, nutrition resources, and guideline-driven nephrology care to achieve 
the goals of decreasing cardiovascular morbidity and slowing the progression of 
renal disease (Turner et al. 2002).  
 Although prevention of the progression of CKD should begin early in the 
course of CKD with reno- and vasoprotective medications (Laures et al. 2005), 
the importance of a proper renal individualised diet and physical activity 
recommendations cannot be underestimated. However, giving proper diet 
recommendations for CKD patients is not as easy as believed. Before giving 
any advice, much work should be done with every single individual considering 
the patientʼs diagnosis, body measures, laboratory values and other factors. 
Dietary intake studies have shown difficulties in adhering to the scope and 
complexity of the diet parameters for CKD. No single educational or clinical 
strategy has been shown to be consistently effective across CKD populations. 
The highest adherence has been observed when both diet and education efforts 
are individualized for each patient and adapted over time to changing lifestyle 
and CKD variables (Beto et al. 2000).  
 Thus, in anticipating the progression of CKD, non-drug methods are inte-
grated into the changes of the patientʼs lifestyle as complex treatment re-
commendations. The aim of this type of treatment is to keep the lowered kidney 
function stable to slow down the progression of kidney and heart disease.  
 
 
2.2. Anthropometrical investigations of the patients with 
chronic kidney disease  
The importance of anthropometrical investigations of CKD patients during the 
course of the progression of the disease has been appreciated by many authors 
(Meier-Kriesche et al. 1999, Meier-Kriesche et al. 2002, El Haggan et al. 2002, 
Moreau et al. 2006, Marcén et al. 2007, Chang and McDonald 2008, Zaydfudim 
et al. 2010, Hoogeveen et al. 2011, Zrim et al. 2012, Curran et al. 2013). 
Although basic anthropometry is in use in the clinical routine in nephrological 
practice, no systematic investigations have been carried out among kidney 
disease patients in Estonia. Today, anthropometry is an important measurement 
on the basis of scientific literature and should be used in various categories of 
CKD patients, including kidney transplant patients for the estimation of body 
composition before nutritional counselling (NKF-K/DOQI 2002, KDIGO 
2012).  
Anthropometry is the science of measuring the height, weight and size of 
component parts of the human body, including skinfold thickness, to study and 
compare the relative proportions under normal and abnormal conditions for the 
use in anthropological classification and comparison (Mosbyʼs Medical 
Dictionary 2009). The first measuring of the proportions of the human body in 
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growth and development was carried out in Italy nearly three centuries ago. The 
first book about changing proportions was written by an art professor and it was 
entitled “Anthropometria” (Knussmann 1988). The anthropometric standardi-
zation reference manual for anthropometric measurement procedures and over 
40 anthropometric dimensions was written by Timothy G. Lohman and co-
authors and it was used by researchers or for clinical purposes to measure the 
human body (Lohman et al. 1991). The measurement technique of skinfold 
thickness followed the methodology provided in Harrisonʼs handbook ”Skinfold 
thicknesses and measurement technique” (Harrison et al. 1991).  
 Anthropology became an independent branch of science during the latter 
half of the 19th century, although its roots extend into the distant past (Kongo 
2009). The underlying principles of anthropometric research were derived by  
R. Martin (1864–1924). His textbook became an authoritative handbook of 
anthropometric measurement methods and has served as the foundation for 
measurement methodology until the present time (Martin 1928). 
 Anthropometrical investigations. Body weight (BW) remains an important 
anthropometric variable by screening malnutrition or obesity. The accuracy of 
the study can be improved by paying attention to the details of the techniques of 
the measurement of body composition as well as to proper terminology for all 
anthropologists, anthropometrists or medical researchers (Hertzberg 1968, 
Tesedo et al. 2011).  
 Other important anthropometrical parameters measured are body height, 
mid-arm circumferences, waist and hip circumferences, triceps and subscapular 
skinfold thicknesses as well as calculated mass of body fat. The above-
mentioned anthropometrical investigations constitute the main measurements 
recommended in clinical practice.  
 
 
2.3. Body composition after kidney transplantation 
After kidney transplantation, BW gain in patients generally increases which can 
be influenced by improved appetite and the reversal of the uremic state. 
However, in the long run, BW gain may appear an important risk factor for the 
development of chronic transplant nephropathy. Many authors have indicated 
the differences in the results of anthropometric measurements between male and 
female kidney transplant patients in the post-transplant period. In Coroasʼ study, 
during the pre-transplant period, male patients displayed undernutrition and 
female patients had normal BW, but in the post-transplant period the body 
weight increased both in male and female groups (Coroas et al. 2005). At the 
Vanderbilt Transplant Centre of Nashville, Tennessee, U.S., the retrospective 
cohort study included 464 adult kidney transplant patients and demonstrated 
that pre-transplant overweight and obesity do not affect the survival and 
physical quality of life after kidney transplantation (Zaydfudim et al. 2010). 
Obesity does not seem to constitute a major risk factor for adverse outcomes 
most notable of which are increased incidence of wound infection and 
17 
continued BW gain through the first post-transplant year (Merion et al. 1991). 
The new immunosuppressive regimes (cyclosporine, tacrolimus) may reduce 
post-transplant weight gain. Marcén and co-authors studied one thousand 
consecutive kidney transplant recipients and indicated that post-transplant 
weight gain above 5% or 10% did not influence graft or patient outcomes 
(Marcén et al. 2007). The main post-transplant BW gain after the first year is 
significantly affected by the cumulative steroid dose and increased 3.9 ± 6.2 kg 
and after 5 years 6.2 ± 8.6 kg (van den Ham et al. 2000, van den Ham et al. 
2003). Chang and co-authors studied a group of kidney patients in post-
transplant periods and indicated that stable BW gain (0–4.9%) was associated 
with better outcomes, but the BW gain of the first year more than 20% and the 
second year more than 10% was associated with poorer transplant outcomes 
(Chang et al. 2008). Coroas and co-authors studied the evolution of anthropo-
metrical parameters, and found that BW, body fat mass, triceps and subscapular 
skinfold thickness increased significantly in female transplant patients, but not 
in male transplant patients (Coroas et al. 2005). The rational screening of 
anthropometric variables is easy to use in routine care and helps to assess the 
nutritional status of kidney transplant patients (Briggs 2005, Moreau et al. 2006, 
Sezer et al. 2006). Thus, according to literature, BW gain often develops after 
kidney transplantation and may influence the long-term outcome. The rational 
use of anthropometric measurements helps to monitor patients and should 
belong to routine clinical practice.  
 
 
2.4. Measurements of body composition  
The main components of body composition are body density (Db) and body fat 
mass, and they were calculated with the help of two regression equations by 
Jack H. Wilmore and Albert R. Behnke or by Durnin and Rahaman (Wilmore 
and Behnke 1970, Durnin and Rahaman 1967). The human body build 
characteristics consist of body fat mass and fat-free mass components. These 
body composition features can be measured using direct or indirect methods. 
The most exact measurement results of body mass are based on hydrodensito-
metric measurements taken under water using the direct method. To estimate 
the body fat mass and lean body weight in calculation, a variety of anthropo-
metric parameters are measured – fat folds, width and circumferences. The body 
mass index (BMI), waist to hip ratio (WHR), body surface area (BSA), body 
density (Db), relative mass of fat by Siri, the main skinfold thickness at eleven 
sites and the mass of subcutaneous adipose tissue (kg; %) can be calculated 
using appropriate equations. 
 To calculate body density (g/cm3), two components which characterize the 
bodyʼs fat mass and the bodyʼs mass without fat or muscle mass are used. The 
average value of Db for fat density is 0.9168 g/cm3 and for lean tissue density 
1.0997 g/cm3 or 0.90 and 1.1 g/cm3, consequently the density of fat is lower 
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than the density of muscles and bones. The basis of the two models by Brodie 
has been more often used for calculating body density (Brodie et al. 1998). 
 To calculate body fat mass (BF%) on the basis of the Db, two-component 
models by Siri and by Brozek have mostly been used but there is no significant 
difference between these equations (Durnin and Womersley 1974). The BF 
mass is calculated from body density using the Siri equation (1956):  
  
BF mass (%) = [(4.95 / Db) – 4.50] x 100 
 
Body surface area (BSA) is used in clinical practice to estimate the kidney 
graft function ratio. Body surface area is calculated with the help of the DuBois 
and DuBois formula (1916): 
  
BSA (m2) = 0.007184 x (patientʼs weight, kg) 0.0425 x (patientʼs height, cm) 0.725 
 
Body Mass Index (BMI) is the most popular index in clinical practice and it is 
recommended to use it together with other anthropometric features in the 
complex assessment of the nutrition of patients. The Word Health Organisation 
classification of BMI (kg/m2) is divided into seven classes: severe underweight, 
underweight, normal weight range, overweight, obesity class I, obesity class II 
and obesity class III. However, very high BMI and very low BMI before kidney 
transplantation are important risk factors for kidney graft survival in long-term 
renal transplantation outcome (Meier-Kriesche et al. 1999, Meier-Kriesche et al. 
2002, Weissenbacher et al. 2012). In the case of elevated BMI there is a bigger 
danger for post-operation complications (Zrim et al. 2012). Marks together with 
co-authors found that 23 morbidly obese kidney transplant patients (BMI 35, 
range 37 to 56 kg/m2) had significantly longer hospital stays, higher read-
mission rates, a higher wound infection rate, and poorer quality of life after 
kidney transplantation than 224 not obese recipients (BMI 25 kg/m2) during the 
three-year period (Marks et al. 2004).  
 Waist circumference and hip circumference ratio (WHR) are similarly 
correlated with the measures of risk factors for coronary heart disease. Waist 
and hip circumferences represent visceral fat accumulation that causes obesity-
related disease. A waist circumference bigger than 1,020 mm in men and 880 
mm in women is a risk factor for cardiovascular disease, there is a pre-
disposition for obesity (Pi-Sunyer 2000). Waist circumference and hip circum-
ference as simple anthropometrical measurements are important to use in 
clinical practice. 
 However, much research has been carried out in the world studying the body 
composition of healthy people but there is little information about the research 
where all the abovementioned methods would have been used for investigating 
patients with a transplanted kidney (Meier-Kriesche et al. 1999, Meier-Kriesche 
et al. 2002, El Haggan et al. 2002, Lee et al. 2011, Weissenbacher et al. 2012). 
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2.5. Body composition measurements  
by instrumental methods: bioimpedance and 
densitometric investigations after kidney transplantation 
The bioelectrical impedance analysis (BIA) is a commonly used method for 
estimating body composition, and in particular body fat. The bioimpedance 
method is simple, quick and non-invasive, and it is suitable for the assessment 
of overweight and obesity. It is possible to perform a bioelectrical impedance 
analysis in the patients with BMI 16–34 kg/m2, but the method cannot be 
recommended for routine assessment in the patients with abnormal hydration, 
extreme body mass and height (Kyle et al. 2004, Kyle et al. 2004).  
 The  bioimpedance analyses in CKD patients, in critical care patients and 
obese subjects have shown that the vectors falling outside 75% cases indicate 
abnormal tissue impedance which is combined with the changes in hydration 
and soft tissue mass. Harada with co-authors indicated in their study that in 37 
male and 18 female kidney transplant patients, BMI, body composition by 
bioelectrical impedance, lipid profile, dietary and exercise protocols can prevent 
muscle atrophy and fat gain, and significantly decreased body water and the 
bone mass one year after kidney transplantation (Harada et al. 2012).  
 Von Düring and co-authors studied 167 patients without diabetes after 
kidney transplantation and found an association between BMI and 2-hour oral 
glucose tests. Visceral fat was better related to impaired glucose metabolism 
than BMI after kidney transplantation (von Düring et al. 2015). The association 
with central obesity should encourage additional studies on lifestyle inter-
ventions to prevent post-transplant diabetes (von Düring et al. 2015).  
 Dual-energy x-ray absorptiometry (DXA) is used for the measurement of 
bone mineral density in kidney transplant patients and the observation of 
skeletal status or total body composition. The DXA method is used for 
measuring body composition when the body is divided into fat, lean soft tissue 
and the bone mineral compartment. The DXA method is not for the mea-
surement of body fat. Post-transplant bone disease evolution in kidney trans-
plant patients depends on pre-transplant risk factors: age, gender, malnutrition, 
history of fractures, peritoneal dialysis or haemodialysis, the status of bone 
mineral density, the reduction of kidney graft function, secondary hyper-
parathyroidism, affected calcium and phosphorus metabolism, glucocorticoid 
therapy (Report of WHO Study Group 1994, London et al. 2010, Govindarajan 
et al. 2011). 
 The European Best Practice Guidelines for Renal Transplantation (EBPG) 
have shown that the post-transplant bone disease is a multifactorial disease 
(EBPG Expert Group on Renal Transplantation 2002). Approximately 7–10% 
of kidney transplant patients are predisposed to the progressive bone disease, 
but also to fractures of vertebrae. The fracture frequency is even higher in post-
menopausal kidney transplant patients. Sikgenc and co-authors indicated that 
the bone disease is very common in the region of lumbar vertebra and they 
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found that T-scores were normal in 21.2%, osteopenia in 49.4% and osteo-
porosis in 29.4% of transplant patients in the first years after kidney trans-
plantation (Sikgenc et al. 2010). Grotz and co-authors studied 115 kidney 
transplant patients and found the reduction of bone loss (7 ± 10%; 1 ± 9%) in 
the region of lumbar spine in the first and the second year after kidney 
transplantation (Grotz et al. 1995). Many investigations have proved the im-
portance of densitometry among other body composition measurement methods, 
and the need for a complex preventive and individual therapeutic treatment by 
increase in bone mineral density in kidney transplant patients in the pre- and 
post-transplant period (Mazzaferro et al. 2006). DXA can be used in clinical 
care to validate other bioimpedance and anthropometrical methods (Haapala et 
al. 2002, Leib et al. 2004, and Leib et al. 2006). The guidelines of KDIGO 2012 
suggest that bone mineral density testing is not performed routinely in clinical 
practice in those with eGFR < 45 ml/min/1.73 m2 as information may be mis-
leading or unhelpful (KDIGO 2012), but in scientific work instrumental body 
composition investigations are important for the comparison with anthropo-
metrical data and for further understanding of body composition peculiarities.  
 
 
2.6. Laboratory investigations in  
kidney transplant patients 
Serum creatinine and glomerular filtration rate. Over the years, chronic kid-
ney injury also develops in the transplanted kidney and represents a progressive, 
irreversible decline of the kidney function assessed by GFR. Elevated serum 
creatinine in kidney transplant patients has been shown as a strong and inde-
pendent risk factor for cardiovascular all-cause mortality, but not for a stroke or 
non-fatal myocardial infarct (Fellström et al. 2005). According to the clinical 
guidelines recommendations (KDIGO 2012) clinicians should use a glomerular 
filtration estimating equation (eGFR) in CKD patients to derive GFR from 
serum creatinine rather than relying on the serum creatinine alone. The Modi-
fication of Diet in Renal Disease (MDRD) equation was recommended to 
classify the stages of chronic kidney disease by the National Kidney Foun-
dationʼs Kidney Disease Outcomes Quality Initiative (NKF-K/DOQI 2002), and 
the recommended definition for CKD of a GFR < 60 ml/min per 1.73 m2 
(National Kidney Foundation 2002, Levy et al. 2011). Today, CKD classi-
fication has been updated and should be based on a cause, GFR category (6 
categories) and albuminuria category (KDIGO 2012). According to KDIGO, the 
report of eGFRcreat in adults should be performed using the CKD-EPI creatinine 
equation (KDIGO 2012). 
 C-reactive protein. The inflammatory status and the oxidative stress play a 
role as aggravation or progression factors of CKD (Locatelli et al. 2004, Annuk 
et al. 2005, Gluba et al. 2010, Fernández-Fresnedo et al. 2010). A risk for 
cardiovascular disease and its mortality risk are associated with C-reactive 
protein level (CRP). Winkelmayer and co-authors studied 438 kidney transplant 
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patients and found that a CRP level over 5 mg/L was associated with an 83% 
greater mortality risk when compared with the patients of lower serum CRP 
values (Winkelmayer et al. 2004). After kidney transplantation, most of the 
patientsʼ inflammatory status with high CRP decreased to the normal level and 
the serum albumin level increased rapidly to reach normal values by the end of 
the first month and stabilized thereafter (Moreau et al. 2006). 
 Proteinuria. The development of proteinuria in kidney transplant patients is 
a hallmark of kidney damage. Proteinuria after kidney transplantation is signi-
ficantly associated with cardiovascular disease (CVD) and the decreased kidney 
function (Ibis et al. 2009, Nauta et al. 2011). Guida and co-authors indicated the 
role of dietary intervention on metabolic abnormalities in forty-six recipients 
after kidney transplantation in the first post-transplant year and follow-up of a 
12-month period, and in conclusion indicated that an adequate dietary regimen 
is associated with a reduction in BW and lower plasma levels of cholesterol, 
triglycerides and glucose, and can reduce the risk of long-term complications 
(Guida et al. 2007). KDIGO guidelines suggest lowering protein intake to 
0.8/kg/day in adults with diabetes or without diabetes a GFR < 30 mL/min/ 
1.73m2 (KDIGO 2012). The same guidelines suggest avoiding high protein 
intake (> 1.3/kg/day) in adults with CKD at progression (KDIGO 2012). 
KDIGO guideline recommended measuring serum levels of calcium, phosphate, 
PTH, and alkaline phosphatase activity at least once in adults with GFR  
45 mL/min/1.73 m2 (KDIGO 2012). 
 Anaemia. The pathogenesis of anaemia in kidney transplant patients is 
multifactorial and associated with iron, vitamin B12 and folic acid deficiency, 
and an inflammatory state induced erythropoietin resistance. Intracellular folate 
and vitamin B12 deficiency contribute to these complex metabolic defects and 
may contribute to a worse prognosis in CKD patients by altering gene expres-
sion, the synthesis of membrane proteins, phospholipids and neurotransmitters 
(Herrmann et al. 2007). The retrospective study of 100 anaemic kidney patients 
(the mean haemoglobin value was 10.2 ± 1.4 g/dL for female and 9.9 ± 1.3 g/dL 
for male patients) indicated that vitamin B12 and folic acid deficiency were the 
major causes of nutritional anaemia (Karakus et al. 2004). Sezer and co-authors 
excluded iron, vitamin B12 and folic acid deficiency in the study of 229 renal 
patients and found the prevalence of anaemia which increased in parallel with 
the post-transplant duration: 41.5%, 35.3% and 93.2% at 3, 5, and 10 years 
(Sezer et al. 2006). Cross-sectional study data from ten European centres were 
collected from 5,834 renal post-transplant patients, and there were 42% of 
anaemic patients whereas only 24% of them were getting an erythropoiesis-
stimulating agent treatment (Molnar et al. 2011). 
 Homocysteine. Hyperhomocysteinaemia (HHCY) is a cardiovascular di-
sease risk factor for kidney transplant patients depending on other determinants: 
age, genetic polymorphisms, B-vitamins and albumin levels, renal function 
(Frideman et al. 2002, Teplan et al. 2003). HHCY > 17 µmol/L is very common 
in patients with CKD and is considered an independent risk factor for athero-
thrombotic vessel cardiovascular disease in these patients. Winkelmayer and co-
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authors studied 733 kidney transplant patients during a median follow-up of 6.1 
years and indicated that an elevated homocysteine level ≥ 12 µmol/L) was 
associated with the increased risk of kidney allografts loss in 260 patients and 
154 patients died (Winkelmayer et al. 2005). Einollahi and co-authors studied 
159 kidney transplant patients, and indicated that serum creatinine con-
centration was the major determinant of increased HCY concentration in renal 
transplant recipients. Their study found no correlations between the kidney graft 
function and HCY concentration (Einollahi et al. 2011). 
 Hyperparathyroidism, calcium and vitamin D deficiencies predispose bone 
disease progression and increased fracture rates after kidney transplantation. 
The highest parathyroid hormone (PTH) production was observed in the first 
post-transplant year, but at the later post-transplantation period it had a 
tendency to decrease. Parathyroid glandsʼ hyperfunction, negative effects of 
steroid therapy, disorders of calcium metabolism and lower kidney graft 
function were the most significant causes for developing osteopenia on average 
5 or more years after kidney transplantation or more years after kidney trans-
plantation (Babarykin et al. 1999). 
 
 
2.7. Scientific methods of the measurement of  
diet and nutrition 
2.7.1. Overview of nutrition history 
The investigations of the influence of food on health, the supply of the organism 
with nutrients, biochemical and anthropometrical indicators are the themes 
which interest medical specialists. In the case of a particular investigation, the 
choice of the methods used in the nutrition investigation depends on many 
aspects. Nutrition investigations are planned at the level of nations or popu-
lations (adults, pupils), also at the level of the people with fixed nutrition 
traditions (vegetarians) or the groups of patients with the certain features of a 
disease (chronic heart or kidney disease, oncological diseases). Such investi-
gations require much work and are very expensive. This is why the planned 
investigations and the collected data must be to the point to avoid the mis-
leading influence of food factors. To study and assess the connections between 
nutrition and health, the choice of investigation methodology should be made 
according to the aim of the investigation.  
For example, in the investigations of high blood pressure it is important to 
know the consumption of salt, in the case of heart diseases the quality of food 
fats and the amounts of food, in the case of oncological diseases the proportions 
of fibre, in the case of kidney diseases food protein and several microelements 
(potassium, sodium, phosphorus, calcium). There is no ideal methodology for 
nutritional research (Saava 1997). When comparing the materials of different 
databases, no important differences have been found in basic nutrients by 
chemical composition (Saava 1997, Vaask et al. 2004).  
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During nutrition studies or nutrition surveys, the data of dietary intake and 
nutritional status are collected. A dietary intake means the food or nutrient 
intake during which both qualitative and quantitative data are obtained about the 
food consumption survey and the dietary survey. A nutritional status charac-
terizes the situation of the supply of food and nutrients during which the 
estimation of the situation is given through the clinical, biochemical and 
anthropometrical indicators. 
The methods to collect the dietary intake data on an individual level can 
roughly be divided into two categories: short-term and long-term instruments. 
The short-term dietary assessment methods collect the dietary information on 
current intake of the previous day from recalling (24-hour recall), or the 
information based on keeping a record of the intake of food and drinks over one 
or more days (dietary record). The long-term dietary assessment methods 
collect information on usual food intake over the previous months or years 
(dietary history or food frequency questionnaire). The methods for data 
collection are a food record, food recall or food interview, food history and food 
frequency.  
 Food record. A dietary record of 3 days is recommended for gathering 
information on the mean food consumption. A well-trained professional 
explains to the person being studied how to write down the time of eating, the 
title of food, the amount of food in certain measures (a portion, a slice, a piece, 
a glass, a cup, etc.) or in grams, cooking methods, etc. For the skilled pro-
cessing of the collected material it is important to take into consideration the 
amounts of food eaten by a person being studied and the percentage of loss 
caused in the process of cold or hot preparation (of food in Saava 1997, Biro et 
al. 2002).  
 Food recall. The 24-hour dietary recall, originally attributed to Wiehl 
(1942), is an interview (Biro et al. 2002). The recall period starts with the last 
eating event and moves 24 hours backwards. The disadvantages of the 24-hour 
recall include the inability of a single dayʼs intake to describe the typical diet 
(PEP 6305: Measurement in Health and Physical Education 2015).  
 Food history. The classic version of a diet history is the Burke Diet History 
(Burke 1947) which consists of three components: 1) detailed questions about 
usual patterns of eating, organized by meals (meal pattern interview), 2) a list of 
foods and beverages for which usual frequency and amount are queried, and 3) 
a self-administered 3-day food record. The food list and the 3-day food record 
are used only as cross-checks to modify the information gathered during the 
meal pattern interview. The traditional Burke Diet History approach has been 
modified in a variety of ways in different research settings (Dietary Assessment 
Primer 2015). 
 Food frequency. Burke created the frequency method in 1947 when he, in 
addition to the 24-hour method and 3-day written questionnaire, asked questions 
about the food consumed during the last month (Burke 1947). Later, the 
correction of questionnaires was developed which can be considered the 
beginning of the use of the frequency method. The main principle is to learn 
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how often a particular food was eaten (in a week, month, even a year). The 
respondent independently fills in the variants about the past, what was eaten and 
how often. In compiling the informative questionnaire, only the names of foods 
and nutrients, most important for the study, are taken into consideration. FFQs 
designed to estimate a larger number of nutrients generally include between 50 
and 150 or more food items (Saava 1997, Biro et al. 2002). The investigators 
must be rather careful in making conclusions about the influence of food on the 
disease and health.  
Marking the comparison of the consumption of food obtained with different 
methods, the results of correlation and regression analysis may not always give 
equal parameters for giving the estimation (Saava 1997). In addition to that, 
other environmental factors such as socio-economic food patterns, ethnic 
factors (eating patterns, meal patterns) and hereditary influence may cause 
different interpretation of food influence (Saava 1997). Nutrition investigations 
also study food availability, food consumption, food intake or dietary intake, 
food use at an individual, family or group level. 
 
 
2.7.2. Questionnaires of nutritional habits 
Guida et al. (2007) indicated the role of dietary intervention after kidney trans-
plantation on the basis of a personal interview by a detailed food-frequency 
questionnaire (FFQ), including 130 foods. The quality of life and physical acti-
vity in CKD patients can be assessed, using FFQ. A special FFQ, compiled by 
the Centre for Physical Anthropology at the University of Tartu, has been drawn 
up for socio-economic, physical activity and nutrition research, including 128 
foods (Kiisk et al. 2010).  
The diet history questionnaire (DHQ) was first described by Bertha Burke in 
1947 and it was used in population nutrition studies (Burke 1947). The original 
Burke questionnaire started with an overview of what was eaten during the past 
24 hours and continued with the frequency of foods eaten during the past 28 days 
(Burke 1947). More researchers have described in their studies a diet history 
questionnaire (DHQ) that was developed using an audio self-administered 
computer-assisted interview technique, which was programmed to be self-
administered using a computer with a touch screen, and includes 54 main food 
group questions, specific food items within the main food groups and food pre-
paration as well as questions about general eating practice (Slattery et al. 2008).  
The FFQ method is one option among other methods in the development of 
clinical nutrition guidelines for personal counselling. The FFQ method allows to 
study nutrition with the purpose of working out clinical guidelines and personal 
counselling. This questionnaire and adequate dietary counselling can help 
reduce the risk of metabolic complications in the follow-up period, and prevent 
significant weight gain after kidney transplantation in the long perspective. 
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2.7.3. The 3-day menu research 
Nutritional counselling is performed by a dietitian who considers the patientsʼ 
age, gender, stage of chronic kidney damage, body build, eating and meal 
patterns, food consumption or dietary intake as well as the need for food energy 
and nutrients. The traditional Burke Diet History (Burke 1947) has been modi-
fied in a variety of ways in different research settings; there are no strictly 
prescribing questionnaires and food diaries. Two major methods have been 
accepted in nutrition research: 24-hour dietary recalls and dietary records. The 
24-hour dietary recall was designed to quantitatively assess current nutrient 
intake. The method of recall is often used, and the interview can be carried out 
face-to-face, by telephone or via an internet based computer program. The 
method is problematic due to the limitations of memory. The dietary recall is a 
retrospective method of dietary assessment during a determined period of time, 
typically the previous day or the preceding 24 hours (PEP 6305. Measurement 
in Health and Physical Education. Topic 15: Measuring Diet and Nutrition).  
The dietary record is the main food diary method which can be used in re-
search. The dietary record is typically obtained from 3 or 4 days. However, 
seven-day records were historically used as the gold standard for validating 
other methods. CKD patients themselves write down detailed information: food/ 
drink name, the content of sugar and fat, including food quantities consumed.  
Relying on scientific literature, no studies based on 3-day dietary records 
have been performed in Estonia among CKD patients, but Born and co-authors 
have investigated CVD patientsʼ nutritional peculiarities with the mentioned 
methodology (Born et al. 2002). The researchers of other countries have studied 
kidney transplant patientsʼ nutritional habits with the data analysis of only the 
twenty-four-hour dietary recalls or the records after kidney transplantation.  
Dietary intervention plays an important role in determining the effects of the 
modifications of metabolic abnormalities. The cross-sectional postal Finbalt 
Health Monitor was carried out in the Baltic Republics and in Finland in the 
years 1998, 2000, 2002. They studied differences in the consumption of foods 
that contain fat: meat and meat products, cheese, high-fat milk, butter on bread, 
vegetable oil for cooking. The results of this study indicated a positive as-
sociation between the level of education and consumption of vegetable oil used 
in food preparation. Cheese was the most popular in Finland (Petkeviciene et al. 
2007).  
An appropriate renal diet in CKD patients has an utmost importance in the 
management of these patients because they are considered to be at high risk for 
CVD complications. An individualized hypoenergic-hypolipidemic diet, but 
with folic acid and vitamin B6 supplementation can help to reduce athero-
sclerotic processes (Teplan et al. 2003, Teplan et al. 2007). Several authors have 
demonstrated the association between body weight gain and increased fat mass 
with energy intake whereas better results were found in males during the first 
post-transplant year (Guida et al. 2007, El Haggan et al. 2002). The lowering of 
dietary protein intake in CKD patients will prevent hyperfiltration, albuminuria 
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and histologic changes, but the recommended dietary protein intake must be 
considered in adults, the level is 0.5 g/kg/day. Guida and other researchers 
studied the role of dietary intervention on metabolic abnormalities and nutri-
tional status in forty-six recipients after kidney transplantation in the first post-
transplant year and follow-up of a 12-month period, and in conclusion, this 
study indicated that an adequate dietary regimen is associated with a reduction 
in BW and lower plasma levels of cholesterol, triglycerides and glucose, and 
can reduce the risk of long-term complications (Guida et al. 2007). 
The great difference between the food content of databases depend on 
regional variations, climatic conditions and agricultural practices. Since 1997, 
in the Baltic Republics, a profound computer program for the calculation of the 
nutritional composition menus has been implemented. It was drawn up on the 
basis of the Finnish Micro-Nutrica Nutritional Analysis program. Vaask with 
co-authors has found the differences in the observed two food databases used to 
convert foods into nutrient intakes: the Finnish Micro-Nutrica Nutritional 
Analysis program and the Russian database (Vaask et al. 2004).  
Since 2010, for assessing the nutritional composition of food, a contem-
porary electronic nutritional program which was designed on the basis of the 
research data on nutrition by the National Institute for Health Development and 
other internationally recognized data of nutritional research (NutriData Food 
composition Database 2014), has been used in Estonia. The program is used for 
analysing foods and menus in treatment and care centres, also for drawing up 
personal menus and comparing nutritional recommendations for different 
gender and age groups. In calculating the menus, beside Estonian data bases, it 
is also possible to use internationally recognized data bases which contain food 
values for ready-made foods, fruits and vegetables which our local data bases 
do not contain (www.calorie-ecount.com, www.fineli.fi). If patients follow a 
special diet, it is recommended to consult a physician or dietitian before making 
any changes in the diet (www.fineli.fi; Rastas 1989). 
 
 
2.8. Basis of nutritional counselling 
2.8.1. Rationale of the new system of treatment diets 
For several decades, the so-called Nomenclature of Pevzner Diets was used in 
the Estonian hospitals. Its author was professor Pevzner (1872–1952), medical 
researcher and gastroenterologist from Moscow University who was also the 
founder of clinical feeding treatment and the developer of diet treatment in 
Russia. The use of the system of Pevznerʼs diets was obligatory in all the 
hospitals of the Republic of Estonia (Pokrovski et al. 1981). The hospital 
feeding treatment relied on many legal documents, including the norms of 
feeding patients and the prescribed costs of daily food. All these documents 
gave norms to our activities and established a fixed framework with diffe-
rentiated monetary and nutritional norms. Several diets, in spite of their exis-
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tence in the Pevzner nomenclature, did not have a reason for such a detailed 
implementation. The numeration 1–15 in the classification of Pevznerʼs diets 
together with subgroups was not rational for practical use and gave no 
information. The feedback from the doctors of clinics showed that the choice of 
foods and nutrients in the menus of the patients having acute diseases of 
digestive tract was too small, which was not justified.  
In the Maarjamõisa Hospital, the implementation of the new integrated diet 
system was started in 1995 to guarantee the optimal and adequate diet treat-
ment. In connection with the formation of the food service at the Tartu Univer-
sity Hospital on 1 May 1999, new important issues of management and 
organisation beside specific dietology issues have gained importance in 
patientsʼ nutrition.  
The author of the thesis has drawn up a preliminary systematized list of diets 
(Kiisk 2002) and started to compile a collection of articles which takes the 
contemporary principles of feeding treatment into consideration in order to 
finalize the common system of diets for treatment. The updated system was 
developed during the doctoral studies.  
 
 
2.8.2. Organization of the counselling of  
chronic kidney disease patients 
Dietology treatment is the foundation stone of the complex treatment of CKD 
patients and it is the basis for the prognosis. The lifestyle counselling of CKD 
patients and kidney transplant patients together with dietology guidance is 
extremely important. According to CKD guidelines a CKD category (KDIGO 
2012) should be taken into account at the same time. As already mentioned, 
nutritional counselling is performed by a dietitian who considers the patientsʼ 
characteristics: age, gender, body build, eating and meal patterns, food con-
sumption or dietary intake and the need for food energy and nutrients. The 
patients with a transplanted kidney are also considered CKD patients (KDIGO 
2012). 
The European Federation of the Associations of Dietitians (EFAD) defines a 
dietitian as a person with a legally recognised qualification in nutrition and 
dietetics, who applies the science of nutrition to the feeding and education of 
groups of people and individuals in health and disease (EDAC 2012. 
www.efad.org). Within Europe, the EFAD definition of a dietitian has been 
adopted in two categories: the dietitian and the expert. A dietitian may work in a 
variety of settings and have a variety of work functions. An expert is a person 
whose work is based on research and experience in a particular area of study. 
The European Dietetic Advanced Competences (EDAC) indicators are accepted 
by EFAD (www.efad.org).  
Professional dietitians in the European countries have three main areas of 
specialization: the administrative dietitian, the clinical dietitian and the public 
health or community dietitian. The administrative dietitiansʼ competence is food 
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service management and providing nutritionally adequate quality food to 
individuals or groups in health and disease in an institution or a community 
setting (EDAC 2012. www.efad.org). A clinical dietitian has the competence 
for planning, education, supervision and education of a clinically devised eating 
plan to restore the client or patient to functional nutritional health, and can work 
in primary care as well as in institutions (EDAC 2012. www.efad.org). Public 
health or community dietitians are involved in health promotion and policy 
formulation that is focused on the promotion of food choice amongst indivi-
duals and groups to improve or maintain their nutritional health and minimizes 
the risk of nutritionally derived illnesses (EDAC 2012. www.efad.org). 
 
 
2.8.3. Individual nutritional counselling of chronic kidney 
disease patients 
The assessment of CKD patientsʼ nutritional status after kidney transplantation 
should be associated with individual diet therapy. Individual nutritional coun-
selling is carried out by a nephrologist or dietitian or nurse according to a parti-
cular need, kidney disease, accompanying diseases and the peculiarities of 
treatment. Nutritional screening or rescreening is composed of the analysis of a 
patientʼs food and nutrition history, socio-economic status, medical diagnosis, 
body composition, anthropometrical measurements, biochemical monitoring, 
food nutrient intake; and a dietitianʼs systematic review is also necessary in 
complex rehabilitation (KDIGO 2012).  
At the present time, doctors in Estonia are guided by the Estonian treatment 
instructions (Estonian Society of Nephrology), the instructions for the treatment 
of kidney transplantation: immunosuppressive treatment, the routine monitoring 
of a patient after kidney transplantation (www.nefro.ee), or internationally re-
cognized treatment instructions (NKF-K/DOQI Clinical Practice Guidelines for 
Chronic Kidney Disease, 2002; KDIGO. Kidney Disease: Improving Global 
Outcomes, 2012).  
Lowering excess weight is advisable for the patients with CKD and the 
motivation to change dietary habits should be the result of education. Patel and 
Nicol (1997) indicated that various renal diets are ethnically oriented, and most 
consider the nutritional traditions of patientsʼ food selection. According to lite-
rature, Patel and co-authors indicated in their study a significant difference in 
weight gain in two groups of patients in one year after kidney transplantation. 
The patients with individualized intensive dietary advice had a lower weight 
gain (mean 5.5 kg) and the patients who had not received any dietary advice had 
a higher weight gain (mean 11.8 kg) after kidney transplantation (Patel and 
Nicol 1997, Patel 1998).  
The research about the management of progression and complications in 
CKD patients recommended that people with CKD be encouraged to undertake 
physical activity compatible with cardiovascular health and tolerance (aiming 
for at least 30 minutes 5 times per week), achieve a healthy weight (BMI 20 to 
29 
25, according to country specific demographics), and stop smoking (KDIGO 
2012). BIA is not currently used in routine clinical practice in every nephrology 
centre.  
Intensive nutritional counselling plays an important role during the first 
years after kidney transplantation, allowing patients to be informed about 
possible body composition changes and preparing them to follow a healthy diet. 
Nutritional counselling can be performed according to internationally re-
cognized CKD treatments and complex guidelines which consider socio-eco-
nomic situation, education, psychosocial factors, body composition, laboratory 
parameters, nutritional monitoring, physical activity and other lifestyle factors.  
 
 
2.9. Summary 
Optimal nutritional evaluation, the use of biochemical analyses of blood 
together with anthropometry in clinical practice is of great importance in all 
chronic kidney disease phases, including the post-transplant period. Body 
weight gain often develops after kidney transplantation and influences the long-
term outcome. Much research has been carried out in the world studying the 
body composition of healthy people but there are limited data about the research 
where these methods together with other clinical parameters have been used for 
investigating patients with a transplanted kidney. Body composition assess-
ments in a complex manner, including the biochemical analyses of blood as 
well as anthropometrical and nutritional peculiarities of the patients with a 
transplanted kidney, have not been previously studied in Estonia. According to 
literature, the main problem after kidney transplantation is the gain of body 
weight; therefore, we planned to test if intensive nutritional counselling has an 
effect on patientsʼ nutritional habits in preventing the gain of body weight. 
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3. AIMS OF THE STUDY 
The general aim of the present study was to analyse the body build and nutri-
tional habits of the end-stage chronic kidney disease (CKD) patients. We hypo-
thesised that intense nutritional counselling significantly improves nutritional 
habits, and, ultimately, the gain of body weight after kidney transplantation will 
be prevented. 
 
The specific aims of the present study were as follows: 
1. To analyse anthropometric measurements data of the end-stage CKD pa-
tients and to compare the body composition of the dialysis and transplant 
patients. 
2. To test if intensive nutritional counselling has an effect on body composition 
of kidney transplant male and female patients. 
3. To evaluate the effect of intensive nutritional counselling on the changes of 
anthropometric, biochemical and nutritional parameters of kidney transplant 
patients after the follow-up and to describe gender-specific associations 
between the studied parameters. 
4. To estimate the long-term effect of intensive nutritional counselling on 
anthropometrical measures of kidney transplant patients. 
5. To evaluate the follow-up changes of the intake of nutrients of kidney 
transplant patients on the basis of a 3-day menu. 
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4. PATIENTS AND METHODS 
4.1. Subjects of Study 
The prospective long-term study was carried out during the years 2003–2015 at 
the Department of Internal Medicine at the University of Tartu. Totally, 150 
chronic kidney disease patients were studied. The kidney transplant patients had 
their transplantation at the Transplant Center of the Tartu University Hospital.  
The first anthropometric study population consisted of 75 consecutive non-
diabetic CKD patients (37 males and 38 females) on renal replacement therapy 
(HD, 5 males and 6 females; PD, 11 males and 6 females; RT, 21 male and 26 
female patients) treated in the nephrology division at the Tartu University 
Hospital who agreed to participate in the study. Participation was voluntary and 
all patients signed a written informed consent. 
The transplanted patients population was formed from the consecutive stable 
ambulatory non-diabetic kidney transplant patients (12 males at the age of  
42.8 ± 16.1 years and 16 females at the age of 47.0 ± 14.9 years) monitored by 
nephrologists at the Tartu University Hospital who agreed to participate in the 
study. Participation was voluntary and all patients signed a written informed 
consent. 
The transplanted patients control population was formed from 47 clinically 
consecutive stable ambulatory non-diabetic kidney transplant patients (27 males 
at the age of 45.6 ± 9.4 years and 20 females at the age of 48.7 ± 12.8 years) 
monitored by nephrologists at the Tartu University Hospital or at the West-
Tallinn Central Hospital who agreed to participate in the study. Participation 
was voluntary and all patients signed a written informed consent. 
Population controls consisted of the population measured by an anthropo-
metrist of the Centre for Physical Anthropology at the University of Tartu: 85 
males (age range 40–49 years) and 256 females (age range 40–49 years). 
All the studied 28 kidney transplant patientsʼ measurements, including 
anthropometry, densitometry, biochemistry, the food frequency questionnaire 
(FFQ) and the 3-day dietary records analysis were carried out. The data of 
anthropometry, biochemistry and the 3-day dietary records analysis were per-
formed in patients twice: one and a half years after the first cadaveric kidney 
transplantation (the first measurement, FM) and then, three years after the 
kidney transplantation (follow-up, FU). Densitometry was performed in patients 
once after the transplantation during three years follow-up (FU).  
Preventive nutritional counselling and dietary consultation by a dietitian 
were carried out for all the kidney transplant patients during one and a half 
years after the kidney transplantation. Initial data were compared with the 
results obtained at the end of the study. 
Last anthropometric measurements (LM) ten years after the kidney trans-
plantation both in counselled KTx pts and in control KTx patients were carried 
out. 
The study designs can be seen in Table 1.  
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4.2. Methods 
4.2.1. Anthropometric measurements 
The anthropometric measurement of renal transplant patients was carried out 
during the years 2003–2015 at the Department of Internal Medicine, the 
Nephrology Department of the University of Tartu. The anthropometric mea-
surements were carried out on average one and a half years after kidney trans-
plantation (FM, 1.3 ± 0.2 years) and for the second time on average three years 
later (FU, 2.7 ± 0.3 years). Last anthropometric measurements (LM) were 
performed ten years after the kidney transplantation. 
Measurements were performed in the morning between 9.00 and 12.00. All 
the patients had had a light breakfast 2 hours before the study. Anthropometrical   
measurements were performed by a trained anthropometrist.  
The methodology of the anthropometric study relied on the long-term 
research carried out on many populations at the Centre for Physical Anthropo-
logy at the University of Tartu (Kaarma 1995, Kaarma 1996, Lintsi et al. 2002, 
Lintsi et al. 2003).  
The studied patients were measured according to the classical method of 
Martin that considers classical measures (Martin 1928, Knussmann 1988). For 
measuring the skinfolds, the methodology provided in Knussmannʼs handbook 
(Knussmann 1988) was followed. Body height (BH) was measured in centi-
metres (precision ± 0.10 cm) using a Martin metal anthropometer. Body weight 
(BW) was weighed in kilograms (precision ± 0.05 kg) on the Soehnle (Ger-
many) electronic medical scales. Depths and breadth measurements were mea-
sured with the Martin calipers (precision ± 0.10 cm), circumferences with a 
metal measuring tape, skinfoldsʼ thicknesses with the Holtain skinfold calipers 
on the right side of the body.  
The RRT patients anthropometric measurements were divided into three 
groups: hemodialysis patients, peritoneal dialysis patients and kidney transplant 
patients. A total of 11 body measurements was taken. The measured anthropo-
metric variables were: the body height (cm), the body weight (kg), 4 circum-
ferences (cm), 4 skinfold thicknesses (mm) and the sum of 4 skinfolds (mm). 
All the data were collected and analyzed in the first follow-up. From these basic 
anthropometric measurements and indices the body composition characteristics 
were calculated.  
In kidney transplant patients a total of 36 body measurements, including 
11 skinfolds, were taken. From these basic measurements, indices and body 
composition characteristics were calculated. The measured anthropometric 
variables were: the body height (cm), the body weight (kg), 2 depths (cm), 8 
breadths measurements (cm), 13 circumferences (cm) and 11 skinfold thick-
nesses (mm). The measured anthropometric parameters were: 
 
1)  Length. The length measurements were of the body height. 
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2)  Breadth-depth. The breadth-depth measurements were biacromial, the 
chest, the waist and the pelvic breadth, the chest and abdomen depths. 
3)  Thickness of bones. To assess the thickness of limb bones, the upper limb 
humerus and the wrist breadths were measured, and the femur and the ankle 
breadths were measured in the lower limb. 
4)  Circumferences. The measured circumferences of the trunk included the 
head, the neck, the chest, the waist and the hip circumference. The measured 
circumferences of the upper limb included the mid-arm circumference, 
flexed and tensed, the forearm and the wrist circumference. The measured 
circumferences of the lower limb included the proximal thigh, the middle 
thigh, the calf and the ankle circumferences. 
5)  Skinfolds. The measured skinfold thicknesses were the chin, the chest, the 
side, the waist, the suprailical, the umbilical, the subscapular, the biceps, the 
triceps, the thigh and the calf skinfold thicknesses. 
 
The healthy populationʼs controls data which were collected by anthropo-
logist Saluste were: mean age, mean BH, mean BW, mean BMI. All these data 
were compared with kidney transplant patientsʼ mean BH, mean BW and mean 
BMI in FM.  
The second control group consisted of kidney transplant non-diabetic 
patients. A total of the measured data contained the body height (cm) and the 
body weight (kg). All the baseline data were collected and analyzed, and the 
BMI (kg/m2) were calculated. 
Last anthropometric measurements (LM) after the kidney transplantation 
were performed both in the counselled KTx patients and in the control KTx 
patients. The measured data were BW, BH and BMI (kg/m2). All the measured 
data were calculated and compared with FU anthropometric data.  
 
 
4.2.2. Body composition characteristics 
The structure of the body is determined by a complex of anthropometrical vari-
ables. Basic measured anthropometrical variables were calculated on the body 
composition, characteristics of renal transplant patients 1.5 years (FM) and 3 
years (FU) after kidney transplantation. Last anthropometric measurements 
(LM) were performed ten years after the kidney transplantation. 
The calculated body composition characteristics of renal transplant patients 
were the body mass index (BMI), the waist to hip ratio (WHR), the body 
surface area (BSA), the body density (Db), the relative mass of fat by Siri, the 
mean skinfolds, the mass of the subcutaneous adipose tissue and the relative 
mass of the subcutaneous adipose tissue. Basic measured anthropometrical and 
individual data were calculated using the following equations: 
1)  BMI (kg/m2) = body weight (kg) / body height (m2) 
2)  Waist to Hip Ratio (WHR, m) = Waist circumference (m) / hip 
circumference (m) 
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3)  Body surface area by DuBois & DuBois (BSA, m2) = 71.84 x  
weight (kg) 0.425 x height (cm)0.725 / 10,000 
4)  Body density (Db, g/cm3) = 1.06234 - (0.00068 x chin skinfolds thickness) – 
(0.00039 x biceps skinfold thickness) - (0.00025 x thigh skinfold thikness) 
5)  Relative mass of fat by Siri (%) = 100 x (4.95 / body density) – 4.50 
6)  Mean skinfoldsʼ thicknesses (mm) = (chin + chest + side + waist + 
suprailical + umbilical + subscapular + biceps + triceps + thigh + calf) / 11 
7)  Mass of subcutaneous adipose tissue (kg) = (mean skinfolds / 2) x body 
surface area x 0.9 x 10 
8)  Relative mass of subcutaneous adipose tissue (%) = mass of subcutaneous 
adipose tissue (kg) / body weight (kg) x 100 
 
 
4.2.3. Bioimpedance measurements 
The bioimpedance measurements were carried out at the Department of Internal 
Medicine of the University of Tartu. The body fat measurements were taken 
twice: one and a half years (FM), and three years (FU) after kidney transplan-
tation in kidney transplant patients. 
To analyse body fat levels, the fat loss or the fat gain, the method for deter-
mining bioelectric impedance (BIA) was used in measurements. To assess body 
fat percentage OMRON® BF 300 the body fat monitor (OMRON/ Matsusaka 
Co Ltd., Japan) with the new hand-held BIA electrodes for the right and the left 
hand was used. The data about the subjectʼs age, sex, height and weight was 
entered into the BIA data collection equipment. After seven seconds after pres-
sing the start button the fat percentage (%) and the fat mass (kg) are shown on 
the display OMRON® BF 300 Body Fat Monitor (OMRON. Instructional 
Manual 1998). On the basis of OMRON® BF 300 body fat monitor individual 
data were calculated: the body fat mass (BF, kg) and the body fat percentage 
(BF, %), standard deviation (SD), minimum and maximum. 
 
 
4.2.4. Densitometric measurements 
The densitometric study was carried out at the Department of Internal Medicine 
of the University of Tartu Densitometric Study Centre. In the study the dual-
energy X-ray absorptiometry (DXA) method with using GE LUNAR DPX-IQ 
densitometer (Lunar Corporation, Madison, Wisconsin, US, software version 
4.7e) was used by IOF-certified technicans. 
The densitometrically studied kidney transplant patients constituted clinical-
ly stable consecutive nondiabetic groups: 12 males at the age of 42.8 ± 16.1 
years, and 16 females at the age of 47.0 ± 14.9. Densitometric measurements of 
all kidney transplant patients were carried out once, on average three years afer 
the kidney transplantation (FU). 
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To assess bone mineral density (BMD) for the measured anatomical region, 
the total body (arms, legs, trunks, spine) and the second to the fourth lumbar 
vertebrae L1 to L4 were used. For the total body and the AP lumbar spine the 
absolute bone mineral density (BMD) for each site in quantitation (g/cm2) was 
calculated. To compare the individual BMD for the total body and the AP 
lumbar spine, T-score and/or Z-score were calculated. To analyze appropriate 
measured groups, the reference values were used whereas they were given on 
the basis of the Reference Population Database of the German population re-
search. The mean male BMD and the mean female BMD absolute values for 
total body sites and SD g/cm2 for each site are listed below under the site name 
(LUNAR DPX-IQ Reference Manual 5.5. Reference Population Database).  
These scores were necessary for the comparative assessment of bone density 
to distinguish whether it was normal or the patient had osteopenia or osteo-
porosis. On the basis of the densitometric measurement results the bone density 
of each site for the patient was received both in absolute values (absolute BMD 
values in g/cm2) and in T-scores (German AP Spine Reference Population. 
Young Adult Ages 20–40) and Z-scores (matched for age, weight 25–100 kg). 
The World Health Organization definition (Report of WHO Study Group et 
al. 1994) of the international reference standard and the International Society for 
Clinical Densitometry (ISCD Official Positions 2005) recommendations have 
set the values for interpreting. T-scores and Z-scores criteria to distinguish 
osteopenia (low bone mass or low bone density), osteoporosis and normal bone 
mineral density. T-scores measured the criteria as follows: above -1: bone den-
sity is considered normal; between -1 and -2.5 this T-score is a sign of osteo-
penia; below -2.5 bone density indicates osteoporosis. 
We used the reference population database for the LUNAR DPX-IQ instru-
mentarium (Lunar Radiation Corporation, Madison, WI, USA), whereas based 
on ambulatory subjects from the general a German population research, who 
were free from chronic diseases affecting bone. The dual-energy X-ray absorp-
tiometry (DXA) method for all the BMD parameters was used in the Tartu 
University Hospital. Other reseachers used for comparison reference values for 
BMD to different machine-specific databases reference values. In general the 
DPX software is used. It is supported by a large database from the population 
research studies in the USA, the UK and Northern Europe (Kroger 1992, 
Matkovic 1994). 
 
4.2.5. Laboratory research 
Laboratory research was carried out at the United Laboratories of the Tartu 
University Hospital in Tartu. The kidney transplant patients whose blood was 
biochemically studied constituted clinically stable consecutive nondiabetic 
groups: 12 males at the age of 42.8 ± 16.1 years, and 16 females at the age of 
47.0 ± 14.9. The biochemical analyses were performed twice: firstly one and a 
half years after the kidney transplantation (FM), and secondly three years after 
the kidney transplantation (FU). 
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The following biochemical parameters were studied: serum protein (S-Prot, 
g/L), serum albumin (S-Alb, g/L), C-reactive protein (S-CRP, mg/L), serum 
creatinine (S-Crea, µmol/L), serum urea (S-Urea, mmol/L), serum uric acid (S-
UA, µmol/L), serum alkaline phosphatase (S-ALP, U/L), serum calcium ionized 
(S-iCa, mmol/L), serum phosphate (S-P, mmol/L). Also, blood hemoglobin (fB-
Hb, g/L) was sudied.  
The following lipid profile was studied: serum cholesterol (S-Chol, mmol/L), 
serum HDL-Cholesterol (S-HDL-Chol, mmol/L), serum LDL-Cholesterol (S-
LDL-Chol, mmol/L), serum triglycerides (S-Trigl, mmol/L). The serum para-
thyroid hormone (S-PTH, pmol/L), serum homocysteine (S-Hcy, µmol/L) and 
serum cystatin C (S-CysC, mg/L) parameters were studied in FM. 
The Modification of Diet in Renal Disease (abbreviated MDRD) equation 
was used to assess the estimated GFR. The estimated glomerular filtration rate 
(eGFR, ml/min/1.73m2) was calculated with the equation of age, S-Crea, S-Urea 
and S-Alb (Levey et al. 2006, van Biesen et al. 2006). All the studied bio-
chemical parameters FM were compared with the biochemical parameters FU 
after kidney transplantation and were applied to be compared with different 
laboratory normal ranges of the United Laboratories of the Tartu University 
Hospital (Laboratory Manual IV). 
 
 
4.2.6. Methodology for studying nutrition 
4.2.6.1. Development of the new system of treatment diets  
for health care institutions 
The author of the thesis has worked out a preliminary systematized list of diets 
(Kiisk 2002) and started to compile a collection of articles which takes into con-
sideration contemporary principles of feeding treatment in order to finalize the 
common system of diets for treatment. The updated system was worked out 
during the doctoral studies.  
 The systematization of the nomenclature of treatment diets in the multi-
profile health care institution is an important part in patientsʼ care. The whole 
system of nomenclature of diets consists of ordinary food and of seven groups 
of diet food which are in turn divided into subgroups: ordinary food, lightened 
diets with 8 subgroups, diets with strict restrictions with 4 subgroups, lightened 
liquid diets with 3 subgroups, lightened soft diets with 3 subgroups, diets for 
diabetics with 4 subgroups, various individual diets. Individual nutritional 
recommentatons for energy intake are given in respect to the metabolic rate, the 
body composition, and the degree of physical activity. 
 We worked out indications of diets for disorders of the circulatory system, 
the disorders of lipoprotein metabolism, obesity, the disorders of fluid and 
electrolyte balance, energy malnutrition, lactose intolerance, dialysis, the 
chronic nephritic syndrome, the acute nephritic syndrome, renal failure, dis-
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orders of purine metabolism, food allergy, surgical follow-up care, post organ 
transplantation, in the case of diabetes and other cases.  
The normative values of the energy and of the basic nutrients are in accor-
dance with the Estonian nutritional recommendations and with guidelines for 
patientsʼ health care. We used for planning a new dietary system on the basis of 
the development of nutritional recommentations and the normative values of the 
nutrients which are in accordance with official guidelines: 
1)  CINDI. Countrywide Intergrated Noncommunicable Disease Intervention. 
Dietary Guide issued by the WHO Regional Office for Europe. Word Health 
Organization 2000. www.euro.who.int  
2)  NKF-K/DOQI. National Kidney Foundation. K/DOQI Clinical Practice 
Guidelines for Chronic Kidney Disease: Evaluation, Classification and 
Stratification. National Kidney Foundation, 2002. www.kidney.org  
3)  Nordic Nutrition Recommendations 2004. 4th edition. Integrating nutri-
tion and physical activity. Nordic Council of Ministers, 2005. www.nnr4.org  
4)  Estonian Nutritional Recommendations and Food Based Dietary Guide-
lines 2006. www.nutridata.ee  
 
 
4.2.6.2. Research of nutritional habits on the basis  
of the Food Frequency Questionnaire 
The research of nutritional habits was carried out on the basis of a Food Fre-
quency Questionnaire (FFQ) in male (n = 12) and female (n = 16) kidney 
transplant patients. The patients filled the FFQ once. The first data of the FM 
were collected on average 1.5 years after the kidney transplantation. A special 
food questionnaire “The card of nutritional habitsˮ was worked out by the 
Centre for Physical Anthropology at the University of Tartu and was used for 
nutritional research. “The card of nutritional habitsˮ was worked out for kidney 
transplant patients. A FFQ consisted of six parts and 180 variables which 
covered the questions: 
Part I. Which is your family social-economic situation?  
Part II. Which are nutritional traditions of the family?  
Part III. Which are your own nutritional habits?  
Part IV. How much do you consume drinks, and rye bread-white bread a day?  
Part V. Your attitude to eating and movement?  
Part VI. How often do you eat the following food? The FFQ of foodstuffs 
included questions on nine groups of 128 products: 16 milk and dairy products, 
12 cereal and flour products, 15 meat products, 8 fish products, 18 vegetables, 
15 seasonal fruits and berries, 11 sweets, 19 drinks, 14 ready-made foods. The 
frequency of consumption of each foodstuff was assessed on a five-grade scale: 
daily, often (2–3 times a week), sometimes (1–2 times a week), seldom (1–2 
times a month), never. 
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Preventive nutritional counselling and dietary consultation by a dietitian was 
carried out for all the transplant patients during one and a half years (FM) after 
the kidney transplantation.  
 
 
4.2.6.3. The 3-day dietary records data collection 
The dietary records for 3 days for the kidney transplant patients who had the 
transplantation in 2000–2003 at the Department of Internal Medicine, the 
Nephrology Department of the University of Tartu, were collected and ana-
lyzed. The 3-day dietary records data were collected and analyzed twice: firstly 
one and a half years after kidney transplantation (FM), and secondly, three 
years after kidney transplantation (FU). The primary menus characterized the 
patientʼs ordinary nutrition. 
The first menus were immediately analyzed, and all the patients were advi-
sed by a dietitian after (FM) concerning diet recommendation. The secondary 
dietary record for 3 days helped reveal whether the patients had considered 
nutrition advice and changed their eating habits. The nutritive values of FM and 
FU of three days were calculated, the dynamics of results were analyzed and 
statistical analysis was carried out. 
The daily intake of food energy and nutrients was calculated and analyzed 
with the Finnish food composition database Program Micro-Nutrica 2.0, modi-
fied and translated into the Estonian language at the Tallinn University of 
Technology, Department of Food Processing. This adapted version of the 
Finnish Micro-Nutrica Nutritional Analysis Program in MS Exel, was used in 
Estonia. This Program includes over 1,150 food items and 66 characteristics of 
nutrients (Food and nutrition VI. Tallinn 1998, Vaask et al. 2004). 
All the data were compared with the Estonian Nutrition Recommendations 
and Food Based Dietary Guidelines (2006). The Estonian nutrition-related re-
commendations are based on the Nordic Nutrition Recommendations which were 
approved in 2004 (Nordic Nutrition Recommendations 2004. www.nnr5.org).  
 The consumption of energy and main nutrients content in 3-day menus of 
male and female kidney transplant patients were calculated with the Program 
Micro-Nutrica in MS Exel. The energy value of each food is given in kilo-
calories (kcal). The amount of protein, fat, carbohydrate and alcohol using the 
following conversion factors: protein 4 kcal/g (17kJ/g); fat 9 kcal/g (38 kJ/g); 
carbohydrates 4 kcal/g (17 kJ/g) and alcohol 7 kcal/g (30kJ/g). If kilojoules (KJ) 
were given in kilocalories (kcal), then coeficient 0.239 was used. The energy 
value for dietary fibre is very low and there are no reliable data for the energy 
content.  
 The frequency (%) of the consumption of nutrients (proteins, fats, carbo-
hydrates) and food energy content were given in absolute numbers and per 
kilogram of body weight (energy/body weight, proteins/body weight). The daily 
cholesterol (mg) intake of food portions was calculated. 
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Vitamins are given in two forms: fat-soluble vitamins and water-soluble 
vitamins. The content of vitamins consisted of 12 components: vitamin A, 
vitamin D, vitamin E, tiamin (B1), riboflavin (B2), niacin (B3), pyridoxine 
(B6), cyanocobalamin (B12), folic acid (B10), pantothenic acid (B5), biotin (H), 
and vitamin C.  
Minerals are given in 7 components: sodium (Na), potassium (K), calcium 
(Ca), phosphorus (P), magnesium (Mg), iron (Fe), selenium (Se). 
During the 3-day dietary records analysis and counselling of CKD patients, 
giving answers to their questions about their food and portion sizes, the dietitian 
used the standards portions book for snacks, drinks, fruit, vegetables, meat and 
fish with many photographs (Kiisk 2002, Kiisk and Rosenberg 2010, KDIGO 
2012). 
 
 
4.2.7. Counselling of chronic kidney disease patients 
We studied 28 clinically stable consecutive non-diabetic kidney transplant pa-
tients: 12 males at the age of 42.8 ± 16.1 years, and 16 females at the age of 
47.0 ± 14.9 years. The kidney transplantation was performed at the Tartu Uni-
versity Hospital.  
Dietary consultations by a dietitian was carried out for all the kidney 
transplant patients during one and a half years after the kidney transplantation. 
Initial data were compared with the results obtained at the end of the study. 
Intensive individual nutritional counselling was performed by the dietitian 
who considers the patientʼs age, gender, the stage of chronic kidney damage, 
body build, the twenty-four-hour need for food energy and nutrients, the 
patientʼs eating habits. During intensive counselling dietitians consider the 
results of anthropometry, densitometry, biochemistry, the food frequency 
questionnaire (FFQ) and the 3-day dietary records analysis.  
Two main methods have been accepted in nutrition research: the food 
frequency questionnaire (FFQ) and the 3-day nutrition diary. A special FFQ, 
compiled by the Centre for Physical Anthropology at the the University of 
Tartu, was used in the current study for social-economic, physical activity and 
nutrition research, including 128 foods. The consumption of energy and main 
nutrients content in 3-day menus of kidney transplant patients was calculated 
and analyzed with the Finnish food composition database program Micro-
Nutrica Nutritional Analysis adapted for use in Estonia (Food and Nutrition VI 
1998, FINELI. www.fineli.fi). All the data were compared with the Estonian 
Nutrition Recommendations. 
In CKD patients nutritional counselling must consider also a systematized 
list of diets. This created system allows achieving individual patient´s coun-
selling which considers the patient´s disease, the type of body build and the 
peculiarities of metabolism, the made clinical analyses. 
Ethics. The study was approved by the University of Tartu Ethics Review 
Commitee on Human Research (protocol no 141/30, 2005).  
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4.2.8. Statistical analysis 
Statistical comparisons of different anthropometrical, laboratory and nutritional 
parameters between initial and final measurements were made for the kidney 
transplant patients. Statistical analysis was performed using the Statistical 
Package (SAS 1989). Standard statistical methods were used to calculate for the 
all anthropometric measurements and biochemical blood characteristics basic 
statistics means x, standard deviations (SD), minimum (min) and maximum 
(max) for the initial and the final observation period. The mean anthropometric 
parameters, the BMI, the sum of skinfolds, the glomerular filation rate (e-GFR) 
and the waist to hip ratio (WHR) were calculated. Statistical comparisons were 
made using independent t-tests. The Pearson correlation coefficients were used 
to determine the relationships between dependent variables. The level of 
significance was accepted at p ≤ 0.05. Linear correlation coefficients were used 
to determine the relationship between anthropometric measurements, bio-
chemical blood values for the initial and the final period were calculated. 
Multiple regression models between anthropometrical and laboratory para-
meters were calculated. The consultant on data processing and the performer of 
the statistical analysis Mrs. Säde Koskel M.Sc. is from the Institute of Mathe-
matical Statistics at the University of Tartu. 
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5. RESULTS 
5.1. Results of anthropometric research in CKD patients 
with renal replacement therapy (Paper II) 
The results of this study indicate that the anthropometric profile is different in 
the Estonian CKD patients groups who were in renal replacement therapy 
(RRT). In the studied RRT patients groups were significantly different by the 
mean age (p < 0.05). A great mean age variety of the subjects was from 18 to 78 
years. The subjects were divided into three groups according to renal replace-
ment therapy: HD (5 male and 6 female patients), PD (11 male and 6 female 
patients), RT (21 male and 26 female patients). All the measured anthropo-
metric variables were: BH (cm), BW (kg), circumferences (cm), skinfolds thick-
nesses (mm), BF (kg), BF (%), BMI (kg/m2), WHR (m). The characteristics of 
anthropometric measurements in the renal replacement therapy of male patients 
(n = 37) and of female patients (n = 38) are shown in Paper II. 
The study indicates that the anthropometric profile was quite similar in the 
Estonian CKD male and female patients who were in renal replacement therapy 
(RRT) only. We found two significant differences (p < 0.05) in male groups 
(waist and upper leg circumference HD versus RT), and three significant diffe-
rences (p < 0.05) in female groups (biceps skinfolds HD versus PD; biceps 
skinfolds PD versus RT; triceps skinfolds PD versus RT). The mean BW for 
three groups RRT male and female patients indicated no significant differences.  
In the group of males only 54% of the subjects with the mean BMI had 
normal weight (BMI 18.5–24.9 kg/m2), while another 27% males had over-
weight (BMI 25–29.9 kg/m2). One male patient was malnourished, mean BMI < 
18.5 kg/m2 and one patient was of obese class III (BMI ≥ 40 kg/m2). In the study 
WHO body mass indices classification was used. The studied RRT male 
patientsʼ the mean BMI is seen in Figure 1.  
In the group of females with the mean BMI 34% of the subjects had normal 
BMI, while other 24% females were overweight (BMI 25–29.9 kg/m2). Only 
three patients had malnutrition with BMI 14.9; 18.4 and 16.2 kg/m2. Two 
female patients had the obese class III with the mean BMI 43.8 and 46.1 kg/m2. 
The studied RRT female patientsʼ mean BMI is seen in Figure 2.  
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Figure 1. Data of the mean BMI in the renal replacement therapy of male patients  
(n = 37) 
 
 
 
Figure 2. Data of the mean BMI in the renal replacement therapy of female  patients  
(n = 38) 
 
 
Anthropometric parameters showed overweight and obesity, fat accumulation in 
the body, especially in the abdominal region of the body in the females group 
(BF, 34–38%). In the males group the mean body fat is lower than in women 
(BF, 18.9–20.3%). 
45 
5.2. Results of anthropometric research in kidney 
transplant patients (Paper I, Paper IV, Paper VI) 
The results of the anthropometric measurements were analysed twice: 1.5 years 
after the kidney transplantation (the first measurement, FM) and 3.0 years after 
the kidney transplantation (follow-up, FU). The data at the beginning of the 
research were compared with the results at the end of the research. The mean 
age of the studied male patients was 42.8 ± 16.1 years, and the mean age of 
female patients was 47.0 ± 14.9 years. The data of basic anthropometric mea-
surements in male and female kidney transplant patients are given in Paper IV.  
 
Male patients (n = 12).  
Body height. The mean BH of male patients is decreased signifiantly by  
1.29 cm which can be caused by the posture or the habitus of the studied male 
kidney patients. The mean BH at FM, 174.82 cm to FU, 173.53 cm (p-value 
0.001). In the studied male patients the minimal BH was at FM, 166.50 cm to 
FU, 164.00 cm, and the maximal BH was at FM, 190.00 cm to FU, 189.30 cm.  
Body weight. The mean BW increased significantly in kidney transplant 
male patients and the mean difference was 8.21 kg. The mean BW at FM,  
75.13 kg to FU, 83.34 kg (p-value 0.001). In the studied male groups the 
minimal BW at FM, 57.10 kg to FU, 61.15 kg, and the maximal BW was at FM 
134.10 to FU, 138.10 kg.  
Breadth and depth. In the breadth and the depth measurements significant 
statistical changes were found only in the measurements of the biacromial 
breadth, the pelvis breadth and the ankle breadth. The mean biacromial breadth 
mesurements decreased significantly at FM, 40.76 cm to FU, 40.29 cm (p-value 
0.044), and the difference was -0.47 cm. The mean pelvis breadth value in-
creased essentially and the difference was 2.47 cm (at FM, 31.62 cm to FU, 
34.09 cm, p-value 0.021) in male patients. In the chest breadth measurements 
there was a decrease of -0.08 cm (from FM, 30.56 cm to FU, 30.48 cm), and, 
the waist breadth measurements decreased 0.29 cm (at FM, 30.03 cm to FU, 
29.74 cm), but statistically not significantly. In the measurements of the chest 
depth (at FM, 23.45 cm to FU, 23.78 cm) and the abdomen depth (at FM,  
24.75 cm to FU, 25.04 cm) no significant changes were found.  
Thickness of bones. The upper limb mean humerus breadth (at FM, 7.30 cm 
to FU, 7.32 cm), and, the mean wrist breadth (at FM, 5.87 cm to FU, 5.85 cm) 
measurements did not have statistically significant changes in male patients. In 
the case of the lower limb femur breadth the measurements were not 
statistically significant (at FM, 10.14 cm to FU, 10.19 cm). In the case of the 
lower limb the mean ankle breadth mesurements decreased significantly at the 
FM 7.35 cm to FU, 6.93 cm (difference -0.42 cm; p-value 0.014). 
Circumferences. The hip circumference increased significantly after FU, 
the difference was 3.85 cm (at FM 99.19 cm to FU, 103.04 cm, p-value 0.012). 
In the case of the upper limb circumferences 2 measurements increased statis-
tically significantly. These were: follow-up the mean mid-arm relaxed circum-
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ference difference 1.94 cm (at FM, 30.96 cm to FU, 32.49 cm, p-value 0.035), 
and, the mean mid-arm circumference flexed and tensed difference 1.92 cm (at 
FM, 32.81 cm to FU, 34.73 cm, p-value 0.022). Considering the lower limb 
circumferences: the mean proximal thigh (at FM, 56.26 cm to FU, 56.11 cm), 
the mean middle thigh (at FM, 49.07 cm to FU, 50.44 cm) and the mean ankle 
circumferences (at FM, 23.10 cm to FU, 23.33 cm) did not have statistically 
significant changes. Considering the lower limb circumferences: the mean calf 
circumference increased statistically significantly in FU, and the difference was 
2.47 cm (at FM, 34.26 to FU, 36.73 cm, p-value 0.005).  
Skinfolds. The measured mean chin (at FM, 7.88 mm to FU, 10.67 mm, p-
value 0.008), the mean chest (at FM, 11.17 mm to FU, 14.13 mm, p-value 
0.030), the subscapular skinfold difference 3.65 mm (at FM, 10.17 mm to FU, 
13.82 mm, p-value 0.011), the biceps skinfold difference is 2.73 mm (at FM, 
4.93 mm to FU, 7.66 mm, p-value 0.027) and the triceps skinfolds thicknesses 
difference 2.46 mm (at FM, 10.67 mm to FU, 13.13 mm, p-value 0.038), and 
have statistically significant changes in FU. The mean measured 6 skinfolds: 
side, waist, suprailiac, umbilical, thigh and calf skinfold thicknesses did not 
reveal statistically significant changes (p ≤ 0.05). 
 
Female patients (n = 16) 
Body height. The mean body standing height of female patients is dynamic and 
it decreased significantly by 1.38 cm which can be caused by the posture or the 
habitus of the studied female kidney patients (at FM, 164.88 cm to FU,  
163.50 cm, p-value 0.001). In the studied female patients the minimal BH was 
from FM, 150.00 cm to FU, 147.30 cm, and the maximal BH was from FM, 
171.50 cm to FU, 169.50 cm. 
Body weight. The body weight in female patients did not change signifi-
cantly, then the body weight of female patients increased non-significantly. The 
mean BH difference was 2.23 kg (from 74.35 kg to FU, 76.58 kg). In the 
studied female goups the minimal body weight was from FM, 40.00 to FU, 
46.20 kg, and the maximal body weight was from FM, 126.50 kg to FU,  
124.90 kg.  
Breadth and depth measurements. In female patients the biacromial, the 
chest and the waist breadth measurements were without changes. The mean 
biacromial breadth decreased non-significantly and difference was -0.39 cm (at 
FM, 35.89 cm to FU, 35.50 cm), the mean chest breadth difference 0.16 cm (at 
FM, 27.73 cm to FU, 27.89 cm) and the mean waist breadth value diffe- 
rence -1.00 cm (at FM, 28.46 cm to FU, 27.46 cm) in female patients. In the 
pelvis breadth measurements female patients have significant changes which 
was evidently caused by the changes in the thickness of the subcutaneous fat 
tissue, and the difference was 1.43 cm (at FM, 31.58 cm to FU, 33.01 cm, p-
value 0.035). The mean abdomen depth and the humerus breadth, the wrist 
breadth, the femur breadth, and the ankle breadth measurements were insigni-
ficantly decreased in female patients. In the chest depth and the abdomen depth 
no significant changes were found. 
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Thickness of bones. The upper limb humerus breadth (at FM, 6.56 cm to 
FU, 6.43 cm) and the wrist breadth (at FM, 5.28 cm to FU, 5.30 cm) 
measurements had no statistically significant changes in female patients. In the 
case of the lower limb femur breadth (at FM, 9.53 cm to FU, 9.31 cm) and the 
ankle breadth measurements statistically insignificant changes were found (at 
FM, 6.33 cm to FU, 6.11 cm, difference -0.22 cm in female patients). 
Circumferences. In the case of the trunk circumferences there were three 
statistically significant changes. These were: the head circumference, the neck 
circumference and the waist circumference difference -1.98 cm (the mean 88.55 
to 86.57 cm, p-value 0.032) in female patients. In the case of the measurement 
of upper limb circumferences had no statistically significant changes. The 
upper limb forearm circumference decreased, and a statistically significant 
change was revealed, the difference -0.48 cm (from FM, 25.28 cm to FU, 24.80 
cm, p-value 0.035) in female patients. In the lower limb circumferences the 
mean proximal thigh had a statistically significant difference -1.1 cm (at FM, 
59.19 cm to FU, 58.09 cm, p-value 0.045). In the lower limb, the calf circum-
ferences (at FM, 37.28 cm to FU, 37.41 cm), the middle thigh circumference (at 
FM, 51.74 cm to FU, 50.80 cm) and the ankle circumferences (at FM, 23.58 cm 
to FU, 23.01 cm) there were no statistically significant changes in female 
patients. 
Skinfolds. In female patients there were no statistically significant changes. 
The measured chin skinfold (at FM, 9.31 mm to FU, 10.03 mm), the chest (from 
12.16 mm to 11.28 mm), the side (at FM, 12.77 mm to FU, 12.83 mm), the 
waist (at FM, 14.75 mm to FU, 13.94 mm), suprailiac (at FM, 14.55 mm to FU, 
15.64 mm), umbilical (at FM, 18.38 mm to FU, 19.00 mm), the subscapular 
skinfold (at FM, 14.56 mm to FU, 15.48 mm), the biceps (at FM, 8.68 mm to 
FU, 10.18 mm), the triceps skinfold (from 18.59 mm to 16.94 mm), the thigh 
skinfold (at FM, 21.59 mm to FU, 20.25 mm) and the calf skinfold thickness (at 
FM, 15.91 to FU, 15.03 mm) in female patients were obtained as results. 
The mean BH decreased signifiantly in male patients by 1.29 cm and in 
female patients by 1.38 cm, which can be caused by the posture or the habitus 
of the studied kidney patients.  
The mean BW increased much more significantly in men (the mean 8.21 kg) 
after the follow-up compared with female patients who inreased non-signi-
ficantly (the mean 2.23 kg).  
Biacromial breadth measurement decreased significantly in the follow-up 
in male patients (p-value 0.044), and decreased non-significantly in the follow-
up in female patients. The pelvis breadth and the ankle breadth parameters 
increased significantly in male patients, and in female patients there was only 
significant increase in the pelvic breadth parameter (p-value 0.035) in the 
follow-up. Other breadth or depth measurements: the chest breadth, the waist 
breadth, the chest depth and the abdomen depth in males compared with 
females did not differ statistically in the follow-up. 
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Thickness of bones parameters: the humerus breadth, the wrist breadth and 
the femur breadth in males compared with females were not significantly 
different in the follow-up. 
The trunk circumferences: head, neck, and waist circumferences decreased 
significantly only in female patients, and the hip circumference increased 
significantly only in male patients in the follow-up. 
The upper leg arm circumference and the arm flexed-tensed circumference 
increased significantly in male but not in female patients in the follow-up. Only 
the forearm circumference decreased significantly in female patients compared 
with men in the follow-up. 
The lower leg calf cicumference increased statistically only in males, and, 
the proximal thigh circumference decreased statistically only in female patients 
(p-value 0.045). The middle thigh circumference and the ankle circumference 
had no statistical differences in male and female patients in the follow-up. 
Skinfolds ticknesses: chin, chest, subscapular, biceps and triceps were much 
more increased in the male patients after the follow-up compared with females 
(p ≤ 0.050). 
We noticed statistically significant changes in the comparison of KTx male 
patients BW data with healthy population controls in FM (n = 86, p = 0.008), 
but not in FU (p < 0.470). In female KTx patients group comparison BW data 
with healthy population controls (n = 256) there were statistically non-signi-
ficant changes in FM. Overweight was found in 15% of studied male and in 
25% of female patients. Only two female patients had malnutrition with BMI 
14.9 and 16.2 kg/m2 (Paper I). 
 The comparison of kidney transplant patientʼs mean BW data with the 
control group kidney transplant patients were given in Paper IV. The mean BW 
gain in the control group kidney transplant patients was significant both in the 
male and in female groups. BW was significantly lower in males at FM com-
pared with the population controls but at FU body weight was not different. In 
females, BW did not differ significantly from the population control group at 
FM or FU. BMI was significantly lower in males at FM compared with the 
population controls but at FU BMI was not different. In females, BMI did not 
differ significantly from the population controls at FM or FU (Paper IV). 
 Ten years after the kidney transplantation BW data in KTx patients and 
control kidney transplant patients were compared with BW data ten years after 
kidney transplantation and were given in Paper VI. We noticed BW gain in all 
KTx patients both in males and females as follows: in standard care group 
males the mean BW gain was 6.4 kg, females 7.0 kg and among intensively 
counselled males 4.6 kg, females 1.1 kg. But, we demonstrate statistically non-
significant weight change among counselled living KTx patients with long-term 
graft survival both in males (n = 9, p = 0.068) and females (n = 11, p = 0.317) 
which was registered ten years after the KTx. Among standard care control KTx 
patients weight change was statistically significant in both genders (males: n = 
21, p = 0.002; females: n = 15, p = 0.004) ten years after the KTx (Paper VI).  
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5.3. Results of body composition characteristics (Paper IV) 
The results of the body composition characteristic of the renal transplant pa-
tients were analysed twice: 1.5 years (the first measurement, FM) and 3 years 
(follow-up, FU) after kidney transplantation. The calculated body composition 
characteristics of the renal transplant patients were the body mass index (BMI), 
the waist to hip ratio (WHR), the body surface area (m2), the body density 
(g/cm3), the relative mass of fat by Siri (%), the mean skinfolds (mm), the mass 
of subcutaneous adipose tissue (kg) and the relative mass of subcutaneous 
adipose tissue (%). The structure of the body composition in kidney transplant 
male and female patients, which is determined on the basis of anthropometric 
variables and was calculated using classical formulas and methods, is shown in 
Table 3, and the comparison of kidney transplant patientsʼ mean BMI data with 
healthy control groups is shown in Table 4.  
 The body composition characteristics indicated systematic differences 
between renal transplant male and female patients. The calculated mean body 
surface area, the mean body density, the mean relative mass of fat by Siri, the 
mean skinfolds, the mean mass of subcutaneous adipose tissue and the mean 
relative mass of subcutaneous adipose tissue in male patients inreased 
significantly in the follow-up (p ≤ 0.050), but not in female patients. The mean 
BMI characteristics of kidney transplant patients increased significantly in both 
patients groups: in males the FM mean 24.66 ± 7.19 kg/m2, and the FU mean 
27.73 ± 6.77; in females the FM mean 27.26 ± 7.48 kg/m2 and the FU mean 
28.53 ± 7.71 kg/m2 (male, p < 0.001 and female p > 0.013). The mean WHR in 
male patients increased little non-significantly, but in female patients decreased 
significantly (p-value 0.037). 
 
Male patients (n = 12) 
Body surface area. Male patientsʼ mean body surface area (m2) increased 
significantly from FM, 1.89 ± 0.21 m2 to FU, 1.97 ± 0.20 m2 (p < 0.005). 
Body density. The calculated mean body density (g/cm3) in kidney trans-
plant male patients increased significantly from FM, 1.05 ± 0.01 g/cm3 to FU, 
1.05 ± 0.006 g/cm3 (p < 0.003).  
Relative mass of fat by Siri. The calculated mean relative mass of fat by 
Siri (%) was significantly increased in the observation period from FM, 21.02 ± 
3.03% to FU, 22.56 ± 2.86% (p < 0.003).  
Mean skinfolds thicknesses. The calculated mean skinfolds thicknesses 
(mm) were increased significantly from FM, 11.43 ± 6.78 mm to FU, 13.33 ± 
5.74 mm (p < 0.003). 
Mass of subcutaneous adipose tissue. The calculated mean mass of sub-
cutaneous adipose tissue (kg) was increased significantly from FM, 9.98 ± 6.69 kg 
to FU, 12.04 ± 6.55 kg (p-value 0.002). 
Relative mass of subcutaneous adipose tissue. The calculated mean rela-
tive mass of subcutaneous adipose tissue (%) was increased significantly from 
FM, 11.57 ± 4.79% to FU, 14.05 ± 4.44% (p-value 0.032).  
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Female patients (n = 16) 
Body surface area. Female patientsʼ mean body surface area (m2) increased 
non-significantly from FM, 1.80 ± 0.25 m2 to FU, 1.81 ± 0.25 m2.  
Body density. The mean body density (g/cm3) in kidney transplant female 
patients was non-significantly different from FM, 1.05 ± 0.01 g/cm3 to FU,  
1.05 ± 0.01 g/cm3.  
Relative mass of fat by Siri. In female patients the mean relative mass of fat 
by Siri (%) was non-significantly increased in the observation period from FM, 
22.69 ± 2.93% to FU, 23.03 ± 2.87%.  
Mean skinfolds thicknesses. The calculated mean skinfolds thicknesses 
(mm) were increased non-significantly from FM, 13.33 ± 6.69 mm to FU, 14.60 
± 6.26 mm.  
Mass of subcutaneous adipose tissue. The calculated mean mass of sub-
cutaneous adipose tissue (kg) decreased non-significantly in female patients 
from FM, 12.51 ± 7.18 kg to FU, 12.49 ± 6.95 kg.  
Relative mass of subcutaneous adipose tissue. The calculated mean rela-
tive mass of subcutaneous adipose tissue (%) in female patients increased non-
significantly from FM, 15.21 ± 5.09% to FU, 15.28 ± 4.55 kg.  
We noticed statistically significant changes in the comparison of KTx male 
patientsʼ BMI data with healthy control group in FM (n = 86, p = 0.008), but not 
in FU (p < 0.935). In female KTx patients group the comparison of mean BMI 
data with healthy control groups (n = 256) were statistically non-significant in 
FM and in FU. In the control group individualsʼ BMI was lower in males (p < 
0.001), and female groups (p < 0.01). The mean BMI was significantly lower in 
males and the first measurements compared with the population controls (p < 
0.009) but at FU the BMI was not different (p < 0.935). In females, the BMI did 
not differ significantly from population controls at the first measurement (p < 
0.941) either FU (p < 0.552). The comparison of KTx male patientsʼ mean BMI 
data with the healthy control group were statistically significant in FM, but not 
in FU. In female KTx patients group the comparison of the mean BMI data with 
the healthy control population was statistically non-significant. 
 
 
5.4. Results of bioimpedance measurement (Paper IV)  
The results of the bioimpedance characteristics of kidney transplant patients 
were analysed twice: 1.5 years (first measurements, FM) and 3 years (follow-
up, FU) after kidney transplantation. The bioimpedance characteristics in kid-
ney transplant male and female patients after renal transplantation are shown in 
Table 5.  
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Table 5. Bioimpedance characteristics in kidney transplant patients  
Measurements 
period FM    FU    P-value 
  after kidney transplantation  after kidney transplantation  FM 
 Mean SD Min Max  Mean SD Min Max vs FU 
Male (n = 12)    
Body fat by  
OMRON (%) 18.19 8.68 7.80 39.40 23.50 8.09 8.40 39.40 0.003* 
Body fat by 
OMRON (kg) 14.92 12.75 5.30 52.80 20.44 12.10 6.60 54.40 0.002* 
Female (n = 16)             
Body fat by 
OMRON (%) 33.06 10.80 9.90 44.80 34.80 11.11 10.50 48.00 0.005* 
Body fat by 
OMRON (kg) 25.74 12.57 4.20 46.50 28.36 14.99 4.90 60.00 0.040* 
 
*Statistically significant difference P ≤ 0.050 
Abbreviations: SD, standard deviation; FM, the first measurements; FU, follow-up measurements.  
 
 
Male patients (n = 12) 
Body fat by Omron (%). In male patients the mean body fat content by 
OMRON (%) increased significantly, the mean difference was 5.31% (FM, the 
mean 18.19%, and the mean FU is 23.50%, p-value 0.003). Body fat by 
Omron (kg). The mean body fat content by OMRON (kg) increased signifi-
cantly in male patients and the mean difference was 5.52 kg (the mean 14.92 kg 
to 20.44 kg, (p-value 0.002).  
 
Female patients (n = 16) 
Body fat by Omron (%). The mean body fat (%) in female patients, which was 
measured by OMRON, increased significantly. The mean difference was 1.74% 
(the mean 33.06% to 34.80%, p-value 0.005). Body fat by Omron (kg). The 
mean body fat (kg) was measured by OMRON. The mean BF content increased 
significantly in female patients and the mean difference was 2.62 kg (the mean 
25.74 kg to 28.36 kg, p-value 0.040).  
 The body fat characteristics, measured by bioimpedance in kidney transplant 
patients in percentage by OMRON (%), indicated that the mean body fat 
content increased significantly in both patientsʼ groups (males 5.31%; females 
1.74%). The body fat characteristics, measured by bioimpedance in kidney 
transplant patients in kilograms by OMRON (kg), indicated that the mean body 
fat in kilograms increased significantly in both patientsʼ groups (males 5.52 kg, 
females 2.62 kg). 
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5.5. Results of densitometric investigations (Paper IV) 
The densitometric measuring was carried out at the Department of Internal 
Medicine of the University of Tartu in the Densitometric Study Centre. Densito-
metric measurement was carried out on average three years after kidney trans-
plantation (FU). We present the results of the bone mineral density (BMD) mea-
surements which were measured with the machine a GE LUNAR DPX-IQ 
densitometer (Madison, WI, US, software version 4.7e) by IOF-certified techni-
cans. The studied renal transplant patients were clinically stable consecutive 
nondiabetic groups: 12 males, the age of 42.8 ± 16.1 (min 18, max 70) years, 
and 16 females, the age of 47.0 ± 14.9 (min 21, max 71). Individual densito-
metric measurement results have been statistically summarized in our thesis. 
The data of densitometric measurement in kidney transplant male and female 
patients are given in Table 6 and the characteristics of body composition para-
meters by DXA in KTx patients in the follow-up are given in Table 7. 
We present the characteristics of densitometric parameters of the studied 
contingent, the numerical data of the total and regional bone density which have 
been measured in different anatomical regions: the total body, arms, legs, 
trunks, spine and the region of anterior-posterior (AP) of lumbar spine (L1–L4). 
All the presented mean numerical values: the bone mineral density (BMD) in 
grams per centimeter squared (g/cm2) for a selected region, T-scores and Z-
scores, also SD, the minimal and the maximal values. The results of DXA mea-
surements after kidney transplantation are compared with the reference values 
in the LUNAR DPX- IQ densitometer data basis and the WHO criteria.  
 Total body bone mineral density. The mean total body BMD (g/cm2) after 
the second follow-up both in male (BMD = 1.151 ± 0.12 g/cm2, min 1.028, max 
1.336 g/cm2) and female (BMD = 1.117 ± 0.10 g/cm2; min 0.941, max  
1.296 g/cm2) renal transplant patient groups were lower than the normal range, 
which does not significantly differ from the BMD reference value for male 
(BMD = 1.210 ± 0.08 g/cm2) and for female (BMD = 1.123 ± 0.08 g/cm2) in 
population. 
Regional body bone mineral density. The regional body bone mineral 
density (BMD) anterior-posterior (AP) spine L2–L4 after the second follow-up 
both in male (BMD = 1.122 ± 0.17 g/cm2, min 0.893, max 1.344 g/cm2) and in 
female (BMD = 1.046 ± 0.16 g/cm2; min 0.774, max 1.395 g/cm2) kidney 
transplant patient groups were BMD lower than the normal range, which does 
not significantly differ from the BMD reference value for males (BMD = 1.180 
± 0.12 g/cm2) and for females (BMD = 1.180 ± 0.12 g/cm2) in population. 
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In Paper IV we present the individualized data in kidney transplant patients in 
absolute figures and percentages (%) by three T-score categories: normal, 
osteopenia and osteoporosis. Individual measures of the total body BMD after the 
second follow-up revealed low mineral density (osteopenia) in 50% of males and 
18% of females but anterior-posterior (AP) lumbar spine (L2–L4) measured T-
scores showed osteopeny in 33% of males and in 25% of females. Osteoporosis 
was not found using total body measurements but in the region AP lumbar spine 
(L2–L4) osteoporosis was found in 8% of male and 25% of female patients. The 
received data we compare with the WHO criteria which were used to distinguish 
normal bone mineral density, osteopenia (low bone mass) and osteoporosis: T-
scores measured criteria as follows: above -1: bone density is considered normal; 
between -1 and -2.5 this T-score is a sign of osteopenia; below -2.5 bone density 
indicated osteoporosis. (Report of the WHO Study Group 1994). 
 
Male patients (n = 12) 
On the basis of the total body bone mineral density by T-score in the group of 
male patients with the transplanted kidney the normal BMD in male patients was 
50% (6 male patients), osteopenia was in 50% male patients (6 male patients) and 
osteoporosis was not found. On the basis of AP Lumbar spine bone mineral 
density by T-score in the group of male patients with the transplanted kidney the 
normal BMD in male patients was 58% (7 male patients), osteopenia was in 33% 
(4 male patients) and osteoporosis was in 8% (1 male patient). 
 
Female patients (n = 16) 
On the basis of the total body bone mineral density by T-score in the group of 
female patients with the transplanted kidney the normal BMD in female patients 
was in 81% (13 female patients), osteopenia in 18% (3 female patients) and 
osteoporosis was not found. On the basis of the AP Lumbar spine bone mineral 
density by T-score in the group of female patients with the transplanted kidney 
the normal BMD in female patients was in 50% (8 female patients), osteopenia 
in 25% (4 female patients) and osteoporosis was in 25% (4 female patients). 
 
 
Table 7. The characteristics of body composition parameters by DXA in kidney 
transplant patients in the follow-up 
 
Variables FU    FU    
  Male (n = 12)  Female (n = 16) 
 Mean SD Min Max  Mean SD Min Max 
Fat Mass          
Total Fat Mass (kg) 19.6 13.9 6.1 60.1  31.4 14.5 8.6 60.0 
Total Fat Mass (%) 23.8 10.2 8.0 49.2  39.9 10.2 19.2 51.8 
Fat Free Mass                  
Total Lean Mass (kg) 55.6 8.3 44.3 70.6  40.9 7.1 33.3 57.7 
Total bone mineral content (kg) 3.0 0.6 2.3 3.9  2.6 0.6 1.6 3.6 
Body Tissu Mass          
Total Tissue Mass (kg) 74.9 16.7 58.6 118.6  72.3 20.2 42.9 114.2 
 
Abbreviations: SD, standard deviation; DXA, dual energy x-ray absorptiometry;  FU, follow-up 
measurements. 
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We have presented the characteristics of measured body composition para-
meters by DXA in the studied contingent: total fat mass (kg; %), total lean mass 
(kg), total tissue mass (kg) 
 
Male patients (n = 12) 
Body fat mass by DXA (kg). The mean total fat mass content (kg) by DXA in 
male patients was 19.6 kg ± 13.9 kg in FU.  
Body fat mass by DXA (%). The mean total fat mass content (%) by DXA 
in male patients was 23.8% ± 10.2% in FU.  
Total lean mass by DXA (kg). The mean total lean mass content (kg) by 
DXA in male patients was 55.6 kg ± 8.3 kg in FU.  
Total tissue mass by DXA (kg). The mean total tissue mass content (kg) by 
DXA in male patients was 74.9 ± 16.7 kg in FU.  
 
Female patients (n = 16) 
Body fat mass by DXA (kg). The mean total fat mass content (kg) by DXA in 
female patients was 31.4 kg ± 14.5 kg in FU. The minimal total fat mass by 
DXA was 8.6 kg and maximal content was 60 kg in female patients. 
Body fat mass by DXA (%). The mean total fat mass content (%) by DXA 
in female patients was 39.9% ± 10.2% in FU.  
Total lean mass by DXA (kg). The mean total lean mass content (kg) by 
DXA in female patients was 40.9 kg ± 7.1 kg in FU. 
Total tissue mass by DXA (kg). The mean total tissue mass content (kg) by 
DXA in female patients was 72.3 ± 20.2 kg in FU.  
 
The total body BMD after the second follow-up both in male and female kidney 
transplant patient groups was lower than the normal range, which does not 
significantly differ from the BMD reference value for males and for females in 
population. 
The regional body bone mineral density (BMD) AP spine L2–L4 after the 
second follow-up both in male and in female kidney transplant patient groups 
was lower than the normal range, which does not significantly differ from the 
BMD reference value for males and for females in population. 
The results of individualized data by T-score in kidney transplant patients 
mainly in the region AP Lumbar in absolute figures and percentages (%) by 
three T-score categories indicated a higher number of osteoporosis in the female 
group. In the region AP Lumbar the normal bone tissue density was in 7 male 
patients and in 8 female patients, ostoepenia was in 4 male patients and 4 
female patients. 
The results of body composition parameters by DXA in kidney transplant 
male patients in the follow-up indicated that the total fat mass (kg; %) was 
lower compared with female patients, and the total lean mass (kg) was higher in 
male patients compared with female patients. 
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5.6. Results of laboratory investigations (Paper IV) 
Laboratory analyses were carried out in the studied patients at the beginning 
(FM) of the investigation one and half years, and then three years after the kid-
ney transplantation (FU). All the laboratory results were compared with Tartu 
University United Laboratories reference ranges (Laboratory Manual IV, 2012). 
Biochemical changes in kidney transplant patients after kidney transplantation 
are demonstrated in Table 8.  
S-Alb mean level significantly improved after transplantation in comparison 
with the first and the FU measurements both in males (p-value 0.008) and 
females (p-value 0.011). S-Prot level was significantly increased in female 
patients at FU compared with the first data, and increased non-significantly in 
male patients. 
S-CRP mean level non-significantly increased in male patients but not in 
female patients and remained at lower levels of the normal range (< 5.0 mg/L) 
after the transplantation. 
S-Crea mean level was non-signifigantly increased in male patients and in 
female patients after the post-transplantation, but the mean S-Urea level was 
non-signifigantly decreased in male patients and little non-signifigantly in-
creased in female patients (8.00 ± 2.39 mmol/L and at FU, 8.99 ± 3.36 mmol/L) 
in FM compared with FU. 
S-UA mean level was little significantly increased in male (p-value 0.014) 
and in female patients (p-value 0.017) at the beginning of the observation after 
kidney transplantation. 
S-ALP mean level during the study was non-significantly decreased in male 
(114.50 ± 60.59 U/L and FU, 110.14 ± 32.91 U/L) and in female patients (86.19 
± 32.35 U/L and FU, 83.75 ± 31.07 U/L) and was in the normal range for male 
(40–130 U/L) and female patients (35–105 U/L). 
S-iCa mean level was non-significantly little increased in male and female 
patients and was in the normal range for a male and a female (1.16–1.32 mmol/L). 
S-P mean level in male and female patients non-significantly decreased and 
was in the normal range (0.87–1.45 mmol/L) after kidney transplanation. 
fB-Hb mean level showed a growth tendency and significantly increased in 
male (116.92 ± 14.60 g/L and FU, 137.50 ± 27.61 g/L, p-value 0.005) and 
female patients (116.69 ± 11.96 g/L and FU, 127.63 ± 13.61 g/L, p-value 0.009) 
but was in the normal range. 
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S-Chol mean level in male (5.84 mmol/L and FU, 5.92 mmol/L) and in female 
patients (6.26 mmol/L and FU, 6.50 mmol/L) was non-significantly little 
increased from the beginning to the end of the observation after the kidney 
transplantation (S-Chol recommended level is  < 5.0 mmol/L). 
S-HDL-Chol mean level in male (1.45 ± 0.38 mmol/L and FU, 1.49 ±  
0.42 mmol/L) and female patients (1.44 ± 0.39 mmol/L and FU, 1.62 ±  
0.36 mmol/L) was non-significantly little increased, compared at the recom-
mended levels S-HDL-Chol normal range (> 1.0 mg/L), from the beginning to 
the end of the observation after the kidney transplantation. 
S-LDL-Chol mean level in male (3.63 ± 0.91 mmol/L and FU, 3.85 ±  
1.27 mmol/L) and female patients (3.98 ± 1.22 mmol/L and FU, 4.44 ±  
0.92 mmol/L) was non-significantly little increased at the recommended levels 
(< 3.0 mmol/L) from the beginning to the end of the observation after the 
kidney transplantation.S-Trigl mean level in male patients was non-significantly 
increased (1.58 ± 0.51 mmol/L and at FU, 1.80 ± 0.89 mmol/L) and, on the 
other hand, in females S-Trigl mean level showed a significantly lowering 
tendency (2.31 ± 1.36 mmol/L and at FU, 1.69 ± 1.13 mmol/L, p-value 0.034). 
Glomerular filtration rate (GFR) raised a little, and non-significantly both 
in male (57.03 ± 21.17 mL/min to 57.67 ± 21.06 mL/min) and in female (49.77 
± 16.31 mL/min to 50.05 ± 17.00 mL/min) patients groups after the kidney 
transplantation (reference value e-GFR > 90 mL/min). 
Serum parathyroid hormone (S-PTH, pmol/L), serum homocysteine (S-
Hcy, µmol/L) and serum cystatin C (S-CysC, mg/L) were measured at the 
follow-up, and laboratory data from parathyroid hormone, homocysteine and 
cystatin C in kidney transplant male and female patients are demonstrated in 
Table 9.  
 
 
Table 9. Parathyroid hormone, homocysteine and cystatin C in kidney  
transplant male and female patients in the follow-up   
 
Variables Laboratory reference
 Mean SD Min Max
Normal 
range
Male (n = 12)  
S-PTH (pmol/L) 8.92 4.77 4.00 17.70 1.60–6.90 
S-Hcys (μmol/L) 19.83 13.38 10.20 57.95 < 12 
S-CysC (mg/L) 1.18 0.55 0.72 2.42 0.47–1.09 
Female (n = 16)  
S-PTH (pmol/L) 21.35 13.29 8.20 44.00 1.60–6.90 
S-Hcys (μmol/L 16.14 3.46 10.60 22.60 < 12 
S-CysC (mg/L) 0.98 0.27 0.66 1.42 0.47–1.09 
 
Abbreviations: SD, standard deviation; S-PTH, serum parathyroid hormone;  
S-Hcys, serum homocysteine; S-CysC, serum cystatin C. 
 
62 
S-PTH mean levels in male patients was little above the normal range (the 
mean S-PTH, 8.92 ± 4.77 pmol/L), but the mean S-PTH for a female is  
21.35 ± 13.29 pmol/L in the follow-up. The normal range for S-PTH is 1.60– 
6.90 pmol/L. 
S-Hcy mean levels in the studied patients groups were a little above the 
normal range (< 12 µmol/L) both in male (the mean 19.83 ± 13.38 µmol/L), and 
female patients (the mean 16.14 ± 3.46 µmol/L). S-CysC mean level of males 
was a little higher compared with the normal range (the mean 1.18 ±  
0.55 mg/L). The laboratory normal range S-CysC is 0.47–1.09 mg/L. But in fema-
les the mean S-CysC remained in the normal range and was 0.98 ± 0.27 mg/L. 
The mean S-PTH level in male patients was little above the normal range, 
but in female patients S-PTH mean level was increased, and was higher from 
the laboratory recommended normal range for an adult (1.60–6.90 pmol/L). S-
Hcys mean levels in the studied patients groups were a little above the normal 
range for male and female patients (12 mmol/L). The mean S-CysC level in 
male patients was a little higher, but in female patients remained in the normal 
range (0.47–1.09 mg/L).  
 
 
5.7. Correlation analysis between anthropometric and 
laboratory variables (Paper IV) 
The correlation analysis of medium anthropometric indicators with medium 
laboratory parameters was carried out separately for males (n = 12) and females 
(n = 16). The results of the correlations analysis between selected anthropo-
metric and laboratory parameters in male and female kidney transplant patients 
after the first measurements (FM) and the follow-up (FU) are given for male 
patients and for female patients in Paper IV. 
 The correlation analysis showed in male kidney transplant patients that the 
mean inflammatory indicators (CRP) were significantly correlated with diffe-
rent body circumferences (waist, hip, mid arm relaxed, mid-arm flexed and 
tensed), and skinfolds thicknesses (suprailiac, subscapular, triceps). In males, no 
clear associations were found between lipid (Chol, S-HDL-Chol, S-LDL-Chol, 
S-Trigl) and anthropometric parameters.  
 The correlation analysis showed in females that no clear associations were 
found between the inflammation status and anthropometric parameters.We 
found more associations between lipid parameters (Chol, S-HDL-Chol, S-LDL-
Chol, S-Trigl) and anthropometrical variables (BW, breadth-depth, circum-
ferences, skinfolds thicknesses, BF, WHR) in FM and in FU. In female patients 
at the beginning and at the end of observations only certain features deserve 
attention; the connection between anthropometrical parameters (circumferences, 
skinfolds, body fat by OMRON) and lipid parameters (Chol, S-LDL-Chol, S-
Trigl).  
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Male patients (n = 12) 
Correlation analysis between selected anthropometric and laboratory 
variables in kidney transplant male patients after FM and FU. We found at 
the beginning of observation (FM) no reliable correlations between blood 
hemoglobin, serum albumin, serum creatinine, serum urea, serum alkaline 
phosphatase, serum calcium ionized, serum phosphate and anthropometric 
indicators (body weight, waist and hip circumferences, skinfolds, indices).  
In males at the beginning of observation the mean serum C-reactive protein 
(S-CRP) was significantly correlated with different body circumferences and 
skinfolds thicknesses, there were seven statistically significant correlations: 
waist circumferences (r = 0.835), hip circumferences (r = 0.735), mid-arm 
circumferences (r = 0.790), mid-arm circumferences flexed and tensed (r = 
0.737), suprailiac skinfolds thicknesses (r = 0.724), subscapular skinfolds (r = 
0.687), triceps skinfolds (r = 0.616), and no reliable correlation with body 
weight (r = 0.256).  
We found at the end (FU) of observation in male patients statistically signi-
ficant positive correlation between nine anthropometric parameters and S-CRP: 
mean waist circumferences (r = 0.710), mean hip circumferences (r = 0.770), 
mean mid-arm relaxed (r = 0.790), mid arm flexed-tensed circumferences (r = 
0.737), suprailiac skinfolds thicknesses (r = 0.614), subscapular skinfolds (r = 
0.727), and no reliable correlations with biceps and triceps skinfolds. At the end 
(FU) of observation there was a significant positive correlation with the mean 
BF by Omron (kg) (r = 0.723), with the mean BMI (r = 0.779) and with body 
weight (r = 0.747).  
Correlation analysis between anthropometric variables and lipid para-
meters in kidney transplant male patients after FM and FU. We found at 
the beginning (FM) of observation positive significant correlations in male 
kidney transplant patients between three anthropometric parameters and S-
LDL-Chol: the mean chin skinfolds (r = 0.747), the mean triceps skinfolds (r = 
0.679) and the mean WHR (r = 0.710). The mean S-HDL-Chol correlated 
significantly with umbilical skinfolds (r = 0.636). In males at the end (FU) of 
observation there were no reliable correlations between anthropometric 
variables and blood lipid parameters in KTx male patients. 
 
Female patients (n = 16) 
Correlation analysis between selected anthropometric and laboratory 
variables in kidney transplant female patients after FM and FU. We found 
at the beginning (FM) of observation statistically significant correlations in 
female kidney transplant patients between eight anthropometric parameters and 
S-ALP: body weight (r = 0.501), waist circumference (r = 0.742), mid-arm 
relaxed (r = 0.532), mid-arm flexed and tensed (r = 0.579), suprailiac skinfolds 
(r = 0.601), subscapular skinfolds (r = 0.553), biceps skinfolds (r = 0.640), 
triceps skinfolds (r = 0.682).  
In females, at the end (FU) of observation similar correlations stayed 
between nine  anthropometric parameters and S-ALP: body weight (r = 0.644), 
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waist circumference (r = 0.522), hip circumference (r = 0.664), mid-arm relaxed 
(r = 0.531), mid-arm flexed and tensed (r = 0.560), suprailiac skinfolds (r = 
0.505), subscapular skinfolds (r = 0.521), biceps skinfolds (r = 0.449), body fat 
(kg) by OMRON (r = 0.617), body fat (%) by OMRON (r = 0.616). We found 
at the end (FU) of observation statistically significant negative correlations 
between nine anthropometric parameters and serum phosphate (S-P): body 
weight, four body circumferences, subscapular skinfold thicknesses, body fat 
(kg; %) by OMRON, and BMI. The mean serum calciun ionized (S-iCa) 
correlated significantly with different body circumferences and skinfolds thick-
nesses: waist circumference, suprailiac skinfolds, biceps skinfolds, body fat, 
BMI. Serum creatinine (S-Crea) and urea (S-Urea) were not significantly cor-
related with body measurements at the beginning or at the end of observation. 
Correlation analysis between selected anthropometric and lipid para-
meters in kidney transplant female patients after FM and FU. We found at 
the beginning (FM) of observation statistically significant strongest positive 
correlations in female kidney transplant patients between twenty-three 
anthropometric parameters and S-Trigl: body weight (r = 0.571), six breadth 
and depth parameters, neck circumference (r = 0.655), chest circumference (r = 
0.573), waist circumference (r = 0.626), forearm circumference (r = 0.621), 
wrist circumference (r = 0.702), chest skinfolds (r = 0.561), side skinfolds (r = 
0.653), waist skinfolds (r = 0.648), supriliac skinfolds (r = 0.542), umbilcal 
skinfolds (r = 0.603), subscapular skinfolds (r = 0.524), biceps skinfolds (r = 
0.587), triceps skinfolds (r = 0.520), body fat (kg) by OMRON (r = 0.518) and 
BMI (r = 0.563) parameters.  
At the beginning the mean Chol was significantly positively correlated only 
with the mean BF (%) by OMRON (r = 0.614) parameters and at the end (FU) 
of observation correlated positively with the mean BF (%) by OMRON (r = 
0.597) parameters. Cholesterol of fat indicators was not significantly correlated 
with other anthropometric features in female patients in the follow-up. At the 
beginning the mean S-LDL-Chol was significantly correlated with the mean BF 
(%) by OMRON (r = 0.517) parameters but at FU there were only significantly 
correlated: body fat (%) by OMRON (r = 0.676) and waist to hip ratio (r = 
0.545) parameters. We found at the end of observation statistically significant 
correlations in female kidney transplant patients between six anthropometric 
parameters and S-LDL-Chol. 
In females, at the end (FU) of observation similar correlations stayed 
between twenty-one anthropometric parameters and S-Trigl: body weight (r = 
0.622), five breadth and depth parameters, neck circumference (r = 0.602), chest 
circumference (r = 0.679), waist circumference (r = 0.559), hip circumference (r 
= 0.567), ankle circumference (r = 0.492), mid-arm flexed and tensed circum-
ference (r = 0.499), forearm circumference (r = 0.568), wrist circumference (r = 
0.594), chin skinfolds (r = 0.638), waist skinfolds (r = 0.580), chin umbilical 
skinfolds (r = 0.630), subscapular skinfolds (r = 0.534), body fat in (kg) by 
OMRON (r = 0.653), body fat (%) by OMRON (r = 0.504), BMI  
(r  = 0.650) parameters. We found at the beginning statistically non-significant 
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correlations between anthropometric parameters and S-HDL-Chol, but at the 
end we found thirteen negative significant correlations. 
 
 
5.8. Multiple regression models between anthropometric 
and laboratory variables 
The results of the multiple regression analysis which were used to evaluate 
associations among different anthropometric and lipid variables. Four models 
were analysed and the results between anthropometric and laboratory variables 
with R-Square components in male (n = 12) and in female (n = 16) kidney 
transplant patients are given in Table 10. 
 
 
Table 10. Multiple regression models between the anthropometrical and the laboratory 
variables in kidney transplant patients  
 
Model 
No Dependent variable Intercept Coefficent Independent variable 
R-
Square 
Male (n = 12)         
Model 1. S-TG (mmol/L) -1.384 -0.068 Hip circumference (cm) 0.6761 
FM    0.211 MAC, tensed (cm)   
Model 2. S-LDL-Chol (mmol/L) -1.914 -0.402 Biceps’ skinfolds (mm) 0.7204 
FM    0.399 Triceps’ skinfolds (mm)   
Female (n = 16)         
Model 3. S-LDL-Chol (mmol/L) -1.010 -0.073 Body weight (kg) 0.6854 
FU   0.271 Body fat (kg)  
      -0.271 BMI (kg/m2)   
Model 4. S-LDL-Chol (mmol/L) -0.920 0.131 Hip circumference (cm) 0.4633 
FM  0.533 MAC, relaxed (cm)  
      0.769 MAC, tensed (cm)   
 
Abbreviations: MAC, mid-arm circumference; S-LDL-Chol, serum low-density lipo-
protein; S-TG, serum triglyceride; FM, the first measurements; FU, follow-up. 
 
 
Four models were analysed and the results revealed the following:  
1)  multiple regression model 1 components FM analysis indicated that trigly-
cerides (S-Tg) content was associated negatively with hip circumference and 
positively with mid-arm circumference (MAC) in male patients (Inter- 
cept -1.384, R-Square 0.6761);  
2)  multiple regression model 2 components FM analysis indicated that S-LDL 
Cholesterol was associated negatively with Bicepsʼ skinfolds and positively 
with Tricepsʼ skinfolds in male patients (Intercept -1.914, R-Square 0.7204);  
3)  multiple regression model 3 components FU analysis indicated that S-LDL 
Cholesterol was associated negatively with body weight, positively with 
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body fat and negatively with BMI in female patients (Intercept -1.101, R-
Square 0.6854);  
4)  multiple regression model 4 components FM analysis indicated that S-LDL 
Cholesterol was associated positively with hip circumference, with MAC, 
relaxed or tensed in female patients (Intercept -0.920, R-Square 0.4633). 
 
 
5.9. Results of the implementation of treatment diets for 
patients (Paper III) 
The establishment of the system of treatment diets to support the patientsʼ 
complex treatment has taken place on three levels: at the Tartu University 
Hospital, in the Estonian Health Care and Social Welfare Institutions and the 
Ministry of Social Affairs by adopting a specific regulation. The system of diets 
developed and used in practice at the Tartu University Hospital was imple-
mented in clinical practice at the hospitalʼs nephrology division, also in other 
Estonian health care institutions.  
On 12 November 2002 the handbook for treatment diets worked out by the 
author of the thesis ”Treatment diets” was published (Kiisk 2002). It is used at 
the Tartu University Hospital and other hospitals in Estonia. The handbook is 
helpful for doctors and nurses when counselling their patients. The handbook 
consists of five chapters. In the first part of the handbook a detailed description 
of the nomenclature of treatment diets for patients is given together with a 
historical overview of the development of treatment diets. In the nomenclature 
of the diets an ordinary food and eight groups of diet foods are given. Each 
group is supplied with the detailed characteristics of the diet, the average 
content of basic nutrients and their indications for the use by groups of diseases. 
A special overview of the four variants of diets recommended for diabetics is 
given. Patients with special needs are recommended to use liquid and soft diet 
foods. There are diets with strict limitations. Also, an overview of the system of 
standardized food probe is given. In the second half of the handbook the author 
has presented a summarizing table of the nomenclature of diets with recom-
mendations for the daily consumption of energy and basic nutrients taking into 
consideration the Estonian nutrition recommendations and instructions for 
treatment (Estonian Nutrition Recommendation and Food Based Dietary 
Guidelines 2006). In the third part of the book the division of foodstuffs into 
groups is given: the group of cereals, milk, meat, potato and vegetables; the 
group of berries and fruits; the group of fat and sweet things; the group of 
drinks; also the group of spices and additives. To cover all the variants of diets, 
there are 25 summarizing tables which contain a list of the recommended, non-
recommended and prohibited foodstuffs by groups. In the fourth part of the 
book the choice of diet foods is presented: soups, fried meat and fish, sauces, 
pot dishes, stews, porridges, desserts, bakeries, salads, fruits, sandwiches, 
additives and drinks. The handbook includes 227 recipes with their composition 
of foodstuffs and basic nutrients. In the fifth part of the handbook there are 
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different daily specimen menus for ordinary food and they are provided for 20-
day periods, and for diet foods daily specimen menus have been composed for 
five different days. All the dietetic dishes in the handbook have been presented 
as sets of daily menus that meet the needs for dietary nutrition in the case of 
different medical conditions.  
In the handbook ”Treatment diets” (Kiisk 2002) the nomenclature of diets 
with recommendations for the consumption of the daily food energy and basic 
nutrients has been presented and it serves as the part which was taken into 
consideration in working out the new regulation. The author of the handbook 
participated in the working group of the people producing the regulation. At the 
present the Regulation of the Ministry of Social Affairs ”Health Protection 
Requirements for the Nutrition in Hospitals and Health Care Institutionsˮ which 
was adopted on 14 November 2002 and entered into force on 1 January 2003 
provides the requirements for the food for patients concerning the composition 
of the food, the content of energy and nutrients (RTL 2002, 131, 1918). A sum-
marizing table titled ”The content of food energy and nutrients” is presented in 
Supplement 3 of the regulation. The systematizised nomenclature of treatment 
diets for a multiprofile health care institution is essential in patientsʼ care, and 
has been used for patientsʼ nutrition in the Tartu University Hospital, and in all 
Estonian Health Care and Social Welfare Institutions (Regulation no. 131, 
Health Protection Requirements for Nutrition in Health Care and Social Welfare 
Institutions, issued on 14 November 2002 by the Estonian Minister of Social 
Affairs). Treatment diets are in use for the normative values of the basic 
nutrients in accordance with the Estonian nutritional recommendations. 
In the years 2008–2009 the autor finished producing a big-amount data base 
for ordinary and diet nutrition with planned menus, the titles of diets and codes, 
the titles of foods and codes which have been entered into the hospitalsʼ 
electronic-Health computer system (the implication of documentation, e-HL). 
All the data of the nutrition of patients, the title of the indicated diet, the weight 
of the portion and the real daily menu are connected with the case history of the 
particular patient and can be seen by the medical staff. The programme also 
allows to draw personal menus for the special needs patients. The system of 
diets developed and used in practice at the Tartu University Hospital together 
with its implementation in the electronic-Health computer system is used in the 
nephrological division and all the 16 clinics of the Tartu Univertsity Hospital 
and in other Estonian hospitals and care institutions.  
 
 
 
5.10. Results of the analyses of Food Frequency 
Questionnaire 
We analyse nutritional habits in 12 male and 16 female consecutive kidney 
transplant patients 1.5 years after the transplantation. The data on individual 
nutritional habits were obtained by a Food Frequency Questionnaire in Table 
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11. Results of nutritional habits based on the food-frequency questionnaire. 
Part I–VI. 
 
Table 11. Results of nutritional habits based on the Food Frequency Questionnaire 
Part I. The frequency table (percentage) of social-economic situation for the patients 
with the transplanted kidney 
 
No   Subjects Male     (n = 12) 
Female     
(n = 16) 
  Frequency (%) % % 
1. Your family status   
 single 41.7 31.3 
 married 41.7 37.5 
 cohabitation 16.7 6.3 
 divorced 0.0 25.0 
2. Your education   
 primary 33.3 6.3 
 secondary 41.7 50.0 
 secondary special 16.7 31.3 
 unfinished higher 8.3 0.0 
 higher 0.0 12.5 
3. Do you work   
 no work 75.0 75.0 
 constantly 16.7 12.5 
 temporarily 8.3 12.5 
4. How big is your working load   
 full load 8.3 12.5 
 part time 16.7 12.5 
 freed, disability group 75.0 75.0 
5. How do you assess the familyʼs economic status   
 bad 16.7 12.5 
 satisfactory 75.0 68.8 
 good 8.3 18.8 
6. Does your economic situation allow you to eat at your free choice   
 no opportunities 16.7 6.3 
 meets the elementary (one-sided) basic needs 25.0 6.3 
 freely provides basic food (bread, milk, potato, vegetables) 25.0 37.5 
 freely provides many-sided food 25.0 43.8 
 no limitations in the choice of food 8.3 6.3 
 
 
Patientsʼ marital status. The majority of male and female patients were mar-
ried or cohabited (58.4% of males and 43.8% of females), 25% of female pa-
tients were divorced, 41.7% of males and 31.3% of females were single. 
Patientsʼ family status is shown in Figure 3.   
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Figure 3. Kidney transplant patientsʼ family status based on the food-frequency 
questionnaire (FFQ). All the data of the frequency table are given in percentage (%). 
 
 
Patientsʼ education. Patients with higher education were only among females 
(12.5%) and 91.7% of males and 87.6% of female patients had primary, 
secondary or specialized secondary education. Patientsʼ education is shown in 
Figure 4. 
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Figure 4. Kidney transplant patientsʼ education data based on the food-frequency 
questionnaire (FFQ). All the data of the frequency table are given in percentage (%). 
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Patientsʼ working status. 2/3 of male and 2/3 of female patients did not work 
as they were categorized as disabled, 1/3 of subjects worked either constantly or 
sometimes, either full- or part-time. The studied patientsʼ working status is 
shown in Figure 5.  
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Figure 5. Kidney transplant patientsʼ working status based on the food-frequency ques-
tionnaire (FFQ). All the data of the frequency table are given in percentage (%). 
 
 
Patientsʼ assessment of their familiesʼ economic situation. The economic 
situation of the family was considered poor by 16.7% of males and 12.5% of 
females, satisfactory by 75% of males and 68.8% of females, and only 8.3% of 
male and 18.8% of female patients considered their economic status good.  
Patientsʼ economic situation. For 25% of males and 6.3% of females the 
choice of food was limited: they were able to afford only indispensable and 
unbalanced food (for basic needs). 25% of male and 43.8% of female patients 
could choose satisfactory and varied basic food (potato, bread, milk, vege-
tables), 8.3% of males and 6.3% of females did not have any limitations in 
choosing their food.  
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Table 11. The nutritional habits based on the food-frequency questionnaire 
Part II. The frequency table of the nutrititional traditions of the family 
 
No   Subjects Male (n = 12) Female (n = 16) 
  Frequency (%) % % 
1. Which attention to eating is given in the family   
 no special 16.7 6.3 
 moderate 75.0 87.5 
 big 8.3 6.3 
2. How many meal-times a day   
 no regularity 25.0 6.3 
 one time a regular meal a day 16.7 6.3 
 two times 0.0 25.0 
 three times  50.0 56.3 
 four times and more 8.3 6.3 
3. The richest meal in your family   
 breakfast 0.0 0.0 
 lunch 58.3 62.5 
 supper 33.3 25.0 
 irregular 8.3 12.5 
4. Breakfastʼs regularity and character   
 little and irregular food 8.3 0.0 
 always but little (sandwich, juice, milk, coffee, etc.) 75.0 93.8 
 hot meal (porridges, stews, fried potatoes, etc.) 16.7 6.3 
5. Lunchʼs regularity and character   
 regular lunch at midday, at 12.00–16.00 66.7 87.5 
 at 16.00–18.00 8.3 6.3 
 after 18.00 0.0 6.3 
 irregular 25.0 0.0 
6. Supperʼs regularity and character   
 coincides with later lunch, no more food later 0.0 12.5 
 at 18.00–20.00 66.7 75.0 
 after 20.00 8.3 0.0 
 irregular 25.0 12.5 
7. How many times does the familly eat together   
 never, everybody has his/her times for food 0.0 37.5 
 in the morning 33.3 6.3 
 at midday 16.7 6.3 
 in the evenings 25.0 31.3 
 two or more times together  25.0 18.8 
8. Who prepares most often   
 mother 25.0 37.5 
 father 8.3 0.0 
 all the family members 66.7 62.5 
9. Are there many parties in your family (guests, relatives)   
 no 33.3 12.5 
 seldom (once a month) 33.3 62.5 
 sometimes (once a week) 25.0 12.5 
 often (2-3 times a week) 8.3 12.5 
10. Are your family gatherings or other parties with alcohol   
 never 25.0 18.8 
 seldom 8.3 43.8 
 sometimes 50.0 31.3 
 often 16.7 6.3 
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Attention to eating in the family. The great attention was paid to eating in the 
families of 8.3% of male and 12.5% of female patients.  
Number of mealtimes a day. The greatest percentage of families had four 
or more meals a day (8.3% of males and 12.5% of females), 25% of male and 
6.3% of female patients did not keep to regular meals.  
Regularity and character of breakfast. The majority of male (75%) and 
female (93.8%) patients preferred a light meal (sandwiches, coffee, milk, juice). 
Hot breakfast was eaten in few families (16.7% of males and 6.3% of females). 
The richest meals in the family were lunch and supper, 25% of males and 6.3% 
of females did not keep to regular mealtimes. 
Family gatherings or other parties with alcohol. 16.7% of males and 6.3% 
of females consumed alcoholic drinks frequently, 58.3% of males and 85.1% of 
females did it seldom; 25% of males and 18.8% of females did not consume any 
alcoholic drinks at all. 
 
 
Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part III. The frequency table (percentage) of the own nutrititional habits for the 
patients with the transplanted kidney 
 
No Subjects Male (n = 12) Female (n = 16) 
  Frequency (%) % % 
1. How many times a day do you usually eat   
 two times 0.0 6.3 
 three times 50.0 62.5 
 four times 41.7 31.3 
 five times 8.3 0.0 
2. How many times a day do you have a hot meal   
 once 33.3 25.0 
 two times 33.3 68.8 
 three times 33.3 6.3 
3. In the morning the first meal time   
 at 5 8.3 0.0 
 at 7 25.0 31.3 
 at 8 41.7 31.3 
 at 9 25.0 31.3 
 at 10 0.0 6.3 
4. Character of breakfast   
 only drink (water, juice, coffee, tea, etc.) 0.0 6.3 
 eat vegetables and fruits 83.3 81.3 
 eat a rich hot meal 16.7 12.5 
5. Morning appetite   
 not at all 0.0 6.3 
 no appetite but I can eat 8.3 31.3 
 I have appetite but being in a hurry no time 16.7 0.0 
 good appetite  75.0 62.5 
6. Character of lunch   
 some snacks 8.3 6.3 
 have a hot meal 91.7 93.8 
7.  Character of supper   
 do not eat 0.0 6.3 
 some snacks 0.0 6.3 
 dry meal (sandwiches, chips, etc.) 33.3 6.3 
 have a hot meal 66.7 81.3 
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Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part III. The frequency table (percentage) of the own nutrititional habits for the 
patients with the transplanted kidney (continued) 
 
No Subjects Male (n = 12) Female (n = 16) 
  Frequency (%) % % 
8. Do you eat something in the evening before going to bed   
 no 33.3 25.0 
 seldom 33.3 18.8 
 sometimes 16.7 31.3 
 often 8.3 12.5 
 always 8.3 12.5 
9. Do you eat sweets, fruits, berries, etc. between meals   
 no 8.3 6.3 
 seldom 25.0 25.0 
 sometimes 50.0 56.3 
 often 16.7 12.5 
10. Do you have an unpleasant feeling after some meal   
 no 83.3 62.5 
 seldom 16.7 18.8 
 always 0.0 18.8 
11. The complaints connected with food   
 no complaints 91.7 56.3 
 flatulence 8.3 12.6 
 nausea 0.0 12.5 
 heartburn 0.0 6.3 
 belching 0.0 6.3 
 other complaints 0.0 6.3 
12. Do you like to eat sweet things   
 no 16.7 6.3 
 seldom 0.0 25.0 
 sometimes 58.3 25.0 
 often 25.0 43.8 
13. Do you add salt to ready-made food   
 no 5.0 43.8 
 seldom 33.3 25.0 
 sometimes 16.7 12.5 
 often 0.0 18.8 
14. Do you add pepper and other hot spices to your ready-made food  
 no 16.7 50.0 
 seldom 33.3 12.5 
 sometimes 41.7 18.8 
 often 8.3 12.5 
 always 0.0 6.3 
15. Frequency of stool   
 once a day 91.7 50.0 
 every other day 8.3 43.8 
 after several days 0.0 6.3 
 
 
The number of meals: the patients ate 3-4 times a day, seldom twice a day. The 
usual number of warm meals: 68% of female patients cooked a hot meal at least 
twice a day. Among male patients, 33.3% had a hot meal once a day, 33.3% 
twice a day and 33.3% three times a day.  
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The time of the first meal in the morning: 66.7% of males and 62.6% of 
females had a meal between 7–8 oʼclock, 6.3% of females ate after 10 oʼclock.  
Morning appetite: 75% of male and 62.5% of female patients had a good 
appetite. Some subjects (8.3% of males and 31.3% of females) had no appetite 
but still forced themselves to eat. The complete lack of appetite was mentioned 
by 6.3% of females. The nutritional habits for the kidney transplant patients are 
shown in Figure 6. 
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Figure 6. The nutritional habits for the kidney transplant patients based on the food-fre-
quency questionnaire (FFQ). All the data of the frequency table are given in percentage (%). 
 
 
The character of lunch and of supper: hot lunch was eaten by the majority of 
subjects (91.7% of males and 93.8% of females). Hot supper was eaten by 
66.7% of males and 81.3% of females.  
Eating in the evening before going to bed: a part of males (8.3%) and 
females (12.5%) ate before going to bed, 33.3% of males and 25% of females 
never did it.  
Eating sweets, fruit, berries, etc. between meals: sweets, fruit, berries, etc. 
were eaten between meals seldom by 75% of males and 81.3% of females.  
An unpleasant feeling after a meal. The majority of male and female 
patients did not experience an unpleasant feeling after eating certain foodstuffs. 
An unpleasant feeling after a meal was experienced seldom by 16.7% of male 
and 18.8% of female patients.  
Complaints connected with a food: 37.7% of female patients complained 
of nausea, heartburn, belching or flatulence, 91.7% of males and 56.3% of 
females did not have any food-related complaints. Males (8.3%) complained 
only of flatulence. 
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Eating sweet foods. Sweet foods were eaten mostly by females, less by 
males (25% of males and 43.8% of females). 16.7% of males and 6.3% of 
females did not consume any sweet foods at all. 
Adding salt to a ready-made food: 5% of males and 43.8% of females did 
not add salt to a ready-made food. Salt was seldom added to a ready-made food 
by 50% of males and 37.5% of females. Salt was often added by 18.8% of 
female patients. 
Adding pepper and other hot spices to a ready-made food: 6.3% of 
females added pepper or spices to ready-made foods. Hot spices were often 
consumed by 8.3% of males and 12.5% of females. 
Frequency of stool. Frequency of stool in all the subjects was once daily or 
every other day. 
 
 
Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part IV. The frequency table (percentage) of kidney transplant patientsʼ daily con-
sumption of drinks and rye bread-white bread 
 
No Subjects Male  (n = 12) 
Female  
(n = 16) 
  Frequency (%) % % 
1. How many glasses of milk drinks do you consume a day (number)   
 not at all 0.0 6.3 
 one glass 50.0 62.6 
 two to three glasses 50.0 25.0 
 more 0.0 6.3 
2. How many glasses of juice do you drink a day (number)   
 not at all 16.7 18.8 
 one glass 16.6 25.1 
 two to three glasses 58.3 50.0 
 more 8.3 6.3 
3. How many cups of bean coffee do you drink a day (number)   
 not at all 16.7 0.0 
 one cup 41.7 37.5 
 two to three cups 33.3 56.3 
 more 8.3 6.25 
4. How many slices of rye bread do you eat a day (number)   
 not at all 0.0 0.0 
 one to two slices 8.3 37.5 
 three to four slices 66.7 50.1 
 five to six slices 16.6 6.3 
 more 8.3 6.3 
5. How many slices of white bread do you eat a day (number)   
 not at all 25.0 12.5 
 one to two slices 8.33 43.8 
 three to four slices 50.0 31.3 
 five to six slices 8.3 6.3 
 more 8.3 6.3 
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Daily consumption of milk, milk drinks, juice and bean coffee. Two or three 
glasses of milk and other milk drinks were daily consumed by 50% of males 
and 25% of females. Two or three glasses of juice were daily consumed by 
58.3% of males and 50% of females. One cup of bean coffee was daily 
consumed by 41.7% of males and 37.5% of females. Two or three cups of bean 
coffee were daily consumed by 33.3% of males and 56.3% of females, 8.3% of 
males and 6.3% of females drank more than three cups of bean coffee a day. 
Daily consumption of black and white bread: 66.7% of males consumed 
3–4 slices of rye bread daily; 3–4 slices of white bread were consumed by 50% 
of males; 43.8% of female patients consumed 1–2 slices of rye bread and 50% 
2–3 slices of rye bread daily. White bread and products made of it were not 
eaten by 25% of males and 12.5% of females. Some subjects consumed larger 
quantities of bread, 5–6 slices daily (8.3% of males and 6.3% of females). 
 
 
Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part V. The frequency table (percentage) of the kidney patientsʼattitude to eating and 
movement 
 
No Subjects Male  (n = 12) 
Female  
(n = 16) 
 Frequency (%) % % 
1. I like to eat together with others   
 always 25.0 31.3 
 often 50.0 25.0 
 seldom 16.6 37.5 
 never 8.3 6.3 
2. I am afreid to be overweight   
 always 8.3 31.3 
 often 8.3 6.3 
 seldom 33.3 37.5 
 never 50.0 25.0 
3. Avoid eating although I am hungry   
 always 8.3 0.0 
 often 0.0 6.3 
 seldom 33.3 50.0 
 never 58.3 43.8 
4. Avoid drinking although I am thirsty   
 always 8.3 0.0 
 often 0.0 0.0 
 seldom 8.3 6.3 
 never 83.3 93.8 
5. I have pangs of eating which I can not control   
 always 0.0 0.0 
 often 0.0 0.0 
 seldom 25.0 43.8 
 never 75.0 56.3 
6. I am aware of the nutritional value of the food I eat   
 always 25.0 50.0 
 often 16.7 0.0 
 seldom 25.0 43.8 
 never 33.3 6.3 
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Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part V. The frequency table (percentage) of the kidney patientsʼattitude to eating and 
movement (continued) 
 
No Subjects Male  (n = 12) 
Female  
(n = 16) 
Frequency (%) % % 
7. I especially avoid the food rich in carbohydrates  (white bread, pasta)   
 always 8.3 18.8 
 often 0.0 18.8 
 seldom 41.7 31.3 
 never 50.0 31.3 
8. I especially avoid fatty food (pork fat, margarines, fried food)   
 always 16.7 25.0 
 often 33.3 31.3 
 seldom 25.0 25.0 
 never 25.0 18.8 
9. I especially avoid protein-rich in protein (meat, fish, curds, cheese)   
 always 0.0 6.3 
 often 0.0 18.8 
 seldom 50.0 37.5 
 never 50.0 37.5 
10. I eat the same food several times a day   
 always 0.0 6.3 
 often 0.0 12.5 
 seldom 58.3 56.3 
 never 41,7 25.0 
11. I eat diet food, I keep to the diet   
 always 0.0 6.3 
 often 8.3 12.5 
 seldom 41.7 31.3 
 never 50.0 50.0 
12. Other people force me to eat   
 always 0.0 0.0 
 often 0.0 6.3 
 seldom 16.6 31.3 
 never 83.3 62.5 
13. I suffer from constipation   
 always 0.0 6.3 
 often 0.0 6.3 
 seldom 41.7 62.5 
 never 58.3 25.0 
14. I suffer from diarrhoea   
 always 0.0 0.0 
 often 0.0 12.5 
 seldom 8.3 31.3 
 never 91.7 56.3 
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Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part V. The frequency table (percentage) of the kidney patientsʼattitude to eating and 
movement (continued) 
 
No Subjects Male  (n = 12) 
Female  
(n = 16) 
Frequency (%) % % 
15. I control my body weight and weigh myself   
 always 0.0 6.3 
 often 0.0 6.3 
 seldom 50.0 43.8 
 never 50.0 43.8 
16. I try to move much to spend excessive calories   
 always 16.7 0.0 
 often 41.6 43.8 
 seldom 33.3 37.5 
 never 8.3 18.8 
 
 
Fear of being overweight: 50% of male patients and 25% of female patients 
were not afraid of being overweight; 16.6% of males and 37.6% females 
watched their body weight. 
Control of body weight and weighing oneself: 50% of males and 43.8% of 
females did not watch their body weight. Only 6.3% of females always watched 
their body weight. 
Awareness of the nutritional value of the food: 25% of males and 50% of 
females were aware of the nutritional value of the food they consumed; 33.3% 
of males and 6.3% of females did not have this knowledge. 
Keeping to diet. Consumption of dietary food was not needed by 50% of 
males and 50% of females. Only 6.3% of females kept to a diet. 
Constipation and diarrhoea: 6.3% of females had constipation and 6.3% 
had diarrhoea. Males and most females did not have any digestive complaints. 
Moving much to spend excessive calories. Male and female patients tried 
to move a lot to spend excessive calories (58.3% of males and 43.8% of 
females); 41.6% of males and 66.3% of females did not get much exercise. 
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Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part VI. The frequency table (percentage) of consumption of foodstuffs by the kidney transplant patients  
 
 Frequency of 
consumption of main 
food groups                    
(%) 
Daily Often,  
2-3 
times    
a week 
Some-
times, 
1-2 
times    
a week 
Seldom,  
1-2 
times     
a month
Never Daily Often,  
2-3 
times    
a week 
Some-
times,  
1-2 
times    
a week 
Seldom, 
1-2 
times     
a month 
Never
   4 3 2 1 0 4 3 2 1 0 
 No Subjects Males (n = 12)   Females (n = 16)  
 Milk and dairy products            
1 Whole milk 4.5% 8.3 16.7 16.7 8.3 50.0 6.3 18.8 12.5 12.5 50.0
2 Milk 2.5% 16.7 25.0 25.0 8.3 25.0 25.0 12.5 18.8 25.0 18.8
3 Milk 1% 8.3 16.7 0.0 75.0 0.0 0.0 0.0 18.8 81.3 0.0
4 Kephir 1% 8.3 0.0 0.0 16.7 75.0 6.3 6.3 18.8 18.8 50.0
5 Kephir 2.5% 0.0 0.0 16.7 16.7 66.7 0.0 0.0 12.5 18.8 68.8
6 Buttermilk 8.3 8.3 8.3 16.7 58.3 6.3 6.3 18.8 12.5 56.3
7 Sour cream 20% 0.0 16.7 16.7 25.0 41.7 18.8 31.3 18.8 12.5 18.8
8 Sour cream 10% 8.3 8.3 25.0 25.0 33.3 0.0 25.0 18.8 18.8 37.5
9 Coffee cream 10% 16.7 0.0 25.0 16.7 41.7 12.5 18.8 6.3 50.0 12.5
10 Whipping cream 35% 0.0 0.0 0.0 41.7 58.3 0.0 0.0 12.5 31.3 56.3
11 Bioyoghurt 2.5% 8.3 16.7 8.3 16.7 50.0 12.5 6.3 18.8 18.8 43.8
12 Yoghurt 2.5% 0.0 16.7 16.7 16.7 50.0 6.3 12.5 25.0 18.8 37.5
13 Butter 80% 16.7 16.7 8.3 0.0 58.3 18.8 18.8 6.3 18.8 37.5
14 Butter margarine 40% 41.7 8.3 25.0 0.0 25.0 37.5 18.8 12.5 0.0 31.3
15 Cottage cheese  0.0 16.7 58.3 16.7 8.3 12.5 12.5 50.0 18.8 6.3
16 Cheese 8.3 33.3 33.3 8.3 16.7 6.3 31.3 31.3 25.0 6.3
  Cereal and flour products           
17 Rye bread 41.7 16.7 0.0 0.0 41.7 18.8 18.8 25.0 18.8 18.8
18 Fine rye bread 0.0 16.7 25.0 0.0 58.3 18.8 25.0 6.3 18.8 31.3
19 Whole meal seed bread 33.3 16.7 16.7 0.0 33.3 25.0 12.5 6.3 18.8 37.5
20 White bread 50.0 16.7 0.0 16.7 16.7 68.8 6.3 6.3 18.8 0.0
21 Muesli 0.0 0.0 18.7 25.0 58.3 0.0 6.3 0.0 31.3 62.5
22 Rolls, buns 0.0 8.3 41.7 16.7 33.3 6.3 12.5 37.5 31.3 12.5
23 Pasta 0.0 0.0 88.7 16.7 16.7 0.0 12.5 56.3 25.0 6.3
24 Corn  and rice flakes 0.0 0.0 16.7 33.3 50.0 0.0 6.3 6.3 56.3 31.3
25 Popcorn 0.0 0.0 0.0 33.3 66.7 0.0 0.0 0.0 6.3 93.8
26 Kama 0.0 0.0 8.3 16.7 75.0 0.0 0.0 6.3 37.5 56.3
27 Bran 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 12.5 87.5
28 Cereal sprouts 8.3 0.0 0.0 0.0 91.7 0.0 0.0 0.0 18.8 68.8
  Meat products            
29 Pork 0.0 25.0 50.0 16.7 8.3 6.3 31.3 43.8 18.8 0.0
30 Beef 0.0 8.3 25.0 33.3 33.3 0.0 6.3 18.8 37.5 37.5
31 Mutton 0.0 0.0 16.7 16.7 66.7 0.0 0.0 0.0 6.3 93.8
32 Poultry 0.0 8.3 66.7 0.0 25.0 0.0 18.8 37.5 37.5 6.3
33 Rabbit 0.0 0.0 8.3 25.0 66.7 0.0 0.0 0.0 6.3 93.8
34 Game 0.0 0.0 0.0 25.0 75.0 0.0 0.0 0.0 12.5 87.5
35 Liver 0.0 0.0 16.7 41.7 41.7 0.0 0.0 18.8 56.3 25.0
36 Offal (heart, lungs) 0.0 0.0 16.7 33.3 50.0 0.0 0.0 0.0 18.8 81.3
37 Sausage 16.7 50.0 16.7 0.0 16.7 25.0 25.0 18.8 18.8 12.5
38 Wiener 0.0 41.7 50.0 8.3 0.0 0.0 43.8 25.0 25.0 6.3
39 Smoked sausage, ham 8.3 25.0 25.0 25.0 16.7 12.5 37.5 25.0 18.8 6.3
40 Meat paste 0.0 8.3 16.7 50.0 25.0 0.0 6.3 37.5 50.0 6.3
41 Black sausage 0.0 0.0 0.0 58.3 41.7 0.0 0.0 6.3 56.3 37.5
42 Meat balls 0.0 0.0 50.0 33.3 16.7 0.0 12.5 43.8 37.5 6.3
43 Tinned meat 0.0 0.0 8.3 41.7 50.0 0.0 0.0 6.3 37.5 56.3
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Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part VI. The frequency table (percentage) of consumption of foodstuffs by the kidney transplant patients 
(continued) 
 
  
Frequency of 
consumption of main 
food groups 
Daily Often,  
2-3 
times   
a week 
Some-
times, 
1-2 
times    
a week 
Seldom, 
1-2 
times     
a month 
Never Daily Often,  
2-3 
times    
a week 
Some-
times,  
1-2 
times    
a week 
Seldom, 
1-2 
times     
a month 
Never 
    4 3 2 1 0 4 3 2 1 0 
No Subjects Males (n = 12)   Females(n = 16)   
 Fish products                     
44 Freshwater fish 0.0 8.3 33.3 33.3 25.0 0.0 0.0 25.0 62.5 12.5
45 Small herring 0.0 8.3 41.7 25.0 25.0 0.0 12.5 37.5 31.3 18.8
46 Seawater fish 0.0 0.0 41.7 33.3 25.0 0.0 0.0 18.8 68.8 12.5
47 Salted fish (herring) 0.0 0.0 0.0 25.0 75.0 0.0 12.5 31.3 25.0 31.3
48 Smoked fish 0.0 8.3 8.3 41.7 41.7 0.0 6.3 18.8 56.3 18.8
49 Dried fish 0.0 0.0 0.0 25.0 75.0 0.0 0.0 0.0 0.0 100.0
50 Fish burgers 0.0 0.0 16.7 50.0 33.3 0.0 0.0 25.0 43.8 31.3
51 Tinned fish 0.0 8.3 8.3 33.3 50.0 0.0 0.0 18.8 43.8 37.5
  Vegetables                     
52 Potato 33.3 58.3 8.3 0.0 0.0 50.0 50.0 0.0 0.0 0.0
53 Fresh cabbage 16.7 25.0 33.3 0.0 25.0 0.0 31.3 56.3 6.3 6.3
54 Sauerkraut 8.3 8.3 16.7 25.0 41.7 0.0 0.0 37.5 56.3 6.3
55 Swede 8.3 8.3 0.0 41.7 41.7 0.0 0.0 37.5 37.5 25.0
56 Carrot 8.3 41.7 41.7 0.0 8.3 18.8 31.3 43.8 6.3 0.0
57 Red beet 8.3 8.3 50.0 16.7 16.7 6.3 12.5 43.8 37.5 0.0
58 Radish 0.0 0.0 0.0 25.0 75.0 0.0 0.0 0.0 25.0 75.0
59 Celery 0.0 0.0 0.0 25.0 75.0 0.0 6.3 18.8 12.5 62.5
60 Parsley 0.0 16.7 8.3 33.3 41.7 6.3 6.3 31.3 43.8 12.5
61 Onion 0.0 33.3 41.7 0.0 25.0 37.5 31.3 18.8 12.5 0.0
62 Garlic 16.7 0.0 50.0 16.7 16.7 18.8 25.0 18.8 31.3 6.3
63 Pumpkin, zucchini 0.0 0.0 16.7 41.7 41.7 0.0 6.3 18.8 37.5 37.5
64 Fresh cucumber 8.3 16.7 41.7 16.7 16.7 25.0 25.0 31.3 18.8 0.0
65 Tomato 8.3 16.7 50.0 0.0 25.0 25.0 18.8 25.0 25.0 6.3
66 Pepper 0.0 16.7 25.0 8.3 50.0 6.3 18.8 6.3 43.8 25.0
67 Garden beans 0.0 8.3 16.7 25.0 50.0 0.0 6.3 0.0 37.5 56.3
68 Lettuce 0.0 25.0 16.7 33.3 25.0 0.0 6.3 37.5 37.5 18.8
69 Dill 8.3 0.0 33.3 25.0 33.3 12.5 18.8 31.3 25.0 12.5
  Fruits, berries (seasonal)            
70 Apples 8.3 33.3 33.3 16.7 8.3 6.3 56.3 12.5 12.5 12.5
71 Plums 0.0 16.7 8.3 41.7 33.3 0.0 18.8 12.5 50.0 18.8
72 Pears 0.0 16.7 16.7 25.0 41.7 0.0 25.0 12.5 37.5 25.0
73 Cherries 0.0 0.0 33.3 25.0 41.7 0.0 6.3 18.8 31.3 43.8
74 Strawberries 0.0 8.3 16.7 33.3 41.7 0.0 25.0 18.8 37.5 18.8
75 Raspberries 0.0 0.0 25.0 25.0 50.0 0.0 18.8 12.5 31.3 37.5
76 Currants 0.0 0.0 16.7 41.7 41.7 0.0 18.8 12.5 37.5 31.3
77 Gooseberries 0.0 0.0 16.7 33.3 50.0 0.0 18.8 12.5 18.8 50.0
78 Wild berries 0.0 0.0 16.7 25.0 58.3 0.0 18.8 12.5 31.3 37.5
79 Bananas 0.0 0.0 33.3 16.7 50.0 0.0 12.5 18.8 37.5 31.3
80 Citrus fruits (orange) 0.0 8.3 16.7 33.3 41.7 0.0 12.5 25.0 43.8 18.8
81 Grapes 0.0 0.0 16.7 41.7 41.7 0.0 12.5 0.0 68.8 18.8
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Table 11. Results of nutritional habits based on the food-frequency questionnaire 
Part VI. The frequency table (percentage) of consumption of foodstuffs by the kidney transplant patients 
(continued) 
 
  
Frequency of 
consumption of main 
food groups 
Daily Often  
2-3 
times    
a week 
Some-
times, 
1-2 
times    
a week 
Seldom, 
1-2 
times     
a month 
Never Daily Often,  
2-3 
times    
a week 
Some-
times,  
1-2 
times    
a week 
Seldom, 
1-2 
times     
a month 
Never 
    4 3 2 1 0 4 3 2 1 0 
 No Subjects Male  (n = 12)     Female (n = 16)    
  Sweets                     
82 Raisins 0.0 0.0 0.0 58.3 41.7 6.3 12.5 12.5 43.8 25.0
83 Water melons 0.0 0.0 8.3 33.3 58.3 0.0 12.5 6.3 50.0 31.3
84 Dried fruits 0.0 0.0 0.0 41.7 58.3 0.0 6.3 6.3 25.0 62.5
85 Ice-cream 0.0 0.0 25.0 58.3 16.7 0.0 6.3 31.3 43.8 18.8
86 Sherbet, zephyr 0.0 0.0 0.0 33.3 66.7 0.0 0.0 6.3 18.8 75.0
87 Halvah 0.0 0.0 0.0 41.7 58.3 0.0 0.0 6.3 25.0 68.8
88 Chocolate 0.0 8.3 16.7 33.3 41.7 0.0 6.3 31.3 43.8 18.8
89 Caramel sweets 0.0 8.3 25.0 16.7 50.0 0.0 18.8 12.5 31.3 37.5
90 Marmalade, jellies 0.0 0.0 8.3 16.7 75.0 0.0 6.3 0.0 37.5 56.3
91 Jam, compote 0.0 8.3 25.0 16.7 50.0 0.0 12.5 25.0 37.5 25.0
92 Nuts 0.0 0.0 16.7 25.0 58.3 0.0 0.0 18.8 31.3 50.0
93 Cream cakes 0.0 0.0 0.0 41.7 58.3 0.0 6.3 12.5 50.0 31.3
94 Short pastry products 0.0 0.0 16.7 41.7 41.7 0.0 6.3 31.3 43.8 18.8
95 Creams, puddings 0.0 0.0 8.3 33.3 58.3 0.0 18.8 12.5 31.3 37.5
  Drinks                     
96 Apple juices (natural) 0.0 0.0 41.7 16.7 41.7 0.0 6.3 18.8 25.0 50.0
97 Citrus fruit juices 0.0 8.3 16.7 16.7 58.3 0.0 6.3 25.0 31.3 37.5
98 Fruit juices 0.0 8.3 33.3 25.0 33.3 0.0 12.5 50.0 18.8 18.8
99 Berry juices, fruit water 0.0 0.0 25.0 8.3 66.7 0.0 18.8 25.0 25.0 31.3
100 Fresh fruit juices 0.0 8.3 16.7 16.7 58.3 0.0 0.0 0.0 18.8 81.3
101 Lemonade 0.0 0.0 8.3 25.0 66.7 0.0 12.5 6.3 18.8 62.5
102 Tea 33.3 25.0 8.3 8.3 25.0 43.8 18.8 12.5 6.3 18.8
103 Herb tea 16.7 25.0 8.3 16.7 33.3 12.5 18.8 6.3 18.8 43.8
104 Pure coffee 0.0 33.3 8.3 16.7 41.7 0.0 75.0 12.5 6.3 6.3
105 Grain coffee 0.0 0.0 0.0 0.0 100.0 0.0 6.3 0.0 0.0 93.8
106 Cocoa 0.0 0.0 8.3 33.3 58.3 0.0 0.0 25.0 18.8 56.3
107 Mineral water 25.0 33.3 16.7 8.3 16.7 12.5 12.5 25.0 18.8 31.3
108 Coca-cola 0.0 0.0 16.7 16.7 66.7 0.0 0.0 0.0 12.5 87.5
109 Tonics 0.0 0.0 0.0 8.3 91.7 0.0 0.0 0.0 6.3 93.8
110 Beer 0.0 0.0 8.3 8.3 83.3 0.0 0.0 0.0 0.0 100.0
111 Wine 0.0 0.0 0.0 8.3 91.7 0.0 0.0 0.0 25.0 75.0
112 Strong alcoholic drinks 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 87.5
113 Liqueur 0.0 0.0 0.0 0.0 100.0 0.0 0.0 0.0 0.0 100.0
114 Gin long drink 0.0 0.0 0.0 8.3 91.7 0.0 0.0 0.0 6.3 93.8
  Ready-made foods                     
115 Meat soups 0.0 25.0 50.0 8.3 16.7 12.5 37.5 31.3 12.5 6.3
116 Milk soups 0.0 25.0 16.7 25.0 33.3 0.0 18.8 18.8 37.5 25.0
117 Porridges 33.3 16.7 41.7 0.0 8.3 6.3 43.8 18.8 25.0 6.3
118 Meat dishes 0.0 33.3 33.3 8.3 25.0 25.0 37.5 25.0 6.3 6.3
119 Fish dishes 8.3 8.3 50.0 0.0 33.3 0.0 12.5 50.0 25.0 12.5
120 Vegetable dishes 8.3 33.3 33.3 0.0 25.0 18.8 18.8 50.0 0.0 12.5
121 Mushroom dishes 0.0 0.0 8.3 41.7 50.0 0.0 0.0 12.5 56.3 31.3
122 Egg dishes 0.0 0.0 50.0 16.7 33.3 0.0 25.0 25.0 43.8 6.3
123 Mixed salads 0.0 0.0 8.3 58.3 33.3 0.0 6.3 37.5 50.0 6.3
124 Salad dressing 0.0 8.3 16.7 8.3 66.7 0.0 6.3 31.3 31.3 31.3
125 Mayonnaise 0.0 0.0 25.0 25.0 50.0 0.0 25.0 31.3 31.3 12.5
126 Ketchup 0.0 0.0 33.3 33.3 33.3 6.3 6.3 18.8 37.5 31.3
127 Desserts, kissels 0.0 8.3 33.3 33.3 25.0 0.0 6.3 50.0 31.3 12.5
128 Bakings 0.0 8.3 41.7 8.3 41.7 0.0 12.5 37.5 50.0 0.0
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From cereal and flour products patients consumed more often rye bread daily 
41.7% or 2–3 times a week: 16.7% by males, and by females white bread pro-
ducts (68.8%) were preferred. Rye bread was consumed more often by males; 
females preferred white bread products. Buns, pasta, muesli, kama (mixture of 
rye-, oat-, barley- and peasemeal) and cereal sprouts were not consumed daily. 
Buns, pasta, muesli, kama and cereal sprouts were not consumed daily. 
Butter was consumed daily by fewer patients (16.7% of males and 18.8% of 
females) than margarines (41.7% of males and 37.5% of females).  
Milk and dairy products. Consumption of milk products depended on the 
fat content of milk. Kephir and low-fat milk were consumed every day by 
16.6% of males and 6.3% of females. Milk was not consumed by 25% of males 
and 18.8% of females. Drinking yoghurt was consumed seldom. No yoghurts 
were consumed at all by 50% of males and 43.8% of females.  
Cottage cheese was consumed seldom, once or twice a week (males 58.3%, 
females 50%). Cheese products were consumed by 1/3 of subjects 2–3 times a 
week or more seldom. Cheese was consumed daily by 8.3% of males and 6.3% 
of females. Consumption of cheese, cottage cheese and milk products for male 
and female kidney transplant patients are presented in Figure 7 and Figure 8. 
 
 
 
 
Figure 7. The consumption of foodstuffs by the kidney transplant male patients based 
on the food-frequency questionnaire (FFQ). All the data of the frequency table are given 
in percentage (%). 
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Figure 8. The consumption of foodstuffs by the kidney transplant female patients based 
on the food-frequency questionnaire (FFQ). All the data of the frequency table are given 
in percentage (%). 
 
 
Meat products. Male and female patients consumed mostly pork once or twice 
a week (50% of males and 43.8% of females). Wieners were consumed daily by 
6.7% of males and 25% of females. Tinned meat, meat paste, meat balls and 
black sausage were not consumed daily. 
Fish products. Fish and different fish products were consumed mostly once 
or twice a month. Tinned fish was not consumed by 50% of males and 37.5% of 
females. 1/3 of subjects did not consume fish burghers. 
Vegetables. Potatoes were consumed with great frequency, daily by 33.3% 
of males and 50% of females. Cabbage, carrots, swede and beet were consumed 
daily by 8.3% of males and 18.8% of females. Tomatoes and fresh cucumbers 
were consumed daily by 8.3% of males and 25% of females. 
Fruits, berries (seasonal): 8.3% of males and 12.5% females did not eat 
apples. Consumption frequency of locally grown fruit and berries depended on 
the season. 
Sweets. Sweets were not consumed daily. Ice-cream, zephyr, halvah, choco-
late, jam and nuts were consumed once or twice a week or month. Ice-cream 
was not consumed by 16.7% of males and 43.8% of females. 
Drinks. Apple juice was not consumed by 41.7% of males and 50% of 
females. Tea was consumed daily by 33.3% of males and 43.8% of females. 
Mineral water was consumed by 25% of males and 12.5% of females. 
Ready-made foods. Ready-made foods were consumed at different fre-
quencies. Porridge was consumed every day by 33.3% of males and 6.3% of 
females, while 8.3% of males and 6.3% of females did not eat porridge. 
84 
The questionnaire revealed that the patients consumed different foodstuffs at 
different frequencies, but there was a tendency to excessive consumption of 
foodstuffs rich in proteins and carbohydrates. To the consumption of fat-rich 
foodstuffs a tendency of decrease was shown. The consumption of vegetables 
and fruit was modest compared to Estonian food and nutrition recommen-
dations. The same tendency could be noticed in literature. 
 
 
5.11. Results of the 3-day menu analysis in dynamics 
The results of the 3-day menu analysis in male (n = 12) and female (n = 16) kid-
ney transplant patients were collected twice: for the first time at the beginning 
of the investigation one and half year (the first measurements, FM), and, 
secondly three years after the kidney transplantation (follow-up, FU). The data 
of FM characterize kidney patientsʼ nutrition before, and, the results of FU the 
dietary intake after nutritional counselling. In the data the average energy intake 
(kcal) and the average data of 24 nutrients, SD, the minimal and maximal values 
both in absolute numbers and also in percentage have been presented for the 3-
day menus. All the FM and FU nutritional data of the studied kidney transplant 
patients were compared with each other, and with the normative values of the 
basic nutrients in the Estonian Nutrition Recommendations and Food-based 
Dietary Guidelines (Tallinn, 2006). The comparison of energy and the main 
nutrient content in 3-day menus of kidney transplant patients was shown in 
Table 12.  
 
Male patients (n = 12) 
Daily energy content. The daily average energy content (kcal) in the male pa-
tients group was decreased non-significantly (from baseline 2,689.7 ± 467.5 kcal, 
and to FU 2,424.9 ± 291.4 kcal) and remains in the limits of the recommended 
daily consumption of food energy (the Estonian Nutrition Recommendations: 
2,700 ± 200 kcal). The energy content per kg of body weight (kcal/kgBW/day) 
in male patients decreased significantly, and was from the first measurements 
37.2 kcal/kgBW/day, and to FU 30.2 kcal/kgBW/day (p = 0.0143).  
Dietary protein. The mean consumption dietary proteins intake (g) in male pa-
tients in 3-day menus decreased non-significantly, and was in FM, 106.7 ± 22.4 g, 
and in FU, 91.6 ± 10.7 g. (the Estonian Nutrition Recommendations range for 
men 50–90 g). The percentage of proteins in food energy (%) in male patients 
was in FM, 15.9%, and in FU, 15.2% (the Estonian Nutrition Recommendations 
range 10–15%). The mean consumption of dietary proteins (g/kg/day) in male 
patients decreased statistically significantly (p = 0.0093), and was between 1.5 
to 1.1 g/kg in day. 
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Dietary fats. The amount of food fats (g) decreased non-significantly in FU 
(FM, 101.3 ± 21.4 g; FU 88.3 ± 14.6 g), but still remained higher than the 
recommended norm (the Estonian Nutrition Recommendations range 50– 
90 g/day). The percentage of fats in food energy did not change from FM, 34.1 
± 5.3% to FU, 32.8 ± 4.2%, and remained within the norm of the Estonian 
Nutrition Recommendations range of food fats 25–30%. Cholesterol in food. 
The amount of cholesterol (mg/day) in food decreased non-significantly 
exceeding the upper limit of the Estonian Nutrition Recommendations (see in 
Table 12) norm from FM, 356.1 ± 88.4 mg, and to FU, 337.4 ± 96.9 mg. 
Dietary carbohydrates. The amount of dietary carbohydrates in food (g) 
decreased statistically non-significantly from FM, 329.3 ± 74.0 g, and to FU, 
311.8 ± 49.4 g. but remained within the range of the norm of dietary 
carbohydrates 250–350 g per day. The percentage of carbohydrates in food 
energy increased significantly from FM, 48.9 ± 5.5%, and to FU, 51.4 ± 5.4% 
(p = 0.001). The Estonian Nutrition Recommendations range of carbohydrates 
in food energy is 55–60%. 
Fat-soluble vitamins. Retinol content in food (µg-equiv) in male patients 
exceeded higher from the recommended norm (norm 900 µg-equiv). Vitamin D 
content in food (µg) was statistically non-significantly lower during the whole 
period, constituting 50% of the norm (norm 7.5 µg). Vitamin E content (mg) 
diminished during the change being at FM 10.8 mg, and at FU 9.3 mg, and 
remained within the range of recommendations (mean 10 mg). 
Water-soluble vitamins. Thiamine, niacin, pyridoxine and pantothenic acid 
content in food in male patients did not change and remained within the normal 
range. Biotin values in food were lower than the recommended norm 100–200 
µg. Riboflavin (FM, 2.0 ± 0.6 mg; FU, 2.1 ± 0.8 mg) and cyanocobalamin 
intake (FM, 8.0 ± 5.8 µg; FU, 10.3 ± 11.6 µg) in kidney transplant patients was 
non-significant but higher compared within the normal range at 2.0 µg. Vitamin 
C content increased but not significantly (FM, 72.4 ± 34.6 mg; FU, 84.6 ±  
27.6 mg), and was in the range of the norm 75 mg.  
Minerals. Sodium content (mg) in the consumed food did not differ statis-
tically in male patients, and remained within the normal level (2,751.6 mg–
2,299.9 mg). Salt content was calculated from the amount of sodium in the 
food. Potassium daily intake somewhat exceeded the norm (FM, 3,921.9 ± 
676.0 mg; FU, 3,842.5 ± 636.2 mg). The mean calcium content in food 
exceeded statistically significantly the norm at 800 mg, and had a tendency to 
increase (FM, 1,221.1 mg; FU, 1,022 mg). Phosphate intake from the food 
(mg) exceeded statistically significantly the norm at FM, 2,046.4 ± 455.7 mg to 
FU 1,789.4 ± 250.1 mg and had a tendency to decrease. Magnesium content 
was also increased significantly (p = 0.0473) but remained within the norm. 
Iron content in food (mg) was within the range of the norm for men (9 mg). 
Selenium content in food was non-significantly higher (111.0–94.4 mg) than 
the recommended norm at range 50 mg.  
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Female patients (n = 16)  
Daily energy intake. The daily average energy content (kcal) in the female 
patients group significantly increased (p = 0.0018), and was in FM, 2,028.0 ± 
465.5 kcal and in FU, 2,352.9 ± 487.0 kcal (the Estonian Nutrition Recommen-
dations range 2,000 ± 150 kcal/day). The energy content per kg of body weight 
(kcal/kgBW/day) in female patients increased significantly, and was from FM 
29.2 ± 9.2 kcal/kgBW/day, and to FU 32.9 ± 10.4 kcal/kgBW/day (p = 0.0114). 
Dietary protein. The dietary protein intake (g) in female patients in 3-day 
menus increased statistically significantly (p = 0.0384), and was in FM, 79.6 ± 
19.7 g, and in FU, 89.2 ± 19.5 g (the Estonian Nutrition Recommendations 
range for men 50–90 g). The percentage of proteins in food energy (%) in 
female patients was in FM, 15.8%, and in FU, 15.2% (the Estonian Nutrition 
Recommendations range 10–15%). The mean consumption of dietary proteins 
(g/kg/day) in female patients was in the case of the first and the second research 
1.2 g/kg per day. 
Dietary fats. The amount of food fats (g) increased non-significantly in FU 
(FM, 76.0 ± 23.0 g; FU 88.0 ± 27.1 g), and remained within the recommended 
norm (the Estonian Nutrition Recommendations range 50–90 g/day). The 
percentage of fats in food energy did not change from FM, 33.2 ± 5.6% to FU, 
33.4 ± 4.7%, and remained within the norm of the Estonian Nutrition Re-
commendations range of food fats 25–30%. Cholesterol in food. The amount of 
cholesterol (mg/day) in food exceeded statistically significantly (p = 0.013) the 
upper limit of the Estonian Nutrition Recommendations norm at FM, 271.0 ± 
106.2 mg, and to FU, 359.6 ± 146.4 mg.  
Dietary carbohydrates. The amount of dietary carbohydrates (g) in female 
kidney transplant patients statistically significantly increased (p = 0.033) from 
FM, 252.8 ± 58.3 g to FU, 293.2 ± 61.0 g but remained within the Estonian 
Nutrition Recommendations of dietary carbohydrates 250–350 g. The per-
centage of carbohydrates in food energy during both researches remained at 
range 50.2 ± 5.3% to 50.0 ± 5.3%. The Estonian Nutrition Recommendations 
range of carbohydrates from food energy was at 55% to 60%. 
Fat-soluble vitamins. Retinol content in food (µg-equiv) in female patients 
exceeded higher (1,420.2–1,369.3 µg-equiv) than in the recommended norm 
(norm 700 µg-equiv). Vitamin D content in food (µg) was statistically signi-
ficantly lower (p = 0.0037) during the whole period, constituting 50% of the 
norm (norm 7.5 µg). Vitamin E content (mg) non-significant changes between 
FM 8.2 mg, and FU 8.9 mg, and was within the range of the Estonian Nutrition 
Recommendation for female populations (mean 8 mg). 
Water-soluble vitamins. Tiamine (p = 0.0343), niacin (p = 0.0178), 
pyridoxine (p = 0.0057), folic acid (p = 0.0045), pantothenic acid (p = 0.0080), 
and biotin (p = 0.0142) content in food increased significantly in FU. Biotin 
content in food was lower than the recommended norm 100–200 µg. Riboflavin 
(FM, 1.5 ± 0.5 mg; FU, 1.7 ± 0.5 mg) was in the range of the norm, and 
cyanocobalamin intake (FM, 6.1 ± 6.7 µg; FU, 7.2 ± 5.4 µg) in kidney 
transplant patients had increased but was non-significantly a higher intake 
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compared within the range of the norm at 2.0 µg. Vitamin C content increased 
but not significantly (FM, 54.6 ± 32.4 mg; FU, 87.2 ± 53.0 mg), and was in the 
range of the norm 75 mg. 
Minerals. Sodium content (mg) in the consumed food did not differ statis-
tically in female patients, and remained within the normal level (2,240.1–
2,494.2 mg). Salt content was calculated from the amount of sodium in the 
food. Potassium daily intake somewhat exceeded the normal value (FM, 
2,988.6 ± 814.1 mg; FU, 3,578.5 ± 965.8 mg). The mean calcium content in 
food exceeded statistically significantly the normal value (800 mg), and had a 
tendency to increase (FM, 731.9 mg; FU, 915.0 mg). Phosphate intake from the 
food (mg) exceeded statistically significantly the normal levels (FM, 1,433.3 ± 
408.6 mg; FU 1,616.2 ± 328.3 mg) and had a tendency to increase (p = 0.0373). 
Magnesium content was also increased non-significantly but remained within 
the norm (280 mg). Iron content in food (mg) was within the range of FM, 16.8 mg 
to FU, 17.4 mg, and was at the normal level for female patients (postmeno-
pausal women 9 mg, and 15 mg during menstruation). Selenium content in food 
was significantly higher (84.6–98.3 mg) than the recommended norm (40 mg).  
Comparison of energy and main nutrients content in 3-day menus. 
The daily average food energy content was decreased non-significantly in 
the male patients group at 265 ± 176 kcal (min 64 kcal, max 765 kcal) and 
remained at the normal level in FU, but in females was increased significantly 
at 325 ± 22 kcal (min 252 kcal, max 292 kcal) and had a tendency to increase in 
FU compared within the recommended level. The average food energy content 
per kg of BW (kcal/kgBW/day) decreased significantly in males and inreased 
significantly in female CKD patients groups and remained within the normal 
level. 
The daily average dietary protein intake (g) decreased non-significantly in 
male patients at the 106.7 to 91.6 g, but increased significantly in female 
patients at 79.6 g to 89.2 g. The daily average food proteins intake in g/BW 
decreased significantly in male CKD patients at 1.5 to 1.1 g/kg, and in female 
patients it was unchanged in the follow-up (1.2 g/kg). Data are shown in Figure 
9 and in Figure 10. 
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Figure 9. The dietary proteins intake in kidney transplant patients based on the 3-day 
menu analysis. All the data are given per kilogram body weight a day in dynamics (FM,  
first measurements; FU, follow-up). 
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Figure 10. The dietary proteins intake a day in kidney transplant patients based on the 
3-day menu analysis. All the data are given in grams at FM, first measurements and at 
FU, follow-up. 
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The daily average food fats (g) content decreased non-significantly in male 
CKD patients at the 101 grams to 88 grams, and increased non-significantly in 
female patients from 76 grams to 88 grams, and remained within the normal 
level. Consumption of the food cholesterol was increased significantly in 
female CKD patients at 271 mg to 360 mg, but decreased non-significantly in 
male patients. 
Food carbohydrates intake significantly increased in female patients and 
remaind in FU 293 g in a day (50% carbohydrates of food energy) but non-
significantly decreased in male patients and was in FU 312 g (51% of carbo-
hydrates of food energy) remaining within the normal level. 
The average sodium content in food decreased non-significally in all 
patients: in male patients at 2,752 mg to 2,300 mg (min 1,488 mg in FU), and in 
female kidney transplant patients at 2,240 mg to 2,494 mg (min 1,642 mg in 
FU).  
The average potassium content in food decreased non-significally in male 
patients at 3,920 mg to 3,843 mg (min 3,096 mg in FU), and increased non-
significantly in female kidney transplant patients at 2,988 mg to 3,579 mg (min 
1,805 mg in FU).  
Consumption of the food calcium was increased significantly in female 
CKD patients at 732 mg to 915 mg, but decreased non-significantly in male 
patients at 1,221 mg to 1,022 mg. 
The average phosphorus content in food decreased non-significally in male 
patients at 2.046 mg to 1,789 mg (min 1,471 mg and max 2,378 mg in FU), and 
increased significantly in female kidney transplant patients at 1,433 mg to 1,616 mg 
(min 1,130 mg and max 2,321 mg in FU).  
The average magnesium content in food decreased significally in male 
patients at 455 mg to 398 mg (min 332 mg and max 553 mg in FU), and in-
creased significantly in female kidney transplant patients at 1,433 mg to 1,616 mg 
(min 1,130 mg and max 2,321 mg in FU) but in female patients non-signifi-
cantly little increased. 
The food iron average consumption in CKD male patients is higher (at 22 
mg to 20 mg) from the recommended level (9 mg) and in female patients 17 mg 
in FU. 
Dietary fiber contents were in the recommended range in male at 31 g to 32 g 
in FU, and in female kidney transplant patients at 26 g to 27 g in FU. 
Dietary water solubile vitamins (tiamin, niacin, pyridoxine, folic acid, 
pantothenic acid, biotin, vitamin C) intake inreased significantly in the female 
patients groups and remaind at the recommended level in FU, but in the male 
patients groups non-significant changes in FU were found. Dietary vitamin D 
intake inreased significantly in the female patients groups and remaind under 
the recommended level in FU (4.0 µg), but in the male patients groups non-
significant changes in FU (3.5 µg) were found. Dietary vitamin E content was 
in the recommended range in male and female patients grops (recommended 
range is 8 mg). 
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5.12. Correlation analysis between anthropometric and 
the 3-day menu variables (Paper V) 
The correlation analysis of mean anthropometric parameters with mean nutritio-
nal variables was carried out separately for males (n = 12) and for females (n = 
16). The Paper V presents the correlation coefficients of all the 36 anthropo-
metric variables with 10 indices and consumed energy with 10 food nutrients. 
The results of the correlation analysis between selected anthropometric and 
nutritional parameters in kidney transplant male and female patients after the 
first measurements (FM) and the follow-up (FU) are given for male and for 
female patients.  
 
Male patients (n = 12) 
Correlation analysis between selected anthropometric variables and the 
consumption of energy and the main nutrients in kidney transplant male 
patients after FM. The consumed energy and the amount of ten basic nutrients 
and micronutrients are significantly connected with single features (breadths 
and depths, circumferences, skinfolds, indices). We found at the beginning 
(FM) of observation positive statistically significant correlations in male kidney 
transplant patients between seven anthropometric parameters and of food chole-
sterol: chest breadth (r = 0.581), waist breadth (r = 0.592), neck circumference 
(r = 0.615), calf circumference (r = 0.907), ancle circumference (r = 0.597), 
wrist circumference (r = 0.818), body surface area (r = 0.647). On the basis of 
the table it can be concluded that the male patientsʼ features of body build are 
not significantly connected with the nutritional content and the consumption of 
food energy.  
Correlation analysis between anthropometric variables and the con-
sumption of energy and the main nutrients in kidney transplant male pa-
tients after FU. Non-significant correlations between other anthropometric 
variables and the consumption of energy and the main nutrients in kidney trans-
plant male patients after the follow-up were found. 
 
Female patients (n = 16) 
Correlation analysis between anthropometric variables and the consump-
tion of energy and the main nutrients in kidney transplant female patients 
at FM. We found at the beginning (FM) of observation two statistically signi-
ficant correlations between food cholesterol and body fat indices: body fat (kg) 
by OMRON (r = 0.501), body fat (%) by OMRON (r = 0.537) but statistically 
significant correlations were found between the mean food calcium and the 
mean body height (r = -0.508). Only certain features deserve attention: the con-
nections between cholesterol and the skinfold of chest (r = 0.531) and body fat 
indices by OMRON (r = 0.537, r = 0.501), while the food calcium is statistically 
in the negative correlation with the body height (r = -0.508).  
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Correlation analysis between anthropometric variables and the con-
sumption of energy and the main nutrients in kidney transplant female pa-
tients after FU.  
We found at the end (FU) of observation statistcally significant correlations 
in female kidney transplant patients between seven mean anthropometrical 
parameters and the mean food calcium: waist breadth, biceps skinfolds, thigh 
skinfolds, body fat (%) by OMRON, mean skinfolds, body density. In females 
at the end (FU) of observation positive statistcally significant correlations were 
found between six mean anthropometrical parameters and the mean food phos-
phorus: waist breadth, neck circumference, biceps circumference, thigh circum-
ference, body density.  
The results of our work indicated that the amount of consumed food of the 
studied renal transplant patients was generally little correlated with the 
anthropometric parameters. Therefore, there is no clinical significance of these 
correlations.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
94 
6. DISCUSSION 
6.1. Anthropometrical study 
Among other methods, anthropometrics is a central method in the study of 
anthropometrical parameters and body composition in CKD patients. In scienti-
fic research, the standards developed and implemented into practice by 
anthropometrists and anthropologists are used, including the anthropometric 
measurement technique and terminology (Hertzberg 1968, Moreau et al. 2006, 
Tesedo 2011). Anthropometric parameters together with laboratory tests and 
dietary interviews should be measured routinely because they provide a valid 
and clinically useful characterization of the protein-energy nutritional status for 
the maintenance of dialysis patients (KDOQI, 2002). Several authors have 
underlined that the general state of CKD patients, including transplanted pa-
tients, should be assessed in a complex manner together with the anthropo-
metrical, body composition, laboratory and nutritional assessment methods 
(Patel 1998, El Haggan et al. 2002, Haapala et al. 2002, van den Ham et al. 
2002, Coroas et al. 2005, Moreau et al. 2006, Guida et al. 2007, van Düring et 
al. 2015).  
Therefore, as many studies presented in literature have been performed in 
CKD patients (concerning the parameters of their body build, the indicators of 
body content, the assessment of nutritional status and their connections using 
anthropometrical, laboratory and nutritional scientific methods), we also chose a 
similar approach, using complex methods in our work. Systematic research on 
assessing body composition and nutrition in chronic kidney disease (CKD) 
patients has not been carried out earlier in Estonia. In the current longitudinal 
study we measured and analysed the changes in the body build parameters and 
the nutritional status of male and female end-stage kidney disease (ESKD) 
patients. ESKD means that the patients have to receive renal replacement 
therapy (RRT): either dialysis or transplantation. In the first part of the study we 
analysed the body build of both the dialysis and the kidney transplant patients, 
and thereafter focussed on patients who had transplanted kidneys and were in a 
stable condition after transplantation. We analysed correlative links between the 
studied features at the Tartu University Hospital for the first time (FM) on 
average one and a half years after kidney transplantation and for the second 
time (FU) on average three years after kidney transplantation. Last anthropo-
metric measurements (LM) were performed ten years after kidney transplan-
tation.  
The anthropometrical parameters of the dialysis population are not com-
parable with the ones of the general population because of the accompanying 
protein-energy wasting syndrome in ESKD patients. But after the transplanta-
tion, uremic symptoms disappear, the patientsʼ general state improves and the 
anthropometric measurements of transplant patients may be comparable with 
the general population. On the other hand, depending on the timing of the mea-
surements of transplant patients, anthropometrical parameters may be similar to 
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the dialysis patientsʼ data. This was seen in our first study where the dialysis 
and the male and female transplant patientsʼ anthropometrical parameters were 
almost similar and that is explained by the fact that the measurements in 
transplant patients were performed shortly after transplantation. Although time-
consuming, the measurements of anthropometric variables are helpful and easy 
to use in assessing the nutritional status and taking care of kidney transplant 
patients in the follow-up period (Coroas et al. 2005, Moreau et al. 2006, Briggs 
2005, Sezer et al. 2006). On the basis of scientific literature, today, anthropo-
metry is an important measurement, and as mentioned before, should be used 
regularly in various categories of CKD patients, including kidney transplant 
patients for the estimation of body composition already before nutritional 
counselling (K/DOQI 2002, KDIGO 2012).  
Our study revealed that the mean body height (BH) decreased significantly 
during the follow-up period in both male and female groups of kidney trans-
plant patients, in male patients by 1.29 cm, and in female patients by 1.38 cm. 
However, this change may be associated with body posture or body habitus and 
can also be associated with the underlying disease or bone and mineral dis-
orders. The decrease of the mean BH is an important feature in CKD patients, 
and may show the development of CKD-mineral and bone disorders (CKD-
MBD) (Burger et al. 1994, Grotz et al. 1995, Williams 2009, Mazzaferro et al. 
2006, London et al. 2010).  
Body weight (BW) is an important anthropometric variable when screening 
undernutrition or obesity. The main change after kidney transplantation that has 
been demonstrated by many authors is BW gain that often occurs especially 
during the first post-transplant year (van den Ham et al. 2000, van den Ham et 
al. 2003). The increase in BW, which is common after transplantation, is caused 
by the correction of the anorectic effects of uraemia and by steroid therapy 
(Moreau et al. 2006). Also, van den Ham et al. have demonstrated that BW gain 
in CKD patients generally occurs shortly after transplantation, which may be 
influenced by improved appetite and the reversal of the uremic state (van den 
Ham et al. 2002). Investigators agree that more attention has to be aimed at the 
eating habits in the immediate post-transplant period when obesity may develop 
rapidly (Lopes et al. 1999).  
Our study revealed that after kidney transplantation, the mean BW increased 
significantly more in male kidney transplant patients than in female patients. 
However, our measurements, contrary to others (Zelle et al. 2013), were carried 
out later, more than one year after transplantation, when the first post-transplant 
changes in body build should have already disappeared and corticosteroid use 
minimalized or withdrawn. Subsequently, we studied transplant patients after 
intensive counselling for one and a half years. We found that BW gain in 
females was not significant after the FU and this may be explained partly by the 
fact that together with an improvement in their health, women probably cared 
more about their body shape and followed the dietitianʼs advice which was 
confirmed by analysing the 3-day menu and FFQ (Kiisk et al. 2010). Other 
authors have similarly demonstrated that in the post-transplant period there is 
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believably a bigger BW gain difference in male kidney transplant patients com-
pared with female patients. The BW difference may be explained by the more 
displayed role of undernutrition in male patients in the pre-transplant period, the 
reversal of the uremic state in the post-transplant period, also by a chronic 
inflammatory state and the improvement of the general state (Stenvinkel 2001, 
Coroas et al. 2005, Stenvinkel 2010). Coroas and co-authors indicated in their 
work that female patients, in comparison with male patients, have significantly 
lower BW in the post-transplant period which is caused by a smaller loss of 
weight in female patients in the pre-transplant period (Coroas et al. 2005). Other 
investigators have demonstrated in their research papers a stable mean BW gain 
in the post-transplant period with a tendency to increase after the first year. For 
instance, van den Ham showed a BW gain of 3.9 ± 6.2 kg in the first year, and 
6.2 ± 8.6 kg after 5 years in the studied transplant patients (van den Ham et al. 
2000, van den Ham et al. 2003). On the other hand, although we observed 
statistically significant differences in BW gain between the studied and the 
control group of kidney transplant patients, the mean BW stayed in a range 
similar to the healthy population of Estonians (Saluste et al. 2002).  
The increase in BW is predominantly caused by an increase in body fat (BF) 
mass as shown by the linear correlation between the increase in the percentage 
of the BF mass and BMI (Moreau et al. 2006). The assessment of BF content in 
the male and female kidney transplant patients, studied by us, showed a similar 
change in the direction to increase (discussion given in section 6.2). However, 
the increase of fat mass itself shows a risk for cardiovascular complications. 
Moreau and co-authors in a long-term study of stable thirty-six kidney trans-
plant patients indicated that the body composition in male patients remained 
stable and close to baseline values while female patients had a significant 
increase in BW (14%) because of an increase in fat mass: 3.4 kg (19%) in one 
year and 5.6 kg (30%) in 2 years, and then stabilization was observed over the 
last 3 years (Moreau et al. 2006). Chang and co-authors indicated in their study 
that the post-transplant stable mean BW gain of 0–5% was associated with the 
best outcomes but the BW gain of more than 10–20% was associated with 
poorer transplant outcomes (Chang et al. 2008). Thus, many authors have 
studied metabolic parameters and risk factors for kidney transplant patients as 
well as post-operative complications (Merion et al. 1991, Marcen et al. 2007, 
Zaudfudim et al. 2010, Zrim et al. 2012) where overweight has been found to be 
an important prognostic factor. Curran and co-authors observed in their 10-year 
cohort study that BW reduction in obese patients is important already in the pre-
transplantation period (Curran et al. 2013).  
Lastly, in the current study, ten years after the KTx we further aimed to 
clarify a longitudinal effect of intensive nutritional counselling and guidance on 
WG. We noticed BW gain in all KTx patients, both in males and females as 
follows: in the standard male care group the mean BW gain was 6.4 kg, female 
7.0 kg, and among intensively counselled males 4.6 kg, females 1.1 kg. The BW 
gain was not significant ten years after KTx in the patients who received 
additional intensive nutritional counselling compared with the standard care 
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control group of KTx patients (Paper VI). Thus, our study found intensive 
nutritional counselling and guidance to be effective also in the long term. 
Similar studies have not been performed earlier. 
However, because of the lack of evidence for effective interventions to 
prevent weight gain after kidney transplantation, Australian researchers have 
recently designed a randomized controlled study. Ryan with co-authors is stu-
dying the effect of intensive nutrition interventions (INTENT trial) on BW gain 
after kidney transplantation. An INTENT trial is a single-blind, randomised 
controlled trial to assess the effects of intensive nutrition interventions, in-
cluding exercise advice, on WG and metabolic parameters in the first year after 
transplantation (Ryan et al. 2014). Thus, the results may soon provide important 
data on the effects of intensive nutrition interventions on WG after transplan-
tation and the associated metabolic consequences. However, long-term WG data 
already in our study clearly showed that in KTx patient population, the patients 
who received intensive individual dietary counselling had much more educated 
behaviour in the long term, thereby preventing WG. 
Body Mass Index (BMI) is the most popular index in clinical practice for a 
complex assessment of patientsʼ nutrition together with other anthropometric 
features. Several authors have underlined in their papers that a very high BMI 
or a very low BMI before kidney transplantation constitutes a significant inde-
pendent risk factor for kidney graft failure and the patientʼs death (Meier-
Kriesche et al. 1999, Meier-Kriesche et al. 2002, Coroas et al. 2005, Weissen-
bacher et al. 2012). Marks with co-authors indicated that obese transplant 
patients had a significantly higher complication rate in the post-transplantation 
period, compared with non-obese patients (Marks et al. 2004). Jezior and co-
authors studied 418 kidney transplant patients and noticed that BMI signifi-
cantly increased in male patients (7%) and in female patients (9.6%) during 56 
months after kidney transplantation (Jezior et al. 2007).  
We found that the mean BMI increased significantly in both groups of 
studied kidney transplant patients during the follow-up period. The changes in 
the BMI indicators of the transplant patients we studied were compared with the 
kidney transplant patients in the control group. Our study indicated that the 
mean calculated BMI of male kidney transplant patients increased statistically 
significantly during the observation period, from 24.7 to 27.7 kg/m2 during the 
FU similarly to the control groupʼs increase in BMI from 24.4 to 26.0 kg/m2. 
The mean BMI in female kidney transplant patients increased during the obser-
vation period significantly, from 27.3 to 28.5 kg/m2 but in the control group the 
increase was from 25.0 to 26.0 kg/m2 (Paper IV). When comparing the results 
with the healthy population, we found interestingly that the male patientsʼ mean 
BMI at the first measurement differed significantly from the healthy popu-
lationʼs BMI but in the follow-up measurement no significant differences were 
found. In female patients, the mean BMI at the first measurement, and also in 
the follow-up did not differ significantly when compared with the mean BMI of 
the female group of the healthy population (Paper I).  
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Skinfolds. In the post-transplant period, we noticed a different tendency in 
the studied patientsʼ body composition parameters which was probably caused 
by increased appetite, improved health and uremic status. Out of 11 measured 
folds in male patients, only 5 folds changed statistically significantly in the 
follow-up period: chin skinfolds, chest skinfolds, subscapular skinfolds, biceps 
skinfolds, and triceps skinfolds. In female patients we did not find significant 
changes in skinfold thickness in the follow-up measurements.  
Other authors have also shown statistically significant differences between 
nutritional and anthropometric parameters when comparing male kidney trans-
plant patients with female patients. Coroas and co-authors showed that the 
results in the measurements of triceps, biceps, subscapular and suprailiac 
skinfolds in CKD patients are significantly different between male and female 
patients during the first years after kidney transplantation. Uremic men before 
transplant displayed undernutrition indices, and differently, women started close 
to normal and had significantly increased BW and fat content in the post-
transplant period (Coroas et al. 2005). Srivastava with co-authors studied 
clinical, nutritional, anthropometric parameters and skinfolds thicknesses in 
kidney transplant patients during a 12-month period, and found no correlation 
between body fat percentage and dietary intake among patients with CKD, the 
fact that all the studied patients were allowed regular dietary counselling 
(Srivastava et al. 2014). Although skinfold thickness may give useful infor-
mation about the patientʼs nutritional status, the measurements are not in clini-
cal routine in every centre but, pursuant to a few clinical guidelines, these mea-
surements should be performed regularly in ESKD patients (KDOQI 2002).  
Body composition. Out of 8 calculated body composition characteristics we 
found 7 statistically significant changes in male patients in the FU period, but 2 
statistically significant changes in female patients. In the male group, there were 
statistically significant body content indicators or parameters in the follow-up 
period: the body surface area, the body density, the relative mass of fat by Siri 
in percent, the mean skinfolds, the mass of subcutaneous adipose tissue in 
kilograms, the relative mass of subcutaneous adipose tissue in percentage, the 
BMI, and the WHR. In the female group there was only one statistically signifi-
cant indicator with growth tendency for the body content indicator or BMI, and 
one statistically significant indicator with the falling tendency of the WHR in 
the follow-up period. In addition to the BH and BW we also compared several 
anthropometric features and the changes in their measurements for characte-
rizing body build, consequently a total of 36 anthropometric variables were 
measured: body height, body weight, 2 depth and 8 breadth measurements, 13 
circumferences and 11 skinfold thickness measurements (Paper IV).  
In literature, we have not found such profound measurements of anthropo-
metric features in kidney transplant patients, and no long-term studies exist. 
Several researchers have studied the anthropometric and nutritional parameters 
of kidney transplant patients at baseline and after one year and, contrary to 
female patients, have found no significant change in body composition of men 
(Chang et al. 2008, Srivastava et al. 2014).  
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Circumferences. In connection with the increase of BW, significant in-
crease was also found in the characterized circumferences in both groups of 
studied patients (Paper IV). Significant changes in circumferences were found 
in different directions both in males and females. Out of thirteen measured 
circumferences of males, four significant changes in growth were noted, but in 
females, concerning the same feature, there was an insignificant lowering 
tendency. In male kidney transplant patients, mid-arm relaxed circumference 
and mid-arm flexed-tensed circumference at upper limb as well as calf circum-
ference at lower limb had statistically significantly increased. In male kidney 
transplant patients a significant increase in hip circumference after the FU (FM 
at 99.19 cm to 103.04 cm at FU, difference 3.85 cm) was found. In the male 
group we found in total five significant lowering tendencies in circumferences: 
head circumference, neck circumference, waist circumference, proximal thigh 
circumference and forearm circumference which did not appear in the female 
group. In the female group we still found some significant lowering tendencies 
in waist circumference from FM 88.55 cm to FU 86.57 cm which did not appear 
in the male group.  
Breadths and depths. The mean biacrominal breadth decreased significant-
ly in male transplant patients (0.49 cm), but decreased insignificantly in female 
patients (0.39 cm). The mean waist breadth indicated insignificant lowering 
tendencies both in males and females. We found one significant one direction 
change in the widths of hips in both males and females. The pelvis breadth in-
creased significantly in male and female patients. The changes of pelvis breadth 
were evidently caused by the changes in the thickness of the subcutaneous fat 
tissue (Paper IV).  
Thickness of bone at the upper limb. We noticed non-significant changes 
in the mean humerus breadth and in the mean wrist breadth measurements in 
both male and female patients. Thickness of bone at the lower limb. The data 
of the mean femur breadth showed insignificant changes in both groups. We 
found that the mean ankle breadth decreased significantly in male patients (from 
7.35 cm to 6.93 cm), and decreased non-significantly in female patients (from 
6.33 cm to 6.11 cm).  
On the basis of literature, the data of the anthropometrics of CKD patients 
are often limited to the measurements of mid-arm, waist and hip circumferences 
(Moreau et al. 2006, Ryan et al. 2014). But other investigators have used com-
prehensive measures using biceps, triceps, subscapular and suprailiacal skin-
folds thicknesses, and many indicators of the BF content the BMI, the WHR, 
mean skinfolds, body density, relative mass of fat by Siri, the mass of sub-
cutaneus adipose tissue have been taken into consideration (Patel 1998, El 
Haggan et al. 2002, Haapala et al. 2002, van den Ham et al. 2002, van den Ham 
et al. 2003, Coroas et al. 2005, Moreau et al. 2006, Guida et al. 2007, van 
Düring et al. 2015, Uysal et al. 2015, Vega et al. 2015, Sasaki et al. 2015, Heng 
et al. 2015, Andreoli et al. 2016). Systematised anthropometrics is not stipulated 
in clinical guidelines but should become an obligatory procedure in the routine 
management of kidney transplant patients. 
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6.2. Instrumental assessment methods  
of body composition  
Bioimpedance. In our study, the assessment of the BF content in the kidney 
transplant  male patients showed the significant one-direction change to in-
crease, BF % by OMRON at baseline from 18.2% to follow-up 23.5%, and the 
mean BF in kg by OMRON at baseline from 14.9 kg to follow-up 20.4 kg. The 
assessment of BW content in the kidney transplant female patients studied by us 
showed the one-direction trend to increase: the mean BF% by OMRON from 
33.1% to follow-up 34.8%, and the mean BF in kg by OMRON increased from 
the first measurement 25.74 kg to follow-up 28.36 kg. The minimal BF% of 
kidney transplant patients by OMRON is very low compared with the normal 
range of healthy population, and it was for male patients at the first measure-
ment 7.8% and in the follow-up 8.4%, and for female patients at the first mea-
surement 9.9% and in the follow-up 10.5% (Kiisk et al. 2012). Thus, these mea-
surements show similarity with the anthropometrical data of the BW and BMI. 
Several authors have similarly shown that undernutrition exists in male 
patients before kidney transplantation, and, during the follow-up, they increased 
their BW and BF content, but it remained in the normal range (Marcén et al. 
2007, Mitch 2007). High doses of steroids in the early period after renal 
transplantation are possibly mediated by their inhibiting effect on lipid peroxi-
dation, it also appears to be related to physical inactivity. Hyperlipidaemia, 
overweight or obesity and improved appetite were normalized by dietary 
intervention and exercise training in stable kidney transplant patients (Coroas et 
al. 2005, Marcén et al. 2007, Mitch 2007). Coroas and co-authors studied 11 
men and 7 women anthropometrically, and indicated the difference in male and 
female patientsʼ body fat content as follows: in uremic men, indices of under-
nutrition were found before transplant, and female patients had a significantly 
increased body weight and body fat content after kidney transplantation (Coroas 
et al. 2005, Moreau et al. 2006, Stenvinkel 2010, Tesedo 2011). Our anthropo-
metric and bioimpedance measures showed similar changes of body compo-
sition (Paper IV). 
Densitometry. Dual-energy x-ray absorptiometry (DXA) is used for routine 
clinical care and can be used to validate other methods of measuring the body 
fat. However, pursuant to the clinical guidelines (KDIGO, 2009), measuring 
bone mass density (BMD) after kidney transplantation is needed in the cases 
where patients receive corticosteroids or have risk factors for osteoporosis as in 
the general population and there are insufficient data to guide treatment after the 
first 12 months. After analysing our data and literature data, we feel that the 
DXA usage deserves more attention in the complex management of transplant 
patients. Comparing our investigation with the works of other authors, we have 
found similar results in BMD and bone research results. The total body mean 
BMD after the follow-up both in the male and female kidney transplant patient 
groups was within the lower normal range (Reference Population Database. 
Lunar DPX-IQ Reference Manual). Individual measures of the total body BMD 
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revealed osteopenia in 50% of males and 18% of females but anterior-posterior 
(AP) lumbar spine (L2–L4) measured T-scores showed osteopenia in 33% of 
males and in 25% of females. Osteoporosis was not found using the total body 
BMD measurements but in the region AP lumbar spine (L2–L4) osteoporosis 
was found in 8% of male and 25% of female patients (Paper IV). 
Brandenburg and co-authors showed in their study that the bone loss in 
transplant patients is a long process. A rapid bone loss is seen in the first 3–6 
months after transplantation. Kidney transplant patients had stable BMD in the 
lumbar region during one year, and after 4–6 years it was significantly lower 
(Brandenburg et al. 2004, Mitterbauer et al. 2006). The Canadian researchers in 
the long-term study (1996–2011) investigated the BMD of 326 male and female 
patients (mean age 45 years) three times: the first scan was 0.5 years after 
kidney transplantation, and the second scan was 2.7 years after the first scan, 
and the third measurement was made 8.2 years after the first scan. This study 
investigated long-term changes in CKD patients with the monitoring and 
treatment of osteoporosis. Naylor and co-authors indicated that the bone density 
remained stable or improved for age and sex, and the data of Z scores in lumbar 
spine increased from -0.4 ± 1.6 to + 0.7 ± 1.6 (Naylor et al. 2014).  
Thus, the results of densitometry indicated the need for the complex pre-
ventive and individual therapeutic treatment according to the increase of bone 
mineral density levels. But, the recommendation by KDIGO 2012 suggests that 
no bone mineral density testing is performed routinely in those with eGFR  
< 45 mL/min/1.73 m2 (GFR categories G3b–G5) as information may be 
misleading or unhelpful (KDIGO 2012). 
 
 
6.3. Correlation analysis between the variables of 
anthropometry, biochemical data and food nutrients 
The associations between anthropometrical and biochemical variables were 
different in the male and female patients of kidney transplant. Our study 
revealed that the male patients gained BW in the post-transplant period because 
of the increase of bone, muscle and fat mass. These changes appeared to 
correlate with the inflammatory status. Similar association was not noticed in 
the female patients where BW had not increased significantly. Inflammatory 
status (Ozdemir 2007) and hyperlipidaemia (Dumler 2007, Ramezani 2007) are 
well-known cardiovascular risk factors. In our study, most patients normalized 
their inflammatory status similarly to the studies of the other authors (Moreau et 
al. 2006). As a confirmation of the inflammatory status association with the 
body composition, we found a significant number of correlations in males 
between CRP and different body circumferences and body fat. Previously, it 
had been shown that the graft survival rate in the recipients with hyper-
cholesterolemia was lower than that in the recipients without hypercholes-
terolemia (Akioka et al. 2005). Therefore, lipid profile monitoring is clinically 
important in the management of patients with kidney transplants. Hyper-
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lipidaemia, overweight or obesity, physical inactivity and improved appetite 
were normalized by dietary intervention and exercise training in stable renal 
transplant patients (van den Ham 2002). On the contrary, in our study we found 
a tendency of increase in S-CHL in both males and females after trans-
plantation. Interestingly, many significant correlations were found in females 
between the mean weight, BMI and triglycerides both at FM and after FU. At 
the same time, the skinfolds thicknesses in female patients correlated signi-
ficantly with the serum triglycerides level at the beginning of measurements, 
but less in FU which means that intensive counselling was effective. In males, 
there were no statistically significant correlations between skinfolds thicknesses 
and studied lipids (Paper IV). 
The results of our study revealed that the amount of consumed food was 
generally not much associated with the anthropometrical variables both at FM 
and after FU. 
 
 
6.4. Nutrition assessment of nutritional status and 
nutritional counselling of kidney transplant patients 
The assessment of nutritional status is time-consuming but forms a central part 
in the CKD patientsʼ nutrition management. The nutrition assessment of dialysis 
patients performed by a dietitian includes the compilation of a plan of care that 
incorporates all aspects of nutrition evaluation (assessment of nutritional status, 
nutrition history, patient preferences, and the nutritional prescription). The data 
are incorporated into an active plan that is then implemented by the medical 
team (KDOQI 2002). After transplantation uremic symptoms disappear and the 
patientsʼ general state improves. Therefore, patients feel well and often forget to 
pay attention to healthy eating. As shown earlier, the studied transplant patients 
were generally in a satisfying nutritional status at the first measurement after 
kidney transplantation which can be explained by regular monitoring, co-
operation with treatment, and good collaboration between specialists, but never-
theless, later the BW gain appeared. In the long term, optimal and intensive 
counselling by a dietitian can prevent significant body weight gain after kidney 
transplantation. 
Multiple body composition and nutritional characteristics may be used 
together to estimate the projected long-term risk of BW gain among kidney 
transplant patients. Two main methods have been appreciated in the assessment 
of a nutritional status: the nutrition frequency questionnaire (FFQ) and the 3-
day nutrition diary. However, the 24-hour recall is not appropriate for scientific 
studies but it is often in use in clinical routine practice (KDIGO 2012). The 
nutrition of CKD patients after kidney transplantation has not been studied in 
Estonia but the nutrition issues of the patients with chronic cardiovascular 
disease (CVD) have been studied by Born et al. using 3-day dietary records 
(Born et al. 2002). 
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We implemented a special food-frequency questionnaire (FFQ) compiled by 
the Centre of Physical Anthropology at the University of Tartu. The FFQ con-
sists of the questions concerning socio-economic aspects, physical activity and 
nutrition (Kiisk 2010). The analysis of the FFQ questionnaire shows a diverse 
selection of nutrients with different frequencies but mainly protein-, fat- and 
carbohydrate-rich food products are consumed. Using the above-mentioned 
questionnaire, we analysed prospectively long-term nutritional issues in the 
CKD patients with kidney transplants who were in a stable status after kidney 
transplantation. The differences in the parameters of body build, laboratory data 
and the nutritional status were studied for the first time on average one and a 
half years after kidney transplantation and for the second time on average three 
years after kidney transplantation.  
Similar research has been performed by others where the assessment of the 
nutritional status of the patients with the transplanted kidney is also used beside 
anthropometric measurements, biochemical indicators and FFQs (Levey et al. 
2006, Finkelstein et al. 2006, Yong et al. 2010, Nauta et al. 2011, Hoogeveen et 
al. 2011). However, these studies are usually retrospective and examine patients 
during the first year after kidney transplantation (Zelle et al. 2013). Therefore, 
the risk of BW gain in the first post-transplant year is widely known and, before 
leaving the hospital, patients usually receive routine dietary counselling ac-
cording to clinical guidelines. Medical researchers at the Auckland City Hos-
pital found, based on their research, that the Intensive Nutrition Intervention 
(INTENT study) helps avoid metabolic changes, also important changes of BW 
in the direction of growth if nutritional counselling has already started during 
the first month and later with three-month periods in the first year after kidney 
transplantation (Ryan et al. 2014). Additionally, the influence on the CKD 
patientsʼ lifestyle factors guarantees a stable status after transplantation (Disler 
et al. 1981, van den Ham et al. 2002, Zelle et al. 2013). 
Since the first year BW gain is widely known (Zelle et al. 2013) and our 
patients had routine dietary counselling performed before leaving the hospital 
after transplantation, we aimed to study the stable kidney transplant patients 
after the first post-transplant year with the inclusion of additional intense dietary 
counselling, and found that the intervention had been appropriate in our 
patientsʼ groups to avoid further BW gain. As BW gain after transplantation 
occurs mostly during the first and also during the second year after the trans-
plantation, the second year appears even more critical because patients forget 
the advice given by a dietitian or doctor who monitors them, and further weight 
gain may occur.  
We used the Finnish Micro-Nutrica Nutritional Analysis program which had 
been modified and translated into the Estonian language at the Tallinn Uni-
versity of Technology, Department of Food Processing (Estonian Version 2, 
1997) in analysing the patientsʼ dietary records. The 3-day dietary records data 
of CKD patients were compared with the Estonian Nutrition Recommendations 
(the Estonian Nutrition Recommendations 2006), based on the Finnish Nutrition 
Recommendations (1998) and the Nordic Nutrition Recommendations (2004). 
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There were large variations in the studied kidney transplant patientsʼ nutrition 
parameters based on individual 3-day dietary records analysis. We found 
several examples both in male and female patients which credibly explained all 
their anthropometric changes that had occurred during the study. 
Our 3-day dietary record revealed that the average amount of consumed 
food energy in the male and female groups, diurnally in males, decreased 
insignificantly in the follow-up period (from 2,689.7 kcal to FU, 2,424.9 kcal), and 
in females it increased significantly in the follow-up period (from 2,028.0 kcal to 
FU, 2,352.9 kcal), but remained in the limits of the recommended daily con-
sumption of food energy by the Estonian Nutrition Recommendations, the 
reference energy content 2,000 ± 150 kcal (the Estonian Nutrition Recommen-
dations 2006). In our study, the CKD patients were advised to consume 25– 
35 kcal of food energy per kg of BW a day, which is in accordance with the 
nutritional recommendations. Our results showed that the daily consumption of 
food energy per kilogram of BW decreased significantly in males (from 37.2 to 
30.2 kcal/kg) but increased in females from 29.2 to 32.9 kcal/kg which at the 
same time did not exceed the average recommended reference. Similar findings 
have also been described by others authors (Aparicio et al. 2000, Bernardi et al. 
2000, Srivastava et al. 2014).  
According to the 3-day menu analysis, our study found that male patients did 
not follow the dietitianʼs advice very carefully, when compared with females. 
BW gain in females, contrary to males, was not significant and that may be 
partly explained by the fact that together with the improvement in their health, 
females probably cared more about their body shape and followed the dietitianʼs 
advice. 
After intense additional dietary counselling after FU, the mean intake of 
dietary protein in male patients in the 3-day menus decreased non-significantly 
(106.7 ± 22.4 g, to 91.6 ± 10.7 g in FU), and in female patients the dietary 
protein intake increased significantly in the follow-up (79.6 ± 19.7 g, to 89.2 ± 
19.5 g in FU). According to the Estonian Nutrition Recommendations, the range 
of dietary protein is 50–90 g per day. Thus, after counselling, protein con-
sumption was almost in the normal range. But we have to consider the fact that 
kidney transplant patients belong to the CKD patient population. According to 
clinical recommendations, CKD patients are advised to consume 0.8 to 1 g/ 
kg/day of protein (K/DOQI guidelines). Our results showed that, both in male 
and female patients, the recommended normative value was exceeded in the 
first measurement when the mean consumption of recommended dietary protein 
was 0.8 to 1 g/kg/day of protein per day for one kilogram of BW (g/kg/day). 
But after FU, protein consumption decreased both in male (from 1.5 to 1.1 g/kg, 
p = 0.009) and in female patients (from 1.2 to 1.2 g/kg, p = 0.289). Also, the 
percentage of proteins in food energy decreased non-significantly both in males 
(from 15.9% to 15.2%) and in females (from 15.8% to 15.2%) but remained in 
the normal range, being in accordance with the Estonian Nutrition Recommen-
dations (2006). 
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The average amount of carbohydrates consumed diurnally by the studied 
patients remained in the recommended limits (the Estonian Nutrition Recom-
mendations 2006). However, other investigators have paid attention to high 
carbohydrate consumption because it has been found that overweight patients 
consume carbohydrate-rich drinks and they are physically inactive (Hines et al. 
2000, Zelle et al. 2013).  
Hyperlipidaemia is a well-known clinical feature after kidney transplantation 
and a risk factor for cardiovascular complications. Already a moderate decrease 
in the total amount of fats from 30% to 27% and a decrease in saturated fats 
from 12% to 8% in the amount of diurnally consumed food energy helps avoid 
the appearance of hyperlipidaemia in the post-transplant period and improves 
the indicators of kidney function (Tonstad et al. 1995). The clinical practice 
guidelines are presented for CKD patients, and are used for planning renal diets. 
The major goal in nutrition is to prevent excessive weight gain and dyslipi-
daemia as well as the changes in calcium-phosphate balance (NKDEP. National 
Kidney Disease Education Program 2014). In our study, the total amount of fats 
consumed in food did not show the tendency of growth either in male or female 
patients but the content of cholesterol in menus slightly exceeded the recom-
mended norm, remaining on average in the limits of 356 mg to 359 mg per day. 
In the male group studied by us, statistically insignificant lowering tendencies 
of fats in the 3-day menus, on average from 101.3 g to 88.3 g but in the female 
group from 76.0 g to 88.0 g, remained in the recommended limits (the Estonian 
Nutrition Recommendations 2006). In the pathogenesis, BW gain and dyslipi-
daemia indicated the optimal effect of dietary intervention, the normal renal 
diet, nutritional counselling and physical activity (Disler et al. 1981, Tonstad et 
al. 1995, KDIGO 2012, Zelle et al. 2013, Marckemann et al. 2015).  
The lifestyle factor is certainly important in post-transplant BW gain. Ac-
cording to clinical guidelines (KDIGO 2009), it is recommended that trans-
planted patients follow a healthy lifestyle, with exercise, proper diet, and weight 
reduction as needed. We recommended physical quality walking for all CKD 
patients at least 30 minutes a day, 5 times per week. Although physical activity 
was not additionally investigated in the current study, we obtained general 
background data about the lifestyle of the studied CKD patients with the help of 
the FFQ. The data revealed that the socio-economic situation was poor in 
16.7% of men and 12.5% of women, satisfactory in 75% of men and 68.8% of 
women, and only 8.3% of men and 18.8% of women considered their economic 
status good. Patientsʼ working load may indirectly reflect the intensity of their 
physical activity (PA). Data analysis indicated that 2/3 of male and 2/3 of 
female patients did not work as they were categorized as the disabled, and 1/3 
of subjects worked either constantly or sometimes, either full- or part-time. 
Many authors have indicated that, after transplantation, the socio-economic 
situation, education, psychosocial factors and physical activity play an impor-
tant role in all patients. At the same time, a decreased quality of life, lack of 
education, depression and the decreased nutrient intake in the patientsʼ renal 
diet was found (Stenvinkel et al. 2001, Wells 2003, Lynch et al. 2007, Mitch 
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2007, Guida et al. 2007, Levey et al. 2011). Briggs with co-authors emphasizes 
that there are four important components of lifestyle changes where positive 
changes are especially important for renal patients: body weight, diet, exercise 
and smoking (Briggs 2005). On the other hand, Zaydfudim and co-authors 
(2010) tested the health-related quality of life, and indicated that pre-transplant 
overweight and obesity do not affect the physical activity of CKD patients after 
transplantation in a 10-year period. Our long-term BW gain data clearly showed 
that, in KTx patient population, the patients who received intensive individual 
dietary counselling had much more educated behaviour in the long term, 
thereby preventing BW gain which is a really well-known risk factor for long-
term graft failure as well as for cardiovascular complications and mortality. 
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7. CONCLUSIONS 
 
 
1.  The anthropometrical profile in the studied dialysis and transplant patients 
was almost similar. No significant differences were found in the studied 
anthropometrical parameters of the dialysis and kidney transplant patients 
either in male or female patientsʼ groups which evidently can be explained 
by the fact that transplant patients were studied shortly after the trans-
plantation. 
 
2.  The body composition characteristics indicated systematic differences 
between the male and female patients of renal transplantation. After the 
intensive nutritional counselling, anthropometric measurement changes were 
in accordance with the increase of body weight after the follow-up which 
was statistically significant in the studied males but not in females.  
 
3.  The effect of intensive nutritional counselling on the changes of biochemical 
indices revealed the normalization of inflammatory status in most patients, 
and the studied lipids levels remained within normal reference values. 
 
4.  The associations between anthropometrical and biochemical parameters 
were found to be different in male and female patients. In male patients, 
several anthropometrical parameters were associated with CRP but in 
females with lipids. These associations deserve attention because inflam-
mation and hyperlipidaemia are well-known cardiovascular risk factors. 
 
5.  The amount of consumed food (3-day menu indices of macro- and micro-
nutrients) was not associated with the anthropometrical variables of the 
studied transplant patients which shows that there is no clinical significance 
of these correlations. 
 
6.  Intensive nutritional counselling was effective in a long-term: ten years after 
kidney transplantation, statistically significant BW gain was not seen either 
in males or in females, but on the contrary, BW gain was present in kidney 
transplant patients with the standard care. 
 
7.  The increased consumption of proteins and carbohydrates after kidney trans-
plantation was found in females but not in males. The consumption of fats 
was within the normal range. After intensive nutritional counselling, all the 
values of macronutrients were within normal range in accordance with the 
Estonian nutritional recommendations. 
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8. MAIN PRACTICAL IMPLICATIONS 
Practical usage of accepted treatment diets 
The author of the thesis has drawn up a systematized list of diets and compiled a 
collection of articles which take the contemporary principles of feeding 
treatment into consideration.  
By today, the activities of the Tartu University Hospital in the field of 
nutrition have been reorganised in connection with the introduction of the 
electronic case history in the years 2008–2009. This enables the catering service 
of the Tartu University Hospital to provide for the special needs of 17 clinics 
with ca 1,000 patients every day. The share of the diet food is about 25–28%. 
The electronic database contains the titles of diets for each meal. Personal 
menus are entered in the case history by a dietitian according to the special 
needs of the patient and the indications of the diet treatment. For all the foods, 
there are recipes and the technology for preparing them which should guarantee 
food safety. The food energy and the content of nutrients of ready-made foods 
and menus are calculated on the basis of the nutrition program of the National 
Institute for Health Development (NutriData Food Composition Database 
2014). All the above mentioned changes in dietology have been checked by the 
treating doctors together with a dietitians when monitoring the patients.  
The above-described common system of diets for treatment implemented at 
the Tartu University Hospital was finally accepted by the Ministry of Social 
Affairs, and the special Regulation of the Ministry of Social Affairs dealing 
with feeding treatment (Regulation No 131) was worked out for the nutritional 
care of patients. The common system of diets for treatment has been imple-
mented by now in all the hospitals and care centres in the whole country. The 
normative values of basic nutrients are in accordance with the Estonian Nutri-
tional Recommendations, the nutrition guidelines of the WHO Regional Office 
for Europe, and Regulation number 131 Health Protection Requirements for 
Nutrition in Health Care and Social Welfare Institutions, issued on 14 No-
vember 2002 by the Estonian Minister of Social Affairs. 
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9. SUMMARY IN ESTONIAN 
Pika-ajaline toitumise uuring: antropomeetriliste ja  
kliinilis-laboratoorsete näitajate hindamine neeruasendusravi 
patsientidel intensiivse toitumisalase nõustamise järgselt 
 
Sissejuhatus 
 
Krooniline neeruhaigus (KNH) on vaikselt ja algstaadiumis oluliste kaebusteta 
kulgev haigus, mis progresseerub lõpp-staadiumi neerupuudulikkuseni aastate 
ja sageli aastakümnete jooksul. KNH peamisteks tekkepõhjusteks Eestis on 
glomerulonefriit, suhkur- ja kõrgvererõhktõbi ning harvem muud kroonilised 
neeruhaigused. KNH lõpp-staadiumi haigete arvu suurenemine Eestis ja glo-
baalselt on seotud eelkõige KNH progresseerumist põhjustavate riskitegurite 
laialdase esinemisega elanikkonna hulgas (hüpertensioon, suitsetamine, ülekaal, 
rasvtõbi, jm.), diagnostika- ja ravivõimaluste paranemisega ning dialüüsiapara-
tuuri täiustumisega. KNH-ga kaasnevalt areneb südame- ja veresoonkonna 
kahjustus ning KNH-ga patsientide kardiovaskulaarne suremus on üldrahvas-
tikuga võrreldes oluliselt suurem.  
Lõpp-staadiumi neerupuudulikkuse kõige efektiivsemaks ravimeetodiks on 
neerusiirdamine hemo- ja peritoneaaldialüüsi kõrval. Neeru siirdamise järgselt 
patsiendi üldseisund ja söögiisu paraneb ning sageli kehakaal suureneb. Teadus-
kirjaduses ilmub üha uusi andmeid siirdatud neeruga patsientide antropomeetri-
liste, densitomeetriliste ja biokeemiliste näitajate, toitumisharjumuste ja toidu-
valiku kohta, kuid kehakaalu suurenemise ärahoidmise efektiivsete meetodite 
kohta on läbi viidud väga vähe uuringuid.  
 Käesoleva uurimustöö üldine eesmärk oli analüüsida lõpp-staadiumi kroo-
nilise neeruhaige kehakoostist ja toitumisharjumusi. Me püstitasime hüpoteesi, 
et intensiivne toitumisalane nõustamine võimaldab muuta patsientide toitumis-
harjumusi nii, et peale neerusiirdamist ei teki olulist kehakaalu suurenemist. 
 
Uuringu eesmärgid 
1.  Analüüsida antropomeetriliste mõõtmiste tulemusi lõpp-staadiumi neeru-
puudulikkuse haigetel ning võrrelda dialüüsi ja transplanteeritud haigete 
kehakoostise andmeid. 
2. Testida, kas intensiivsel toitumisalasel nõustamisel on efekti neerutransplan-
tatsiooni mees- ja naishaigete kehakoostisele. 
3.  Hinnata intensiivse toitumis-alase nõustamise mõju antropomeetriliste, bio-
keemiliste ja toitumuse parameetrite muutustele peale jälgimisperioodi ning 
analüüsida nimetatud parameetrite omavahelisi seoseid eraldi siirdatud 
mees- ja naishaigetel. 
4.  Hinnata intensiivse toitumisalase nõustamise pika-aegset efekti kehakaalu 
suurenemisele neerutransplantatsiooni haigetel. 
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5.  Hinnata makro- ja mikrotoitainete kasutust neerutransplantatsiooni haigetel 
3-päeva menüü alusel dünaamikas. 
 
 
Uuritavad ja uurimismeetodid 
Uuring viidi läbi Tartu Ülikooli Kliinikumi Sisekliiniku nefroloogia osakonnas 
aastatel 2003–2005 ja 2015. Uuringul on Tartu Ülikooli inimuuringute eetika-
komitee luba.  
Esimesse uuringugruppi kaasati kliiniliselt stabiilses seisundis järjestiku-
lised neeruasendusravi patsiendid (dialüüsravil ja siirdatud neeruga), kes andsid 
nõusoleku uuringus osalemiseks: 37 mees- ja 38 naispatsienti.  
Teise uuringugrupi moodustasid stabiilses seisundis järjestikulised neeru-
siirikuga patsiendid, kes andsid nõusoleku uuringus osalemiseks: 12 mees-
patsienti (keskmine vanus 42,8 ± 16,1 aastat) ja 16 naispatsienti (keskmine 
vanus 47,0 ± 14,9 aastat). Uuringud viidi läbi kahe visiidi käigus: esimene visiit 
poolteist aastat ja teine visiit kolm aastat peale neerusiirdamist. 
Uurimismeetodid olid järgmised: antropomeetrilised mõõtmised, kehakoos-
tise hindamine bioimpedansi ja densitomeetria abil, laboratoorsete näitajate ko-
gumine ning toitumise uurimine 3-päeva menüüde alusel. Lisaks koostati spet-
siaalne ankeet-sagedusküsimustik toitumise uurimise kohta (Food Frequency 
Questionnare, FFQ). 
Antropomeetrilisi mõõtmisi teostati vastavalt klassikalise Martini (1928) ja 
Knussmann (1988) metoodika järgi. Mõõdeti 36 antropomeetrilist näitajat: 
kehakaal, pikkus, 2 keha sügavusmõõtu, 8 keha laiusmõõtu, 13 ümbermõõtu ja 
11 nahavolti. Kõik mõõtmised teostati litsentseeritud antropometristi poolt. 
Nende mõõtmiste alusel arvutati indeksid ja kehakoostise näitajad: keharasva-
mass (kg; %), kehamassiindeks (BMI, kg/m2), kehapindala (m2), kehatihedus 
(g/cm3), Siri indeks (%), keskmine nahavoldi paksus (mm), nahaaluse rasvkoe 
mass (kg), suhteline rasvkoe mass kehakaalu suhtes. Kehakoostise tähtsamad 
komponendid on kehatihedus (Db) ja keharasvamass (FM), mida arvutati kahe 
regressioni võrrandi (Jack H. Wilmore ja Albert R. Behnke, Durnin ja Raha-
man) alusel.  
Densitomeetriline uuring teostati uuringu teisel visiidil. Osteopeenia ja 
osteoporoosi hindamiseks teostati regionaalne luutiheduse mõõtmine lülisamba 
lumbaalpiirkonnas. Mõõtmised teostati aparaadil GE LUNAR DPX-IQ densito-
meeter (Madison, WI, US, software version 4.7e) sertifitseeritud tehniku poolt. 
Laboratoorsed andmed koguti peale neeru siirdamist uuringu esimesel ja 
teisel visiidil. Vereseerumis määrati 18 olulist laboratoorset parameetrit, seal-
hulgas verelipiidide, parathormooni, homotsüsteiini ja tsüstatiin C tase.  
Toitumise uurimine viidi läbi kasutades kahte meetodit: esimene meetod 
käsitles ühekordset ankeet-sagedusküsimustikku (FFQ), mida uuritav täitis 
ainult uuringu esimesel visiidil. Teine meetod käsitles 3-päeva menüüde kogu-
mist mõlemal visiidil. Individuaalset toitumisalast nõustamist alustati kohe 
peale ankeet-küsitluslehe täitmist ja 3-päeva menüüde analüüsimist. Kroonilise 
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neeruhaige toitumisalase nõustamise aluseks on antropomeetrilised ja keha-
koostise näitajad ning laboratoorsed testid. Lisaks eelnevale arvestati ka haige 
toitumisharjumusi, kuid soovituslikul toiduvalikul lähtuti Eestis kehtivast ja 
autori poolt välja töötatud haiguspuhusest dieetide nomenklatuurist.  
 
Statistiline analüüs  
Meie uuritavatel viidi läbi klassikalised antropomeetrilised mõõtmised ja 
mõõtmisandmete statistiline analüüs (statistikaprogramm SAS), mille alusel on 
toodud kirjeldava statistika näitajad antropomeetriliste tunnuste kohta (kesk-
väärtused, standardhälbed) eraldi mees- ja naispatsientidel. Korrelatsiooniana-
lüüsil uuriti seoseid antropomeetriliste ja kliinilis-laboratoorsete tunnuste ning 
toitainete kasutuse vahel, kasutades Pearsoni korrelatsiooni- analüüsi. Regres-
sioonianalüüsiga arvutati parimad prognostilised mudelid siirdatud neeruga 
patsientide toitumise hindamiseks. Erinevate uuritavate gruppide tunnuste kesk-
väärtuste hindamisel ja varasemate andmetega võrdlemiseks on kasutatud t-
testi. Lubatud statistilise vea piiriks valiti 5% (p < 0.05).  
 
 
Tulemused 
1.  Esimese uuringugrupi neeruasendusravil olnud haigete antropomeetriliste 
mõõtmiste tulemused näitasid, et uuritud dialüüsi ja neerusiirikuga haigete 
gruppide keskväärtusete näitajad olid sarnased. Neerutransplantatsiooni järg-
selt tavaliselt haigete ureemiline seisund taandub, üldseisund paraneb ja isu 
suureneb, mis omakorda avaldub kehakaalu suurenemises, kuid meie esi-
messe uuringugruppi kaasatud neerusiirikuga haigetel ei esinenud veel olu-
list kehakaalu suurenemist.  
2.  Teise uuringugrupi moodustasid neerusiirikuga haiged, kellel viidi läbi 
antropomeetrilised mõõtmised ja dietoloogi poolt toitumisalane intensiivne 
nõustamine 1,5 aastat peale neerusiirdamist (1. visiit) ja 3 aastat peale neeru-
siirdamist (2. visiit). Transplanteeritud haigete kehakoostist hinnati eraldi 
meestel ja naistel. Peale intensiivset toitumisalast nõustamist olid uuritavatel 
paljude antropomeetriliste näitajate muutused kooskõlas kehakaalu suurene-
misega. Samas, meeste kehakaalu suurenemine oli peale jälgimisaega statis-
tiliselt oluline, kuid naistel mitte. See võib olla seletatav sellega, et naised 
järgisid dietoloogi-poolseid soovitusi ja kehakaalu hoolsamalt võrreldes 
meestega.  
3.  Intensiivse toitumisalase nõustamise järgselt kliinilisest aspektist lähtudes, 
esinesid  olulised biokeemiliste näitajate muutused, põletikulise staatuse 
(CRV) normaliseerumine ja lipiidide taseme normi piirides püsimine nii 
meestel kui naistel. 
4.  Antropomeetriliste ja biokeemiliste näitajate vahelised seosed olid meestel ja 
naistel erinevad. Meestel esinesid antropomeetriliste mõõtmiste seosed põle-
tikunäitajatega ja naistel lipiididega. Vaatamata intensiivsele toitumisalasele 
nõustamisele jäid need seosed püsima ka korduval mõõtmisel (3 aastat peale 
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neerusiirdamist). Need seosed väärivad tähelepanu, sest põletikuline staatus 
ja hüperlipideemia on üldtuntud kardiovaskulaarsed riskitegurid. On teada, 
et lõpp-staadiumi neerupuudulikkuse haigetel, sealhulgas neerutransplantat-
siooni järgselt, on peamised surmapõhjused neeruhaigetel just kardiovasku-
laarsed tüsistused.  
5.  Antropomeetriliste näitajate usaldusväärseid seoseid mikro- ja makrotoit-
ainete kasutusega 3-päeva menüüde andmete alusel ei esinenud. Järelikult 
nimetatud seosed ei oma kliinilist tähtsust. 
6.  Intensiivse toitumisalase nõustamise efektiivsus avaldus ka kaugtulemusi 
uurides: 10 aastat peale neerusiirdamist ei esinenud statistiliselt usaldus-
väärset kehakaalu suurenemist nõustamist saanud transplanteeritud meeste 
ega naiste seas erinevalt neerusiirikuga kontrollhaigetest.  
7.  Peamiste toitainete kasutamisel leidsime valkude ja süsivesikute tarbimise 
suurenemist jälgimisperioodi ajal naistel, kuid mitte meestel ning rasvade 
kasutus jäi normi piiresse nii naistel kui meestel. Nii naiste kui ka meeste 
osas on nende makro- ja mikrotoitainete kasutamine kooskõlas Eesti 
toitumis- ja toidusoovitustega. Järelikult, intensiivne toitumisalane nõusta-
mine oli efektiivne, patsientide toitumisharjumused paranesid niivõrd, et 
kehakaal ei suurenenud, kuigi mõnede toitainete osas esines suurenenud 
tarbimise tendents, ei ületanud nende tarbimine kaasaegsete Eesti vabariigi 
toitumissoovituste referentsväärtusi. 
 
Kehakaalu suurenemine leiab aset neerusiirdamise järgsetel esimestel aastatel 
ning seetõttu on oluline õigeaegne ja asjakohane patsientide teavitamine ning 
antropomeetriliste mõõtmiste regulaarne läbiviimine. Kliinilises tavapraktikas 
teeb seda patsiendi raviarst ja dietoloog annab oma soovitused vajadusel neeru-
siirdamise järgselt haiglast lahkudes. Edaspidine dietoloogi-poolne monitoori-
mine ei tarvitse alati olla enam järjepidev kuna haigete üldseisund paraneb ja 
nad külastavad neerukeskust harvem. Transplanteeritud patsientide toitumis-
alane nõustamine peab olema individuaalne ja regulaarne, mis eeldab kõikide 
kliiniliselt oluliste andmete järjepidevat kogumist ja analüüsimist dünaamikas. 
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